<SEC-DOCUMENT>0001178913-16-006243.txt : 20160815
<SEC-HEADER>0001178913-16-006243.hdr.sgml : 20160815
<ACCEPTANCE-DATETIME>20160815172647
ACCESSION NUMBER:		0001178913-16-006243
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		41
CONFORMED PERIOD OF REPORT:	20160630
FILED AS OF DATE:		20160815
DATE AS OF CHANGE:		20160815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Integrity Applications, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54785
		FILM NUMBER:		161834085

	BUSINESS ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zk1618882.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
<head>
    <title>zk1618882.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.2.0-->
    <!--Copyright 1995 - 2015 Summit Financial Printing. All rights reserved.-->
</head>
<body bgcolor="#ffffff" text="#000000" style="DISPLAY: inline; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto" align="center">
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 22.2pt"><font style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 14pt; FONT-WEIGHT: bold">UNITED STATES</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br>
</font><font style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 14pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br>
</font>Washington, D.C. 20549</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif; MARGIN-RIGHT: 22.2pt">FORM 10-Q</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" id="z40b947ca108a4f8694d96ea3e976d9c6" style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td colspan="2" style="WIDTH: 9.26%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(Mark One)</div>
</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">&#160;</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">&#9746;</div>
</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">For the quarterly period ended <font style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">June 30, 2016</font></div>
</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">&#160;</td>
</tr><tr style="HEIGHT: 15px;">
<td colspan="3" style="TEXT-ALIGN: center; WIDTH: 6.22%; VERTICAL-ALIGN: top">or</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">&#160;</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">&#9744;</div>
</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">For the transition period from ________________ to ________________</div>
</td>
</tr><tr>
<td style="WIDTH: 6.22%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 90.74%; VERTICAL-ALIGN: top">&#160;</td>
</tr></table>

<div style="LINE-HEIGHT: 1.25">Commission File Number:&#160; 000-54785</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 16pt/1.25 'Times New Roman', Times, serif; MARGIN-RIGHT: 22.2pt; TEXT-DECORATION: underline">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">(Exact name of registrant as specified in its charter)</div>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<table cellpadding="0" cellspacing="0" id="zeef2ba0ff0424f0a94d0c1215f63ddbc" style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 45.62%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">Delaware</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 7.88%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 46.5%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">98-0668934</div>
</td>
</tr><tr>
<td style="WIDTH: 45.62%; VERTICAL-ALIGN: top; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation or organization)</div>
</td>
<td style="WIDTH: 7.88%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 46.5%; VERTICAL-ALIGN: top; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</div>
</td>
</tr><tr>
<td style="WIDTH: 45.62%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 7.88%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 46.5%; VERTICAL-ALIGN: top">&#160;</td>
</tr><tr>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 45.62%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">19 Ha'Yahalomim Street</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">P.O. Box 12163</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">Ashdod, Israel</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 7.88%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 46.5%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">L3 7760049</div>
</td>
</tr><tr>
<td style="WIDTH: 45.62%; VERTICAL-ALIGN: top; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">(Address of principal executive offices)</div>
</td>
<td style="WIDTH: 7.88%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 46.5%; VERTICAL-ALIGN: top; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">(Zip Code)</div>
</td>
</tr></table>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 72pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 72pt">972 (8) 675-7878

<hr style="TEXT-ALIGN: center; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; MARGIN-RIGHT: auto" align="center" noshade>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">(Registrant&#8217;s telephone number, including area code)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 72pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 72pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 72pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 72pt">N/A

<hr style="TEXT-ALIGN: center; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; MARGIN-RIGHT: auto" align="center" noshade>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.2pt">(Former name, former address and former fiscal year, if changed since last report)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160; </div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yes&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9744;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160; </div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yes&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9744;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company.&#160; See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table border="0" cellpadding="0" cellspacing="0" id="za2d9be6ded5b4fbb90a340c514c431b6" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr style="HEIGHT: 12px;">
<td style="WIDTH: 16.25%">
<div>&#160;</div>
</td>
<td style="WIDTH: 46.53%">
<div>Large accelerated filer&#160;&#9744;</div>
</td>
<td style="WIDTH: 1.12%">
<div>&#160;</div>
</td>
<td style="WIDTH: 35.86%">Accelerated filer&#160;&#9744;</td>
</tr><tr>
<td style="WIDTH: 16.25%">
<div>&#160;</div>
</td>
<td style="WIDTH: 46.53%">Non-accelerated filer&#160;&#9744; (Do not check if a smaller reporting company)</td>
<td style="WIDTH: 1.12%">
<div>&#160;</div>
</td>
<td style="WIDTH: 35.86%">Smaller reporting company &#9746;</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yes&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9746;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.3pt">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; MARGIN-RIGHT: 22.3pt">As of August 15, 2016, 5,805,560<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font>shares of the Company&#8217;s common stock, par value $0.001 per share, were outstanding.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TABLE OF CONTENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif; TEXT-DECORATION: underline">Page</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table border="0" cellpadding="3" cellspacing="0" id="z1ef8743572bf46d5bd9271bbb2bc3a8a" style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; BORDER-TOP: medium none; BORDER-RIGHT: medium none; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr style="HEIGHT: 16px;">
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div><a href="#a3">PART I - FINANCIAL INFORMATION</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>3</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 21.6pt"><a href="#a3">Item 1.&#160;Financial Statements.</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>3</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="MARGIN-LEFT: 36pt"><a href="#a3">Condensed Consolidated Balance Sheets</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>3</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="MARGIN-LEFT: 36pt"><a href="#a4">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>4</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="MARGIN-LEFT: 36pt"><a href="#a5">Condensed Consolidated Statements of Changes in Stockholders&#8217; Deficit</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>5</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="MARGIN-LEFT: 36pt"><a href="#a6">Condensed Consolidated Statements of Cash Flows</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>6</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="MARGIN-LEFT: 36pt"><a href="#a8">Notes to Condensed Consolidated Financial Statements</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>8</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 21.6pt"><a href="#a22">Item 2.&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>22</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 21.6pt"><a href="#a32">Item 3.&#160;Quantitative and Qualitative Disclosures About Market Risk.</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>32</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 21.6pt"><a href="#a32">Item 4.&#160;Controls and Procedures.</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>32</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div><a href="#a33">PART II - OTHER INFORMATION</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: right">33</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 21.6pt"><a href="#a33">Item 6.&#160;Exhibits.</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div>33</div>
</td>
</tr><tr>
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div><a href="#a34">SIGNATURES</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: right">34</div>
</td>
</tr><tr style="HEIGHT: 12px;">
<td style="BORDER-BOTTOM: 4px; BORDER-LEFT: medium none; WIDTH: 91%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div><a href="#a35">EXHIBIT INDEX</a></div>
</td>
<td style="BORDER-BOTTOM: 4px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 9.08%; FONT-FAMILY: 'times new roman', times, serif; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: right">35</div>
</td>
</tr></table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY A<a name="a3">PP</a>LICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PART I - FINANCIAL INFORMATION</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1. Financial Statements.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED BALANCE SHEETS</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>
</div>
</div>
</div>

<table cellpadding="0" cellspacing="0" id="z3572888d0cb04d96b609eb4881cbf2e6" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars (except share data)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A S S E T S</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Assets</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" bgcolor="#ffffff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" bgcolor="#ffffff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 11.35pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Cash and cash equivalents</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,405,534</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">608,701</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 11.35pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Accounts receivable, net</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">69,664</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">18,446</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 11.35pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Inventories</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">698,170</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">816,223</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 11.35pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Other current assets</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">123,465</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">268,792</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total current assets</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,296,833</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,712,162</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Property and Equipment, Net</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">242,142</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">220,463</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr style="HEIGHT: 18px;">
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-Term Restricted Cash</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">35,664</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">35,152</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Funds in Respect of Employee Rights Upon Retirement</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">167,287</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">164,883</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total assets</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,741,926</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,132,660</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; DEFICIT</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -68.05pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Liabilities</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt">Accounts payable</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">466,165</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,082,546</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt">Other current liabilities</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">572,930</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">427,886</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total current liabilities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,039,095</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,510,432</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -68.05pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-Term Liabilities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt">Long-Term Loans from Stockholders</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">161,992</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">160,314</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt">Liability for Employee Rights Upon Retirement</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">176,673</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">174,137</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt">Warrants with down-round protection</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">833,153</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">321,695</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total long-term liabilities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,171,818</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">656,146</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total liabilities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,210,913</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,166,578</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -68.05pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commitments and Contingent Liabilities</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -68.05pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Temporary Equity</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -68.05pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Convertible Preferred Stock of $&#160;0.001 par value ("Preferred Stock"):</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">10,000,000 shares of Preferred Stock authorized as of June 30, 2016 and December 31, 2015</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">376 shares of Series A Preferred Stock issued and outstanding as of June&#160;30, 2016 and December&#160;31, 2015</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">221,152</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">221,152</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">15,031 shares of Series B Preferred Stock issued and outstanding as of June&#160;30, 2016 and December&#160;31, 2015</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">6,715,844</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">6,715,844</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">4,425 and 0 shares of Series C Preferred Stock issued and outstanding as of June&#160;30, 2016 and December&#160;31, 2015, respectively</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,351,816</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total temporary equity</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">9,288,812</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">6,936,996</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stockholders' Deficit</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock of $&#160;0.001 par value ("Common Stock"):</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">40,000,000 shares authorized as of June&#160;30, 2016 and December&#160;31, 2015; 5,805,560 and 5,690,097 shares issued and outstanding as of June&#160;30, 2016 and December&#160;31, 2015, respectively</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,807</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,691</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Additional paid in capital</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">23,652,451</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">22,309,742</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Accumulated other comprehensive income</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">60,129</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">90,168</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Accumulated deficit</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(32,476,186</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(29,376,515</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 22.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total stockholders' deficit</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(8,757,799</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(6,970,914</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total liabilities, temporary equity and stockholders&#8217; deficit</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,741,926</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,132,660</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><br>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

<br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 3 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLIC<a name="a4">AT</a>IONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" id="z99adffd9df564a59902a1e8dd8d8ac41" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="14" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars (except share data)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three month period </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Revenues</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">470,878</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">143,167</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">381,731</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">67,342</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Research and development expenses</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,531,396</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,036,305</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">880,696</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">557,980</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.5pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.5pt; FONT-SIZE: 10pt">Selling, marketing and general and administrative expenses</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,787,309</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,083,762</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,084,465</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">605,565</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Total operating expenses</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">3,318,705</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,120,067</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,965,161</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,163,545</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Operating loss</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,847,827</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,976,900</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,583,430</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,096,203</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 14.2pt; FONT-SIZE: 10pt">Financing (income) expenses, net</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(32,065</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,224,437</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,568</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">570,603</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 36.9pt; FONT-SIZE: 10pt">Loss for the period</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,815,762</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">3,201,337</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,588,998</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,666,806</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other comprehensive (income) loss:</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 14.2pt; FONT-SIZE: 10pt">Foreign currency translation adjustment</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">30,039</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(55,720</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">8,063</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(97,383</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 14.2pt; FONT-SIZE: 10pt">Comprehensive loss for the period</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,845,801</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">3,145,617</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,597,061</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,569,423</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Loss per share (Basic)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.54</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.64</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.30</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.33</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Loss per share (Diluted)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.54</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.64</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.30</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(0.33</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common shares used in computing Basic income (loss) per share</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,716,566</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,382,682</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,742,468</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,441,253</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common shares used in computing Diluted income (loss) per share</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,716,566</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,382,682</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,742,468</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,441,253</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br>
</div>

<table cellpadding="0" cellspacing="0" id="zfc194e9985a34153b5fdbbfa9ca0d69e" style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of these condensed consolidated financial statements.</div>
</td>
</tr></table>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 4 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY AP<a name="a5">PL</a>ICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT</div>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<table cellpadding="0" cellspacing="0" id="zfd32e7f4aec5466ca090c313a201710c" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="22" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars (except share data)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="22" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" style="TEXT-ALIGN: center; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">other&#160;</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>of shares</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Additional paid in capital</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">comprehensive </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">income</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated deficit</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stockholders&#8217; </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">deficit</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of January 1, 2016</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,690,097</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,691</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">22,309,742</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">90,168</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(29,376,515</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(6,970,914</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Loss for the period of six months</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(2,815,762</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(2,815,762</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Other comprehensive loss</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(30,039</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(30,039</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Amounts allocated to Series C-1 and Series C-2 Warrants, net</div>
</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,164,657</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,164,657</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Amount classified out of stockholders </div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">&#160;&#160;&#160; deficit and presented as Warrants </div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">&#160;&#160;&#160; with Down-Round Protection within </div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160; long-term liabilities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(341,662</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(341,662</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Incremental fair market value adjustments of modified warrants issued to placement agent</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">211,077</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">211,077</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">8,563</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">9</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">20,346</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(20,355</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">106,900</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">107</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">253,994</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(254,101</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(9,453</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(9,453</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Stock-based compensation</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">34,297</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">34,297</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 28%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of June 30, 2016</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,805,560</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,807</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">23,652,451</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">60,129</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(32,476,186</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(8,757,799</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr></table>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 5 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGR<a name="a6">IT</a>Y APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</div>

<br>
</div>

<table cellpadding="0" cellspacing="0" id="zcce9af4d82364704aceb59af313af2e7" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six month period ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 5.65pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash flows from operating activities:</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" bgcolor="#cceeff" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Loss for the period</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(2,815,762</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(3,201,337</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Adjustments to reconcile income (loss) for the period to net cash used in operating activities:</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Depreciation</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">27,980</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">18,359</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Stock-based compensation</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">34,297</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">12,147</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Incremental fair market value adjustments of modified warrants issued to placement agent</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">211,077</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Change in the fair value of Warrants with down-round protection</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(64,212</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(91,309</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Linkage difference on principal of loans from stockholders</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(639</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,872</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,270,971</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in assets and liabilities:</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Increase in accounts receivable</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(51,053</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(3,149</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Decrease (increase) in inventory</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">130,203</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(51,036</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Decrease (increase) in other current assets</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">147,697</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(17,474</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">(Decrease) increase in accounts payable</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(638,908</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">145,388</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Increase in other current liabilities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">132,153</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">83,030</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 17pt; FONT-SIZE: 10pt">Net cash used in operating activities</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(2,887,167</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,836,282</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 5.65pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash flows from investing activities:</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Increase in funds in respect of employee rights upon retirement</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(24,279</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Purchase of property and equipment</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(46,397</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(18,892</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 17pt; FONT-SIZE: 10pt">Net cash used in investing activities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(46,397</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(43,171</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 5.65pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash flows from financing activities</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(4,753</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(47,036</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,508,321</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Proceeds allocated to Series C Warrants, net of cash issuance expenses</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,242,158</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Repayment of loan from stockholders</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(439,939</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 17pt; FONT-SIZE: 10pt">Net cash provided by (used in) financing activities</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">3,745,726</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(486,975</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.3pt; FONT-SIZE: 10pt">Effect of exchange rate changes on cash and cash equivalents</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(15,329</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">54,941</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 5.65pt; FONT-SIZE: 10pt">Increase (decrease) in cash and cash equivalents</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">796,833</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(2,311,487</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 5.65pt; FONT-SIZE: 10pt">Cash and cash equivalents at beginning of the period</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">608,701</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,827,560</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -5.65pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 17pt; FONT-SIZE: 10pt">Cash and cash equivalents at end of the period</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,405,534</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">3,516,073</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

<br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 6 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (cont.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplementary information on financing activities not involving cash flows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">$234,008, representing the fair value of warrants issued as consideration for placement agent services, was accounted for as Warrants with Down-Round Protection within long-term liabilities. Of these direct&#160; issuance expenses, $77,503 was allocated to the Series C-1 and Series C-2 Warrants and was recorded as a reduction of additional paid in capital, and $156,505 was allocated to the Series C Preferred Stock and recorded as a reduction of temporary equity.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">$341,662, representing the amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection within long-term liabilities (See Note 2B and Note 3).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">$254,101 and&#160; $20,355 representing the fair value of the shares of Common Stock issued to owners of Series B Preferred Stock and owners of Series C Preferred Stock, respectively, was accounted for as a stock dividend in the statement of changes in stockholders&#8217; deficit and was charged to accumulated deficit against additional paid in capital and Common Stock therein.</div>

<div style="LINE-HEIGHT: 1.25"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

<br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 7 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY A<a name="a8">PP</a>LICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zac9e7fed437b4ca5a14379154f4125d7" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">
<div>GENERAL</div>

<div>&#160;</div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z8f13af64574b4e6b9a4cd5f856956603" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.05pt">&#160;</td>
<td style="WIDTH: 21.95pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">A.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: normal">Integrity Applications, Inc. (the "Company") was incorporated on May&#160;18, 2010 under the laws of the State of Delaware.&#160; On July&#160;15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: "Integrity Acquisition"), a wholly owned Israeli subsidiary of the Company, which was established on May&#160;23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: "Integrity Israel"), an Israeli corporation that was previously held by the stockholders of the Company.&#160; Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger. Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.&#160; As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.&#160; Integrity Israel was incorporated in 2001 and commenced its operations in 2002.&#160; Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes.</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z817149da75b64388a90a3bd9a7810c6d" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.05pt">&#160;</td>
<td style="WIDTH: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">B.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Going concern uncertainty</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 89.85pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.&#160; The development and commercialization of Integrity Israel's product is expected to require substantial expenditures.&#160; Integrity Israel and the Company (collectively, the "Group") have not yet generated any material revenues from operations, and therefore they are dependent upon external sources for financing their operations. As of June 30, 2016, the Group has incurred an accumulated deficit of $32,476,186, stockholders&#8217; deficit of $8,757,799 and negative operating cash flows.&#160; These factors raise substantial doubt about the Group&#8217;s ability to continue as a going concern.&#160; The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&#160; During 2012, the Company raised a total amount of approximately $1.0 million (net of related expenses) from the issuance of Common Stock. During 2013, the Company raised funds in an approximate amount of $5.3 million (net of related cash expenses) from the issuance of units (the &#8220;Series A Units&#8221;) consisting of shares of the Company&#8217;s Series A Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) and detachable warrants to purchase shares of the Company&#8217;s Common Stock (the &#8220;Series A Warrants&#8221; or &#8220;Warrants with down round protection&#8221;).&#160; During the period between August and December 2014, the Company raised funds in an aggregate amount of approximately $7.3 million (net of related cash expenses) from the issuance of units (the &#8220;Series B Units&#8221;), each consisting of (a) one share of the Company&#8217;s newly designated Series B 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series B Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $5.80 per share, (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-1 Warrant&#8221;) and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-2 Warrant&#8221; and, together with the Series B-1 Warrants, collectively, the &#8220;Series B Warrants&#8221;).&#160; During the three month period ended June 30, 2016, the Company raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) through the issuance of 4,425 units (the &#8220;Series C Units&#8221;), each consisting of (a) one share of the Company&#8217;s newly designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series C Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $4.50 per share, (b) a five year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-1 Warrant&#8221;) and (c) a five year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-2 Warrant&#8221; and, together with the Series C-1 Warrants, collectively, the &#8220;Series C Warrants&#8221;), as described in further detail in Note 3.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 8 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z1617ab76bf754ea19e2fec89d06c4338" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">GENERAL</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z3b8b8cc09c3d455688dd2c53560f3e16" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.05pt">&#160;</td>
<td style="WIDTH: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">B.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Going concern uncertainty (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 89.85pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long term loans. There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations as a going concern.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z2a2e40fdebcc42a4b6016473af7e670c" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.4pt">&#160;</td>
<td style="WIDTH: 23.05pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">C.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Risk factors</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">As described in Note 1A and Note 1B above, the Group has a limited operating history and faces a number of risks and uncertainties, including risks and uncertainties regarding continuation of the development process, demand and market acceptance of the Group's products, the effects of technological changes, competition and the development of products by competitors.&#160; Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group's future results and the availability of necessary financing. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts. The Group has not yet generated material revenues from its operations to fund its activities and therefore is dependent on the receipt of additional funding from its stockholders and/ or new investors in order to continue its operations.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z736ab5cb6070415b807e730680809a16" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.4pt">&#160;</td>
<td style="WIDTH: 23.05pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">D.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Use of estimates in the preparation of financial statements</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series C Units, and (iii) the going concern assumptions.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 9 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z07b0863973134126bc8663e54822d6f0" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z115ccb1ba0cb46a78a2fda3dacc4bab8" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.4pt">&#160;</td>
<td style="WIDTH: 23.05pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">A.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Basis of presentation</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accounting Principles</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The results for the six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2016 or for any other interim period or for any future period.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Principles of Consolidation</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.8pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 10 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z06957a510bc148d0b4307622b980f398" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="ze3989ad908ac41208ab938c3981d7098" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.05pt">&#160;</td>
<td style="WIDTH: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">B.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Warrants with down-round protection</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90.7pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The Company has determined its derivative warrant liability with respect to the Series A Warrants and warrants issued to Andrew Garrett, Inc., (&#8220;AGI&#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value. Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&#160; The key inputs used in the fair value calculations were as follows:</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-LEFT: 99pt" align="right">
<table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="WIDTH: 87%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Series A Warrants</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Balance, Beginning of the period</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">321,695</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2,057,618</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Warrants issued as consideration for placement services</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">234,008</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">341,662</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Exchange of Series A Warrants pursuant to the &#8220;most favored nation&#8221; provision</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,573,435</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Change in fair value Warrants with Down-Round Protection</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(64,212</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(91,309</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Balance, End of period</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">833,153</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">392,874</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; CLEAR: both; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The key inputs used in the fair value calculations were as follows:</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-LEFT: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="WIDTH: 87%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom; BORDER-TOP: medium none">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom; BORDER-TOP: medium none">&#160;</td>
<td colspan="6" valign="bottom" style="TEXT-ALIGN: center; VERTICAL-ALIGN: top; BORDER-TOP: medium none; FONT-WEIGHT: bold">June 30,</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom; BORDER-TOP: medium none">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Dividend yield (%)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Expected volatility (%) (*)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">62.16</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">105.14</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Risk free interest rate (%)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">0.72-1.11</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1.01</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Expected term of options (years) (**)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1.70-5.00</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2.70</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Exercise price (US dollars)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">4.50-7.75</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5.80</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Share price (US dollars) (***)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2.38</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">2.31</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Fair value (US dollars)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">0.61</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1.00</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; CLEAR: both; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90.7pt">&#160;</td>
<td style="WIDTH: 28.35pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(*)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90.7pt">&#160;</td>
<td style="WIDTH: 28.35pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(**)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&#160;110.</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90pt">&#160;</td>
<td style="WIDTH: 31.5pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(***)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 11 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z935c05d52e5a4a7d916e5aa54b1ba252" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z88a8390d7f304d73a40584bf75cfbbb6" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 67.5pt">&#160;</td>
<td style="WIDTH: 22.5pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">C.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Recently issued accounting pronouncements</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z13b081dfc9b24a4cb8939f28e70127d0" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90pt">&#160;</td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">1.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standard Update 2014-16, &#8220;Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity&#8221;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Effective January 1, 2016, the Group adopted Accounting Standard Update 2014-16, Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity ("ASU 2014-16").</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The amendments in ASU 2014-16 clarify how U.S. GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. Furthermore, the amendments clarify that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. Rather, the nature of the host contract depends upon the economic characteristics and risks of the entire hybrid financial instrument. The amendments also clarify that, in evaluating the nature of a host contract, an entity should assess the substance of the relevant terms and features (i.e., the relative strength of the debt-like or equity-like terms and features given the facts and circumstances) when considering how to weigh those terms and features. The assessment of the substance of the relevant terms and features should incorporate a consideration of the characteristics of the terms and features themselves; the circumstances under which the hybrid financial instrument was issued or acquired; and the potential outcomes of the hybrid financial instrument, as well as the likelihood of those potential outcomes.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The amendments in ASU 2014-16 apply to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of shares.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The effects of initially adopting the amendments in ASU 2014-16 were required to be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of shares as of the beginning of the fiscal year for which the amendments are effective. However, retrospective application was permitted to all relevant prior periods.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Management analyzed the economic characteristics and risks of the Series A Preferred Stock and the Series B Preferred Stock (including the embedded conversion feature of each) in accordance with the provisions of ASU 2014-16 and determined that such instruments are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Preferred Stock themselves (the 'host contract') are clearly and closely related and accordingly, the embedded conversion feature was not required to be bifurcated. As a result of the above determination, ASU 2014-16 did not impact the classification of the Series A Preferred Stock or the Series B Preferred Stock.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 12 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="za96ce9f8542f4decabe10f1c7ffc9a74" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z4e813f7a8f5b4fe5912259647d3f32d8" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 67.5pt">&#160;</td>
<td style="WIDTH: 22.5pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">C.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Recently issued accounting pronouncements (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zc0777046e1cd4ad384df34848c757cac" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90pt">&#160;</td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">2.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standard Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In May 2014, the FASB issued Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09").</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">An entity should apply the amendments in ASU 2014-09 using one of the following two methods: 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">During 2016, the FASB issued several Accounting Standard Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements and Practical Expedients, Principal versus Agent Considerations and Identifying Performance Obligations and Licensing.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">For a public entity, the amendments in ASU 2014-09 (including the amendments introduced through recent ASUs) are effective for annual reporting periods beginning after December 15, 2016, including interim periods within the first annual reporting period (the first quarter of fiscal year 2017 for the Company). Early application is not permitted.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt/1.25 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt">The Company is in the process of assessing the impact, if any, of ASU 2014-09 (including the amendments introduced through recent ASUs) on its consolidated financial statements.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 13 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z6b041823e9d5438397e347eabebfdd2b" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z049fb6e487f34e728cea11efae005515" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 67.5pt">&#160;</td>
<td style="WIDTH: 22.5pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">C.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Recently issued accounting pronouncements (cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zfa76c0993e284cd2842cc0294a557143" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90pt">&#160;</td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">3.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standards Update 2014-15, &#8220;Presentation of Financial Statements&#8212;Going Concern&#8221;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In August 2014, the FASB issued Accounting Standards Update 2014-15, Presentation of Financial Statements&#8212;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern ("ASU 2014-15").</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2014-15 provides guidance on management&#8217;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued, when applicable).</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2014-15 also provides guidance related to the required disclosures as a result of management&#8217;s evaluation.&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Due to the current financial condition of the Company and the existing uncertainty regarding its ability to continue as a going concern, management does not believe that the provisions of ASU 2014-15 will have a significant effect on its evaluation of the Company&#8217;s ability to continue as a going concern. However, management is currently considering if additional disclosures will be required as a result of ASU 2014-15.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="za84a407cdd8648dbb1de41b73c3d76eb" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 90pt">&#160;</td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">4.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standard Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In July, 2015, The FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) ("ASU 2015-11").</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value. Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance. Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">For a public entity, the amendments in ASU 2015-11 are effective, in a prospective manner, for annual reporting periods beginning after December 15, 2016, including interim periods within the first such annual reporting period (the first quarter of fiscal year 2017 for the Company). Early adoption is permitted as of the beginning of an interim or annual reporting period.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 108pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The Company is in the process of assessing the impact, if any, of ASU 2015-11 on its consolidated financial statements.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 14 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<font style="FONT-WEIGHT: normal"><br>
</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z1bdc38f81db948ff938740db651f898c" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">RECENT EVENTS</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zd9c63d5100a34070a7439b42b0a5d440" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 67.5pt">&#160;</td>
<td style="WIDTH: 22.5pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">A.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During February 2016, the Company entered into an Advisory Agreement with AGI, pursuant to which the Company retained AGI on a non-exclusive basis to provide certain advisory services to the Company. As consideration for such services, the Company extended through December 31, 2019, the expiration date of 422,077 warrants issued to AGI and/or its designees in connection with the Company&#8217;s common stock offering completed in 2010 and the Series A Unit offering completed in 2012. The Advisory Agreement had an initial term of six months, subject to automatic renewal for additional 30 day terms unless terminated by either party with 30 days written notice.&#160;&#160;In April 2016, the Company and AGI amended that Advisory Agreement to extend the term of the Advisory Agreement for an additional six months.&#160;&#160;In consideration for such extension, the Company agreed to modify the terms of the 439,674 warrants issued to AGI and/or its designees in connection with the Series B Unit offering to include full-ratchet anti-dilution protection. As a result of the two agreements the Company recorded in its statement of operations for the six month and three month periods ended June 30, 2016, a one-time charge in the amount of $211,077 representing the incremental fair market value adjustments in respect of the above modified warrants issued to the placement agent. Such incremental fair market value adjustments represent the increase in the fair value of the warrants resulting from the above modifications and were recorded against stockholders&#8217; deficit. In addition, as a result of the inclusion of anti-dilution protection, the Company classified $341,662, representing the fair market value at April 2016 of the above 439,674 warrants issued to AGI out of stockholders deficit and presented them as Warrants with down round protection within long-term liabilities.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z2aee9f8d279b435ab28e691f17484b57" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 67.5pt">&#160;</td>
<td style="WIDTH: 22.5pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">B.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During the three month period ended June 30, 2016, the Company raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) from the issuance in four separate closings of 4,425 Series C Units. As of June 30, 2016, the shares of Preferred Stock comprising the Series C Units are convertible into an aggregate of 983,386 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 1,966,772 shares of Common Stock, in each case subject to adjustment as described below.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Pursuant to a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with AGI, at the initial closing of the sale of the Series C Units the Company paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units. At the end of the second, third and fourth closings of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing. In addition, pursuant to the Placement Agent Agreement, the Company is required to issue to AGI: (a) 5 year warrants to purchase up to 196,678 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 98,339 shares of Common Stock at an exercise price of $7.75 per share. The terms of such warrants will be substantially similar to the Series C Warrants except that the warrants issued to AGI will also be exercisable on a cashless basis and will include full ratchet anti-dilution protection.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 15 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zfbd7aaa3e0a1467baf00756bc6d9bde8" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">RECENT EVENTS (Cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Subject to certain ownership limitations described below, the Series C Preferred Stock is convertible at the option of the holder at any time and from time to time into shares of Common Stock at a conversion price of $4.50 per share (calculated by dividing the stated value per share of Preferred Stock, which is initially $1,000, by the conversion price per share). The conversion price of the Series C Preferred Stock is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect, as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders. In addition, the holders of Preferred Stock will be entitled to receive any securities or rights to acquire securities or property granted or issued by the Company pro rata to the holders of Common Stock to the same extent as if such holders had converted all of their shares of Series C Preferred Stock prior to such distribution. In the event of a fundamental transaction, such as a merger, consolidation, sale of substantially all assets and similar reorganizations or recapitalizations of the Company, the holders of Series C Preferred Stock will be entitled to receive, upon conversion of their shares of Series C Preferred Stock, any securities or other consideration received by the holders of the Common Stock pursuant to the fundamental transaction.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Holders of Series C Preferred Stock are entitled to receive cumulative dividends at a rate of 5.5% per annum, based on the stated value per share of Series C Preferred Stock. Dividends on the Series C Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on June 30, 2016, and on each conversion date (with respect to the shares of Preferred Stock being converted). For so long as required under the terms of the Certificate of Designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, dividends will be payable only in shares of Common Stock. Thereafter, dividends on the Series C Preferred Stock will be payable, at the option of the Company, in cash and/or, if certain conditions are satisfied, shares of Common Stock or a combination of both. Shares of Common Stock issued as payment of dividends will be valued at the lower of (a) the then current conversion price of the Series C Preferred Stock or (b) the average of the volume weighted average price for the Common Stock on the principal trading market therefor for the 10 trading days immediately prior to the applicable dividend payment date. The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Subject to any limitations under the terms of the Certificate of Designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, the Company may become obligated to redeem the Series C Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Series C Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service. In addition, upon the occurrence of certain triggering events, each holder of Series C Preferred Stock will have the option to require the Company to redeem such holder&#8217;s shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder&#8217;s outstanding Series C Preferred Stock.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 16 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<font style="FONT-WEIGHT: normal"><br>
</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z2c47d028aa93416d9010d793cb3db90e" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">RECENT EVENTS (Cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Subject to certain conditions contained in the Certificate of Designations, Preferences and Rights relating to the Series C Preferred Stock (the &#8220;Certificate of Designations&#8221;), the Company will have the option to force the conversion of the Series C Preferred Stock (in whole or in part) if (a) the volume weighted average price for the Common Stock on its principal trading market exceeds $7.00 for each of any 20 trading days during any 30 consecutive trading day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $50,000 or (b) the Company receives approval to list the Common Stock on a national securities exchange.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Subject to certain exceptions contained in the Certificate of Designations, if the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Series C Preferred Stock (the &#8220;Conversion Shares&#8221;) and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a &#8220;Buy-In&#8221;), the Company will be required to: (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder&#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Series C Preferred Stock equal to the number of shares of Series C Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements. In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Series C Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the fifth trading day following the applicable conversion date and the Company will continue to pay such partial liquidated damages for each trading day after such eighth trading day until such certificates are delivered or the holder rescinds such conversion.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">As long as at least 35% of the originally issued shares of Series C Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Series C Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Subject to the beneficial ownership limitation described below, holders of Series C Preferred Stock will vote together with the holders of Common Stock and Series A Preferred Stock and Series B Preferred Stock on an as-converted basis. Holders will not be permitted to convert their Series C Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding Common Stock (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the &#8220;Beneficial Ownership Limitation&#8221;). In addition, no holder may vote any shares of Series C Preferred Stock (on an as-converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 17 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<font style="FONT-WEIGHT: normal"><br>
</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z0612dc0c4eb84740ae813edfc7226cee" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">RECENT EVENTS (Cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Subject to certain limitations, so long as any purchaser holds any shares of Series C Preferred Stock, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series C Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser after taking into account all of the terms and conditions of the terms granted to the purchasers under the purchase agreement and the terms granted in such subsequent issuance or sale, including all of the components of the Series C Units and of the securities or units involved in such subsequent issuance or sale, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The Series C Warrants have a five-year term commencing on their respective issuance dates. Until the end of the applicable term, each Series C Warrant will be exercisable at any time and from time to time at an exercise price of $4.50 per share (with respect to the Series C-1 Warrants) or $7.75 per share (with respect to the Series C-2 Warrants). The Series C Warrants contain adjustment provisions substantially similar to those to the adjustment provisions of the Series C Preferred Stock as described above, except that the Series C Warrants do not include dilution protection for issuances of securities at an effective price per share lower than the conversion price of such Series C Warrants. In addition, the Series C Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Series C Preferred Stock. No holder may exercise its Series C Warrants in excess of the Beneficial Ownership Limitation.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">As a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the Series A Warrants, on April 8, 2016, the exercise price per share of the Series A Warrants decreased from $5.80 per share to $4.50 per share and the number of shares of Common Stock issuable upon exercise of each of the Series A Warrants, in the aggregate, increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, will be equal to the aggregate exercise price prior to such adjustment. Also as a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the certificates of designations for the Series A Preferred Stock and Series B Preferred Stock, on April 8, 2016, the conversion price per share of Series A Preferred Stock and Series B Preferred Stock decreased to $4.50 per share.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Based on the terms of the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, respectively, so long as any initial purchaser of Series A Units or Series B Units, as applicable (each, a &#8220;Purchaser&#8221;) holds any shares of Series A Preferred Stock or Series B Preferred Stock, as applicable, if (1) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (2) a Purchaser then holding Series A or Series B Preferred Stock or Warrants reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such Purchaser, then the Purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such Purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such Purchaser).</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 18 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z20ec128049b04b23a618bd2b9017f092" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">RECENT EVENTS (Cont.)</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Pursuant to the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, the Company was required to and did notify the holders of the Series A Preferred Stock and Series B Preferred Stock of the closing of the sale of the Series C Units,<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font>and following receipt thereof such holders of Series A Preferred Stock and Series B Preferred Stock will be entitled, pursuant to the &#8220;most favored nation&#8221; provisions contained in their respective purchase agreements (as described above), to elect to amend the terms of their purchase of Series A Units and Series B Units, respectively, to match the terms of the Series C Units. The Company is obligated to amend the terms of any of Series A Units or Series B Units who timely makes such election and tenders its Series A Units or Series B Units for exchange.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Upon initial recognition, the Series C Preferred Stock issued together with detachable Series C Warrants (classified as equity) were measured based on the relative fair value basis and were presented net of the direct issuance expenses that were allocated to them.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The Company has determined that due to the economic characteristics and risks of the Series C Preferred Stock, based on their stated or implied substantive terms and features, that such Preferred Stock, are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Series C Preferred Stock themselves (the 'host contract') are clearly and closely related. As a result, the embedded conversion feature was not required to be bifurcated.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 90pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Since at the issuance dates of the Series C Preferred Stock, the exercise price of the conversion feature (based on the effective conversion rate of the Series C Preferred Stock into Common Stock) was higher than the estimated fair value of the Company&#8217;s Common Stock, it was determined that the conversion feature was not beneficial. Also, due to the liquidation preference and certain redemption rights for the benefit of the holders of the Series C Preferred Stock, upon the occurrence of the certain contingent events, which are not considered as solely within the Company's control management determined that the Series C Preferred Stock were to be presented as temporary equity. On each balance sheet date, the Company&#8217;s management assesses the probability of redemption of the outstanding Preferred Stock. In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will recognize a liability in an amount equal to the aggregate redemption price of the Preferred Stock. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and such redemption amount will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 19 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z667aec4ed65d4d59b71405d09c73f460" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 4</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">INVENTORIES</td>
</tr></table>
</div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table align="right" border="0" cellpadding="0" cellspacing="0" id="z8cb6486e075b498aac1b5e8275a81486" style="WIDTH: 90%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="7" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="3" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Raw materials</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">181,461</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">205,645</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Work in process</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">412,000</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">551,111</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 76%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Finished products</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">104,709</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">59,467</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 76%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">698,170</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">816,223</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; CLEAR: both; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table cellpadding="0" cellspacing="0" id="zc405bc12abec4b92a6608532bd1aa16b" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 5</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">FINANCING (INCOME) EXPENSES, NET</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table align="right" border="0" cellpadding="0" cellspacing="0" id="z542e75c8ecc8434fa56490440a0600ba" style="WIDTH: 90%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Israeli CPI linkage difference on principal of loans from stockholders</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(639</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,872</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">825</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,808</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Exchange rate differences</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">24,211</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">38,269</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">19,296</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">90,872</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Change in fair value of Warrants with down round protection</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(64,212</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(91,309</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(20,702</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(25,539</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Interest expenses on credit from banks and other</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">8,575</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">8,378</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">6,149</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,788</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</div>
</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,270,971</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#cceeff" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">497,674</div>
</td>
<td nowrap valign="bottom" bgcolor="#cceeff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(32,065</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">1,224,437</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,568</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">570,603</div>
</td>
<td nowrap valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; CLEAR: both; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 20 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><font style="FONT-WEIGHT: bold">INTEGRITY APPLICATIONS, INC.</font><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (cont.)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table cellpadding="0" cellspacing="0" id="zcbfb569f9c784ed1b372de2f5b423c7b" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 53.85pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 6</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 53.85pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="WIDTH: 14.2pt; VERTICAL-ALIGN: top; ALIGN: right"><font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="WIDTH: 14.2pt; DISPLAY: inline-block; FONT-SIZE: 1px">&#160;</font></td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">LOSS PER SHARE</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In periods of net loss, basic loss per share is computed by dividing net loss for the period after consideration of the effect of dividend on preferred stock by the weighted average number of shares outstanding during the period.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 68.05pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2016 and 2015 are as follows:</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 81pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold" align="right">
<table border="0" cellpadding="0" cellspacing="0" id="z8103e4dce42a4f74a97915ac79ef5c44" style="WIDTH: 90%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US dollars</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Loss for the period</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(2,815,762</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(3,201,337</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,588,998</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,666,806</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(9,453</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(47,036</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(4,753</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(26,522</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(254,101</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(185,795</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(131,281</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(102,558</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="PADDING-BOTTOM: 2px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(20,355</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(20,355</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Loss for the period attributable to common stockholders</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(3,099,671</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(3,434,168</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,745,387</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(1,795,886</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">)</div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; CLEAR: both; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 81pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table border="0" cellpadding="0" cellspacing="0" id="z4f0175498f8045bbb3d0acd515972615" style="WIDTH: 90%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of shares</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of shares</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="6" valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three month period<font style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt"><br>
</font>ended June 30,</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of shares:</div>
</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td colspan="2" valign="bottom" style="VERTICAL-ALIGN: bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Common shares used in computing basic income (loss) per share</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,716,566</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,382,682</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,742,468</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,441,253</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Common shares used in computing diluted income (loss) per share</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,716,566</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,382,682</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,742,468</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">5,441,253</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 52%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt; FONT-FAMILY: 'times new roman', times, serif; MARGIN-LEFT: 11.35pt; FONT-SIZE: 10pt">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">11,220,345</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">9,367,247</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">12,210,613</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">9,537,309</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; WIDTH: 1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; CLEAR: both; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table cellpadding="0" cellspacing="0" id="ze9b77d1c22564edfb3e70983c6c06269" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 68.05pt">&#160;</td>
<td style="WIDTH: 22.7pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">&#160;(*)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 21 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2.&#160;&#160;</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Management&#8217;s Discussion and Analysis of Financial <a name="a22">Co</a>ndition and Results of Operations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cautionary Note Regarding Forward-Looking Statements</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">This Quarterly Report on Form 10-Q contains forward-looking statements. These forward looking statements include statements about our expectations, beliefs or intentions regarding our product development efforts, business, financial condition, results of operations, strategies or prospects. All statements other than statements of historical fact included in this Quarterly Report on Form 10-Q, including statements regarding our future activities, events or developments, including such things as future</font><font style="FONT-STYLE: italic; DISPLAY: inline"> capital raising and financing</font>,<font style="FONT-STYLE: italic; DISPLAY: inline"> revenues, product development, market acceptance, responses from competitors, capital expenditures (including the amount and nature thereof), business strategy and measures to implement strategy, competitive strengths, goals, expansion and growth of our business and operations, plans, references to future success, projected performance and trends, and other such matters, are forward-looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and other similar words and phrases, are intended to identify forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q are based on certain historical trends, current conditions and expected future developments as well as other factors we believe are appropriate in the circumstances. These statements relate only to events as of the date on which the statements are made and we undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking statements made in this Quarterly Report on Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Whether actual results will conform to our expectations and predictions is subject to a number of risks and uncertainties that may cause actual results to differ materially. Risks and uncertainties, the occurrence of which could adversely affect our business, include the risks identified under the caption &#8220;Risk Factors&#8221; included in our annual report on Form 10-K for the year ended December 31, 2015. The following discussion should be read in conjunction with the condensed consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Integrity is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. Integrity Israel was founded in 2001 with a mission to develop, produce and market non-invasive glucose monitors for home use by diabetics. We have developed a non-invasive glucose monitor, the GlucoTrack&#174; model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices. The GlucoTrack&#174; model DF-F utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one&#8217;s earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In June 2013, we received initial CE Mark approval for the GlucoTrack&#174; model DF-F non-invasive glucose monitoring device from DEKRA Certification B.V., our European notified body (the &#8220;Notified Body&#8221;). This original approval required that the device be re-calibrated every 30 days, with each such re-calibration taking between 2.5 and 3 hours to complete. In March 2014 we received CE Mark approval for six months calibration validity of the same device. This approval eliminates the need for monthly re-calibrations, and enables the calibration process to be conducted only when the sensor is replaced, once every 6 months. We believe that this feature of the GlucoTrack&#174; model DF-F is a significant feature of the device. Receipt of the CE Mark allows us to market and sell the GlucoTrack&#174; model DF-F glucose monitoring device in European Union (&#8220;EU&#8221;) member countries that have adopted the European Medical Device Directive (the &#8220;MDD&#8221;) without being subject to additional national regulations with regard to demonstration of performance and safety. However, although the MDD is applicable throughout the EU, in practice it does not ensure uniform regulation throughout the EU.&#160;&#160;Accordingly, member countries may apply and enforce the MDD&#8217;s terms differently, and certain EU member countries may request or require performance and/or safety data additional to the MDD&#8217;s requirements from time to time, on a case-by-case basis. The CE Mark also permits the sale in countries that have an MDD Mutual Recognition Agreement with the EU.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 22 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 31, 2015, we received approval from the Notified Body for improvements to the GlucoTrack&#174; model DF-F to simplify and shorten (from approximately 2.5 hours to approximately half an hour) the initial calibration process for the device. These improvements are intended to reduce the backlog created as purchasers of the device await calibration. In addition, we received approval from the Notified Body on the updated intended use for the device, which expands the intended user population to include not only Type 2 diabetics, but also people suffering from pre-diabetes conditions as well, which we believe represents a material expansion of the potential market for the device. In December 2015, we received approval from the Notified Body for further improvements to the GlucoTrack&#174; model DF-F that increase the accuracy and efficacy of the device. On February 19, 2016, we received an extension of our ISO 13485:2003 certificate and Annex II certification from the EU.&#160;&#160;The ISO 13485:2003 certification signifies that we have met the standards required for company-wide implementation of device quality management system(s).&#160;&#160;The scope of the certification is design, development, manufacture and service of non-invasive glucose monitoring systems for home use.&#160;&#160;Annex II also addresses quality control systems. The certification allows us to self-certify certain modifications and changes and simplifies some of the reporting to and review by the relevant Notified Body.&#160;&#160;This can shorten the CE-mark review process of future GlucoTrack&#174; model DF-F enhancements or revisions, including software updates and other improvements of the device that do not affect the intended use and/or safety performances. Without an Annex II certification, each new device enhancement or modified version would be subject to the full EU CE-mark review process.&#160;&#160;The ISO 13485:2003 and Annex II certifications enable us to potentially reduce the time to market for product sales on new,&#160;&#160;enhanced or modified GlucoTrack&#174;&#160;model DF-F devices.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The GlucoTrack&#174; model DF-F has not yet been approved for commercial sale in the United States. On August 10, 2015, we submitted pre-submission documents to the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) in connection with our proposed future application for FDA approval of our U.S. clinical trial protocol.&#160;&#160;The pre-submission documentation was submitted to the FDA in order to obtain the FDA&#8217;s guidance regarding the U.S. regulatory pathway for the GlucoTrack&#174; model DF-F, the proper approach to refining the trial protocol, and preparing the pre-marketing application. On October 19, 2015, we met with the FDA to discuss the pre-submission documents, including the approach to and details of the clinical trial protocol for the GlucoTrack&#174;&#160;model DF-F.&#160;On May 10, 2016 we submitted a pre-submission supplement (including clinical trial protocol) to the FDA which reflects the feedback received from the FDA at our October 2015 meeting. On July 18, 2016, we completed a teleconference with the FDA to further discuss our pre-submission supplement. At the end of this discussion, we received verbal confirmation from the FDA that clinical trials of the GlucoTrack&#174;&#160;model DF-F constitute non-significant risk device studies, which allows the trials to proceed without an Investigational Device Exemption (IDE) application. Such trials are assessed by the FDA and not considered to present a potential for serious risk to the health, safety or the welfare of subjects. We have identified and are currently negotiating agreements with two US diabetes and endocrinology institutions in the United States, as well as prominent endocrinologists to conduct the clinical trials as Prime Investigators. Subject to finalization of these agreements and to raising sufficient funds to do so, we expect to begin clinical trials in the United States in the third or fourth quarter of 2016.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are continuing to work on improvements of certain features of the GlucoTrack&#174; model DF-F, such as further simplifying the calibration process and improving the accuracy of the device.&#160;&#160;In addition, we are developing a wireless module (&#8220;WLM&#8221;) with embedded Bluetooth Low-Energy (BLE) and Wi-Fi technologies, which we expect will enable transmission of measurement data captured by the GlucoTrack&#174; model DF-F to a cloud based server. We expect this module and the related applications, if successfully developed, to enable easy sharing, viewing and analysis of GlucoTrack&#174; model DF-F glucose measurements and profile by clinicians and others. Subject to our raising sufficient funds to do so, we expect to complete the development of the WLM and related smartphone application as soon as the first quarter of 2017.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since receiving CE Mark approval for our GlucoTrack&#174; model DF-F glucose monitoring device, we have expanded our primary focus to include, in addition to research and development activities, preparation for anticipated future mass-production and distribution of the GlucoTrack&#174; model DF-F in EU member countries and other countries that have an MDD Mutual Recognition Agreement with the EU, as well as other countries which consider the CE Mark as a reference for their regulatory or registration requirements. We have entered into exclusive distribution agreements with more than 15 distributors, and we are continuing negotiations with distributors in additional territories. The effectiveness of these agreements, in many cases, is subject to the receipt of local regulatory approval or registration, if required, for the commencement of sales of the GlucoTrack&#174; model DF-F in the subject territory.&#160;&#160;We cannot provide any assurance that we will receive the required local regulatory approvals in any of the countries in which such approvals are required, and therefore we may never be permitted to commence commercial sales of our products in such territories. Further discussions with other potential distributors are in different stages. Among other jurisdictions, we are in the process of seeking regulatory approval for the GlucoTrack&#174; model DF-F in China (where we have a distribution agreement in place), South Korea (where we have a distribution agreement in place) and Japan (where we do not yet have a distribution agreement in place), and are awaiting local regulatory approval in each of those countries.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 4, 2016 we received regulatory approval from the Korean Ministry of Food and Drug Safety (KMFDS, formerly KFDA) for the GlucoTrack&#174; model DF-F.&#160;&#160;Prior to commencing sales of the GlucoTrack&#174; model DF-F in South Korea, the Company will be required to undergo a GMP (Good Manufacturing Practice) audit. The KMFDS indicated that such audit will not require an on-site audit visit of the factory at which the GlucoTrack&#174; model DF-F is manufactured but, instead, will be limited to a review of the relevant GMP documents.&#160;&#160;All the required documentation has been submitted to the KMFDS and we expect to receive their approval during September 2016, unless further questions will be asked by the KMFDS.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Based on input from our local distributors and regulatory consultants, we estimated that we would complete the local regulatory approval review process in Japan and China by February 2017 and August 2016, respectively. However, we have been informed that the local regulatory bodies in Japan and China (PMDA and CFDA, respectively) have now requested that we conduct additional clinical trials in their respective countries before they determine whether or not to approve the device to be marketed in such countries. Due to these developments, we now anticipate that the regulatory review process in Japan and China will take an additional 17 to 23 months, and potentially longer if the results of the additional clinical trials are not satisfactory to the local regulatory bodies or such regulatory bodies impose additional requirements for approval.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The territories covered by our signed distribution agreements currently represent a potential market opportunity of up to approximately 141 million diagnosed diabetics (inclusive of both type 1 and type 2 diabetes patients).&#160;&#160;This represents approximately 34% of the potential worldwide market of approximately 414 million people, based on estimates included in the International Diabetes Federation&#8217;s (IDF) Diabetes Atlas, 7<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> edition, 2015.&#160;&#160;Of these territories, the territories in which the GlucoTrack&#174; model DF-F has been approved for sale currently represent a potential market opportunity of up to approximately 23 million diagnosed diabetics (inclusive of both type 1 and type 2 diabetes patients), or 5.6% of the potential worldwide market. While we do not have reliable statistics that bifurcate the market opportunity among type 1 and type 2 diabetics, we believe that on average approximately 87% of all people suffering from diabetes have type 2 diabetes. Apart from the diagnosed patients, it is estimated that approximately 192 million people suffer from diabetes but have not yet been diagnosed.&#160;&#160;Based on estimates included in the International Diabetes Federation&#8217;s (IDF) Diabetes Atlas, 7<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> edition, 2015, the market opportunity for undiagnosed diabetics is 71 million people in the territories covered by our signed distribution agreements, of which 11 million people are in the territories in which the GlucoTrack&#174; model DF-F has been approved for sale.. Based on the IDF Diabetes Atlas, 6<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> edition, 2013 the world prevalence of pre-diabetics was 6.92% of the worldwide population, while the prevalence of diagnosed people with diabetes was 8.35%.</font></div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has recently added two additional independent directors, bringing the total number of independent directors serving on our board of directors to 3 of the 5 members of the board. Additionally, the Company has recently formed a Nominating and Corporate Governance committee consisting solely of independent directors.&#160;&#160;The Company will continue to appoint independent board members and create committees as appropriate to support the Company.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In support of our global commercialization, sales and distribution efforts, the Company is currently in an active search for a Chief Commercialization Officer, as well as additional executives with the expertise and experience necessary to fully execute on the commercial opportunity.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 23 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not own commercial manufacturing facilities and do not intend to build commercial manufacturing facilities of our own in the foreseeable future. We currently utilize a third party manufacturer in Israel to manufacture the GlucoTrack&#174; model DF-F.&#160;&#160;In July 2014, we entered into a manufacturing agreement with Wistron Corp. (&#8220;Wistron&#8221;), a Taiwanese entity and the manufacturing arm of Acer Inc.&#160;&#160;Pursuant to such agreement, Wistron has agreed to mass produce and service, on a non-exclusive basis, the GlucoTrack<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#174;</font> model DF-F and any future products, if any, introduced by us. Pursuant to such agreement, Wistron has also agreed to provide full turn-key manufacturing services for the GlucoTrack<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#174;</font> model DF-F, including components procurement, unit assembly, device integration, testing, packaging and delivery to customers (distributors).&#160;&#160;In November 2015, we sent a delegation to Wistron&#8217;s main production facility in Taiwan<font style="DISPLAY: inline; TEXT-DECORATION: line-through">&#160;</font>to, among other things, inspect the readiness<font style="DISPLAY: inline; TEXT-DECORATION: line-through">&#160;</font>of Wistron&#8217;s production line for the GlucoTrack&#174; model DF-F.&#160;&#160;Wistron has produced a small pilot batch and is in the process of producing a second pilot batch of the GlucoTrack&#174; model DF-F device. Subject to satisfactory completion of a GMP audit by the local regulatory authorities in Taiwan, we now anticipate that the production line for the GlucoTrack&#174; model DF-F will be operational during the third quarter or beginning of fourth quarter of 2016.&#160;&#160;Following the completion of Wistron&#8217;s production line, we intend to utilize the services of both Wistron and the Israeli third-party manufacturer to produce the GlucoTrack&#174; model DF-F.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have expanded our Advisory board to include renowned key opinion leaders, in order to support the Company&#8217;s global clinical, regulatory and commercialization efforts. The advisory board now comprises six experts: Prof. Dr. Lutz Heinemann (Chairman): CEO, Science &amp; Co, D&#252;sseldorf, Germany; Prof. Irl B. Hirsch: University of Washington, School of Medicine, WA, USA; Prof. Dr. Michael Heise: University of Applied Science of South-Westphalia, Iserlohn, Germany; Prof. Jan Bolinder: Professor of Clinical Diabetes Research at the Department of Medicine, Huddinge, Sweden; Prof. Katharine Barnard: Health Psychologist, Bournemouth University, Faculty of Health and Social Science, England; and Dr. Barry H. Ginsberg: Diabetes Consultant, DMTC, NJ, USA.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In support of the commercialization effort, we intend to conduct post-market clinical trials , as well as publish scientific and clinical studies, case studies, and white papers. To that end, we have engaged with a leading clinic in Germany, Pfutzner Science &amp; Health Institute, GmbH, headed by Prof. Dr. Andreas Pfutzner, to conduct additional clinical trials on subjects with Type 2 diabetes and pre-diabetics. We are in negotiations with another site in Israel and anticipate adding additional sites in Europe.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Given the improvements to the device that were submitted for approval in the second half of 2015 and approved in August and December 2015, we deliberately postponed sales of the GlucoTrack&#174; model DF-F in the second half of 2015.&#160;&#160;We held an international distributors&#8217; conference in October 2015 during which, we educated our international distributors about the improvements to the device and set the expectation to begin taking orders for the improved device in the first quarter of 2016.&#160;&#160;In early 2016, after introducing the improved version of GlucoTrack&#174; model DF-F, we received orders totaling approximately $300,000, of which orders in the amount of $146,000 have been shipped and recognized as revenues during the first and second quarter of 2016. We expect that the balance of such orders will be shipped and recognized as revenues during the third and fourth quarters of 2016, subject to receipt of payments from the distributors.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We also received orders, totaling approximately $1.75 million that are contingent on the receipt of local regulatory approval to market the GlucoTrack&#174; model DF-F in certain countries.&#160;&#160;We delivered devices totaling $300,000 during the second quarter of 2016 for which we have received payments in the amount of $200,000 and the balance is expected to be paid during the third quarter of 2016. We cannot guarantee when the remaining orders in the amount of $1.45 million will be fulfilled (if at all), due to the pending local regulatory process, and we have not received any pre-payments for these orders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to the improvements to the GlucoTrack&#174; model DF-F described previously, we have also continued to work on additional incremental improvements to the device and the development of new devices and, subject to our raising sufficient funds to do so, intend to continue these efforts in 2016.&#160;&#160;Specifically, we are developing a cloud-connected WLM.&#160;&#160;We also initiated development of the next generation of GlucoTrack&#174; model DF-F devices, as well as a simple model, DF-B, intended for use in developing countries.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">We have not yet generated any material revenues from our operations and, as of June 30, 2016, have incurred an accumulated deficit of $32,476,186, stockholders&#8217; deficit of $8,757,799 and negative operating cash flows. We currently have no material sources of recurring revenue and therefore are dependent upon external sources for financing our operations. There can be no assurance that we will succeed in obtaining the necessary financing to continue our operations. As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Developments</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As previously disclosed, during the three month period ended June 30, 2016 we raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) from the issuance in two separate closings of 4,425 units (the &#8220;Series C Units&#8221;), each consisting of (a) one share of our newly designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series C Preferred Stock&#8221;), convertible into shares of our common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), at an initial conversion price of $4.50 per share, (b) a five year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-1 Warrant&#8221;) and (c) a five year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-2 Warrant&#8221; and, together with the Series C-1 Warrants, collectively, the &#8220;Series C Warrants&#8221;). As of June 30, 2016, the shares of Preferred Stock comprising the Series C Units are convertible into an aggregate of 983,386 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 1,966,772 shares of Common Stock, in each case subject to adjustments in certain circumstances.</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 24 -</font></div>
</div>
</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with Andrew Garrett, Inc. (&#8220;AGI&#8221;), the placement agent for the offering of the Series C Units, at the initial closing of the sale of the Series C Units we paid AGI, as a commission, an amount equal to&#160;&#160;6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units.&#160;&#160;At each of the second, third and fourth closing of the sale of the Series C Units, we paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing. In addition, pursuant to the Placement Agent Agreement, we are required to issue to AGI: (a) 5 year warrants to purchase up to 196,678 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 98,339 shares of Common Stock at an exercise price of $7.75 per share.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">As a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the warrants issued by us to purchasers of units consisting of shares of its Series A 5% Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) and warrants to purchase shares of Common Stock (the &#8220;Series A Warrants&#8221;), on April 8, 2016, the exercise price per share of the Series A Warrants decreased from $5.80 per share to $4.50 per share and the number of shares of Common Stock issuable upon exercise of each of the Series A Warrants, in the aggregate, increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, will be equal to the aggregate exercise price prior to such adjustment.&#160;&#160; Also as a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the certificates of designations for our Series A Preferred Stock and Series B 5.5% Convertible Preferred Stock (the &#8220;Series B Preferred Stock&#8221;), on April 8, 2016, the conversion price per share of Series A Preferred Stock and Series B Preferred Stock decreased to $4.50 per share.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant Accounting Policies</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;US. GAAP&#8221;). In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events, and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Our significant accounting policies are described in Note 2, Summary of Significant Accounting Policies, of the Notes to the Consolidated Financial Statements appearing in our annual report on Form 10-K for the year ended December 31, 2015. Our management believes that, as for the financial statements for the periods included in this report, the going concern assessment is a critical accounting policy. However, due to the early stage of operations of the Company, there are no other accounting policies that are considered to be critical accounting policies by management.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 25 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Going Concern Uncertainty</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The development and commercialization of our product will require substantial expenditures. We have not yet generated any material revenues and have incurred a substantial accumulated deficit and negative operating cash flows. We currently have no sources of recurring revenue and are therefore dependent upon external sources for financing our operations. There can be no assurance that we will succeed in obtaining the necessary financing to continue our operations. Management&#8217;s plans concerning these matters are described in Note 1B to our annual report on Form 10-K for the year ended December 31, 2015. As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recently Issued Accounting Pronouncements</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<table cellpadding="0" cellspacing="0" id="ze8a077c86255414a9bf3f89ec055162e" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 45pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">1.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standard Update 2014-16, &#8220;Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity&#8221;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Effective January 1, 2016, the Group adopted Accounting Standard Update 2014-16, Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity ("ASU 2014-16").</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The amendments in ASU 2014-16 clarify how U.S. GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. Furthermore, the amendments clarify that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. Rather, the nature of the host contract depends upon the economic characteristics and risks of the entire hybrid financial instrument. The amendments also clarify that, in evaluating the nature of a host contract, an entity should assess the substance of the relevant terms and features (i.e., the relative strength of the debt-like or equity-like terms and features given the facts and circumstances) when considering how to weigh those terms and features. The assessment of the substance of the relevant terms and features should incorporate a consideration of the characteristics of the terms and features themselves; the circumstances under which the hybrid financial instrument was issued or acquired; and the potential outcomes of the hybrid financial instrument, as well as the likelihood of those potential outcomes.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The amendments in ASU 2014-16 apply to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of shares.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The effects of initially adopting the amendments in ASU 2014-16 were required to be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of shares as of the beginning of the fiscal year for which the amendments are effective. However, retrospective application was permitted to all relevant prior periods.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Management analyzed the economic characteristics and risks of the Series A Preferred Stock and the Series B Preferred Stock (including the embedded conversion feature of each) in accordance with the provisions of ASU 2014-16 and determined that such instruments are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Preferred Stock themselves (the 'host contract') are clearly and closely related and accordingly, the embedded conversion feature was not required to be bifurcated. As a result of the above determination, ASU 2014-16 did not impact the classification of the Series A Preferred Stock or the Series B Preferred Stock.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 26 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z49190e97453f4f8bb3e57a0c13e268db" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 45pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">2.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standard Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In May 2014, the FASB issued Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09").</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">An entity should apply the amendments in ASU 2014-09 using one of the following two methods: 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">During 2016, the FASB issued several Accounting Standard Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements and Practical Expedients, Principal versus Agent Considerations and Identifying Performance Obligations and Licensing.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-LEFT: 45pt; FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For a public entity, the amendments in ASU 2014-09 (including the amendments introduced through recent ASUs) are effective for annual reporting periods beginning after December 15, 2016, including interim periods within the first annual reporting period (the first quarter of fiscal year 2017 for the Company). Early application is not permitted.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The Company is in the process of assessing the impact, if any, of ASU 2014-09 (including the amendments introduced through recent ASUs) on its consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 27 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z94867cdfaec7488a8de07b76adbeae92" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 45pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">3.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standards Update 2014-15, &#8220;Presentation of Financial Statements&#8212;Going Concern&#8221;</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In August 2014, the FASB issued Accounting Standards Update 2014-15, Presentation of Financial Statements&#8212;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern ("ASU 2014-15").</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2014-15 provides guidance on management&#8217;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable).</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2014-15 also provides guidance related to the required disclosures as a result of management&#8217;s evaluation.&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Due to the current financial condition of the Company and the existing uncertainty regarding its ability to continue as a going concern, management does not believe that the provisions of ASU 2014-15 will have a significant effect on its evaluation of the Company&#8217;s ability to continue as a going concern. However, management is currently considering if additional disclosures will be required as a result of ASU 2014-15.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zb943379923f0490abe670bb6a88f8a21" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 45pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; ALIGN: right">4.</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Accounting Standard Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">In July, 2015, The FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) ("ASU 2015-11").</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value. Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance. Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">For a public entity, the amendments in ASU 2015-11 are effective, in a prospective manner, for annual reporting periods beginning after December 15, 2016, including interim periods within the first such annual reporting period (the first quarter of fiscal year 2017 for the Company). Early adoption is permitted as of the beginning of an interim or annual reporting period.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 45pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The Company is in the process of assessing the impact, if any, of ASU 2015-11 on its consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 28 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">The following discussion explains material changes in our results of operations for the six and three month periods ended June 30, 2016, compared with the same periods ended June 30, 2015. This discussion should be read in conjunction with the financial statements and related notes included elsewhere in this report.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six Months Ended June 30, 2016 Compared to Six Months Ended June 30, 2015</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Revenues</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the six month period ended June 30, 2016, we had revenues of $470,878 from orders for our GlucoTrack&#174; model DF-F glucose monitoring device and personal ear-clip (&#8220;PEC&#8221;) that are replaced every six months, as compared with $143,167 for the prior-year period.&#160;&#160;The increase in revenues resulted from increased orders from customers for our&#160;&#160;improved GlucoTrack&#174; model DF-F for which we received approval from the Notified Body on August 31, 2015 and December 2015.</font></div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize revenues from sales of the GlucoTrack&#174; model DF-F and PECs when delivery has occurred, persuasive evidence of an agreement exists, the fee is fixed and determinable, collectability is reasonably assured and no further obligations exist.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="TEXT-DECORATION: underline">Research and Development Expenses</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses were $1,531,396 for the six month period ended June 30, 2016, as compared to $1,036,305 for the prior-year period. The increase is attributable primarily to higher salary costs and related expenses resulting from increased head-count and higher salaries, higher materials expenses primarily as a result of the engagement of research and development in the initial manufacturing of the GlucoTrack DF-F, and higher regulation related expenses relating primarily to our efforts in seeking regulatory approval for the GlucoTrack&#174; model DF-F in China. Research and development expenses consist primarily of salaries and other personnel-related expenses, including stock-based compensation expenses, materials, travel expenses, clinical trials and other expenses. Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect&#160;&#160;research and development expenses to increase during the remainder of 2016 and beyond, primarily due to hiring additional personnel and developing our product line, as well as improvement of the GlucoTrack&#174; model DF-F; however, we may adjust or allocate the level of our research and development expenses based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Selling, Marketing and General and Administrative Expenses</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Selling, marketing and general and administrative expenses were $1,787,309 for the six month period ended June 30, 2016, as compared to $1,083,762 for the prior-year period. The increase is attributable primarily to higher salaries and related expenses relating to the hiring of our Chief Operating Officer on January 1, 2016 and the hiring of additional sales, marketing and business development personnel. The increase is also attributable to the one-time charges in the amount of $211,077 representing the incremental fair market value adjustments in respect of modified warrants issued to AGI (See Note 3). In addition, the increase is also attributable in part to higher professional fees primarily due to the engagement during the second quarter of 2015 of Ogilvy CommonHealth (Paris). Selling, marketing and general and administrative expenses consist primarily of professional services, salaries, travel expenses and other related expenses for executive, finance and administrative personnel, including stock-based compensation expenses. Other general and administrative costs and expenses include facility-related costs not otherwise included in research and development costs and expenses, and professional fees for legal and accounting services. Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect selling, marketing and general and administrative expenses to increase in 2016 and beyond as we continue our focus on marketing and sales of the GlucoTrack<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#174;</font> model DF-F.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Financing (income) expenses, net</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Financing (income) expenses, net was $(32,065) for the six month period ended June 30, 2016, as compared to financing expense of 1,224,437 for the prior-year period. The change is primarily attributable to the non-cash loss on partial extinguishment of Series A Preferred Stock and Series A Warrants during the six months period ended June 30, 2015 (see Note 10C to our annual report on Form 10-K for the year ended December 31, 2015).</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 29 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Net loss</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss was $2,815,762 for the six month period ended June 30, 2016, as compared to a net loss was $3,201,337 for the prior-year period. The decrease in net loss is attributable primarily to the change in financing (income) expenses, net and increase in revenues offset partially by the increase in operating expenses, as described above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three Months Ended June 30, 2016 Compared to three Months Ended June 30, 2015</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-INDENT: 36pt; FONT: 10pt/1.25 'Times New Roman', Times, serif; TEXT-DECORATION: underline">Revenues</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: normal; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three month period ended June 30, 2016, we had revenues of $381,731 from orders for our GlucoTrack&#174; model DF-F glucose monitoring device and PECs that are replaced every six months, as compared with $67,342<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>for the prior-year period.&#160;&#160;The increase in revenues resulted from increased orders from customers for our&#160;&#160;improved GlucoTrack&#174; model DF-F for which we received approval from the Notified Body on August 31, 2015 and December 2015.</font></div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">We recognize revenues from GlucoTrack&#174; model DF-F and PEC when delivery has occurred, persuasive evidence of an agreement exists, the fee is fixed and determinable, collectability is reasonably assured and no further obligations exist.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Research and development expenses</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses were $880,696 for the three months ended June 30, 2016, as compared to $557,980 for the prior-year period. The increase is attributable primarily to higher salary costs and related expenses resulting from increased head-count and higher salaries, higher materials expenses primarily as a result of the engagement of research and development in the initial manufacturing of the GlucoTrack DF-F, and higher regulation related expenses relating primarily to our efforts in seeking regulatory approval for the GlucoTrack&#174; model DF-F in China. Research and development expenses consist primarily of salaries and other personnel-related expenses, including stock-based compensation expenses, materials, travel expenses, clinical trials and other expenses. Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect&#160;&#160;research and development expenses to increase during the remainder of 2016 and beyond, primarily due to hiring additional personnel and developing our product line, as well as improvement of the GlucoTrack&#174; model DF-F; however, we may adjust or allocate the level of our research and development expenses based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Selling, marketing and general and administrative expenses</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Selling, marketing and general and administrative expenses were $1,084,465 for the three month period ended June 30, 2016, as compared to $605,565 for the prior-year period. The increase is attributable primarily to higher salaries and related expenses relating to the hiring of our Chief Operating Officer on January 1, 2016 and the hiring of additional sales, marketing and business development personnel. The increase is also attributable to the one-time charges in the amount of $211,077 representing the incremental fair market value adjustments in respect of modified warrants issued to AGI (See Note 3). In addition, the increase is also attributable in part to higher professional fees primarily due to the engagement during the second quarter of 2015 of Ogilvy CommonHealth (Paris). Selling, marketing and general and administrative expenses consist primarily of professional services, salaries, travel expenses and other related expenses for executive, finance and administrative personnel, including stock-based compensation expenses. Other general and administrative costs and expenses include facility-related costs not otherwise included in research and development costs and expenses, and professional fees for legal and accounting services. Subject to the receipt of additional funds to finance our operations (of which there can be no assurance), we expect selling, marketing and general and administrative expenses to increase during the remainder of 2016 and beyond as we continue our focus on marketing and sales of the GlucoTrack<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#174;</font> model DF-F; however, we may adjust or allocate the level of our marketing and general and administrative expenses based on available financial resources and based on our commercial needs including the FDA registration process, specific requirements from customers, development of new GlucoTrack&#174; models and others.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 30 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Financing expenses, net</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financing expenses, net were $5,568 for the three month period ended June 30, 2016, as compared to expenses of $570,603 for the prior-year period. The change is primarily attributable to the non-cash loss on partial extinguishment of Series A Preferred Stock and Series A Warrants incurred during the three month period ended June 30, 2015 (see Note 10C to our annual report on Form 10-K for the year ended December 31, 2015).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal; TEXT-DECORATION: underline">Net Loss</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Net loss was $1,588,998 for the three month period ended June 30, 2016, as compared to $1,666,806 for the prior-year period. The decrease in net loss is attributable primarily to the change in financing (income) expenses, net and increase in revenues offset partially by the increase in operating expenses, as described above.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2016, cash on hand was approximately $1.41 million. During 2016 we started fulfilling orders for our improved GlucoTrack<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#174;</font> model DF-F, which resulted in cash collections from our customers as of August 15, 2016 of approximately $489,000.&#160;&#160;While we expect to continue to generate additional cash from sales, we do not anticipate that our income from operations will be sufficient to sustain our operations in the next 12 months.&#160;&#160;Based on our current cash burn rate, strategy and operating plan, we believe that our cash and cash equivalents on hand as of August 12, 2016 in the amount of approximately $413,000, will enable us to operate for a period of less than thirty days from the date of this report. In order to fund our anticipated liquidity needs beyond such period (or possibly earlier if our current cash burn rate, strategy or operating plan change in a way that accelerates or increases our liquidity needs), we will need to raise additional capital.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">We have a credit line with Bank HaPoalim of NIS 150,000 (approximately $39,002 based on the exchange rate of 3.85 NIS/dollar as of June 30, 2016). Borrowings under the line of credit are secured by our funds on deposit with the bank at the time of borrowing, which generally must be sufficient to cover the principal amount of the borrowings in full. As of June 30, 2016 and August 15, 2016, we did not utilize our credit line.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Messrs. Avner Gal and Zvi Cohen collectively loaned Integrity Israel NIS 176,000 ($45,762 based on the same exchange rate) in May 15, 2002 pursuant to a board approval. Messrs. Nir Tarlovsky, Yitzhak Fisher and Asher Kugler loaned Integrity Israel NIS 336,300 ($87,441 based on the same exchange rate) on March 16, 2004. These loans are not required to be repaid until the first year in which we realize profits in our annual statement of operations (accounting profit). At such time, the loans are to be repaid on a quarterly basis in an amount equal to 10% of our total sales in the relevant quarter, beginning on the quarter following the first year in which we realize profits in our annual statement of operations. The total amount to be repaid by us to each lender shall be an amount equal to the aggregate principal amount loaned by such lender to us, plus an amount equal to the product of the amount of each payment made by us in respect of such loan multiplied by the percentage difference between the Israeli Consumer Price Index on the date on which the loan was made and the Israeli Consumer Price Index on the date of such payment. However, notwithstanding the above-mentioned mechanism, we will not be required to repay the loans during any time when such repayment would cause a deficit in our working capital. Our board of directors is entitled to modify the repayment terms of these loans, so long as such modification does not discriminate against any particular lender, and provided that all payments must be allocated among the lenders on a pro-rata basis.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Integrity Israel is required to pay royalties to the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of the State of Israel at a rate ranging between 3-5% of the proceeds from the sale of the Company&#8217;s products arising from the development plan up to an amount equal to $93,300, plus interest at LIBOR from the date of grant. As of June 30, 2016, the contingent liability with respect to royalty payment on future sales equals to approximately $72,993, excluding interest.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 31 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; TEXT-INDENT: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Used in Operating Activities for the Six Month Periods Ended June 30, 2016 a<a name="a32">nd</a> June 30, 2015</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Net cash used in operating activities was $2,887,167 and $1,836,282 for the six month periods ending June 30, 2016 and 2015, respectively. Net cash used in operating activities primarily reflects the net loss of $2,815,762<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</font>for the six month periods ending June 30, 2016 and 2015, respectively. Net cash used in operating activities was partially offset by the one-time charges in the amount of $211,077 representing the incremental fair market value adjustments in respect of modified warrants issued to AGI during the six month period ended June 30, 2016 and loss on extinguishment of Series A Preferred Stock and Series A Warrants during the six month period ended June 30, 2015 in the amount of $1,270,971. Changes in operating assets and liabilities during the six month period ended June 30, 2016 increased our net cash used in operating activities for the six months period ended June 30, 2016 by $279,908, which resulted primarily from payment of deferred balances to suppliers. For the six months period ended June 30, 2015 net cash used in operations was partially offset by changes in operating assets and liabilities in the amount of $156,759 resulting primarily for deferral of payments to suppliers.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; TEXT-INDENT: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Used in Investing Activities for the Six Month Periods Ended June 30, 2016 and June 30, 2015</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Net cash used in investing activities was $46,397 and $43,171 for the six month periods ended June 30, 2016, and 2015, respectively. Net cash used to purchase equipment (such as computers, R&amp;D and office equipment) was $46,397 and $18,892, respectively and cash used to fund deposits in respect of employees rights upon retirement amounted to $0 and $24,279, for the six month periods ended June 30, 2016, and 2015, respectively.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; TEXT-INDENT: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Provided by (Used in) Financing Activities for the Six Month Periods Ended June 30, 2016 and June 30, 2015</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Net cash provided by (used in) financing activities was $3,745,726 and $(486,975) for the six month period ended June 30, 2016 and 2015, respectively. Cash provided by financing activities for the six months period ended June 30, 2016 reflects net capital raised from the issuance of Series C units in the amounts of $3,750,479, offset partially by dividends paid to the holders of our Preferred Stock in the amounts of $4,753. Cash used in financing activities&#160; for the six month period ended June 30, 2015, reflects primarily the repayment of stockholders loan to Stockholders (see Note 9D to our annual report on Form 10-K for the year ended December 31, 2015) in the amount of $439,939 and cash dividends paid to the holders of our Series A Preferred Stock in the amounts of $47,036.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off-Balance Sheet Arrangements</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">As of June 30, 2016, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 3.&#160;&#160;&#160; </font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quantitative and Qualitative Disclosures About Market Risk.</font></div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Not required for smaller reporting companies.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 4.&#160;&#160;&#160; </font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Controls and Procedures.</font></div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; TEXT-INDENT: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Evaluation of Disclosure Controls and Procedures</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2016.&#160; The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June 30, 2016, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; TEXT-INDENT: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Control over Financial Reporting</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">There were no changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 32 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="a33">PA</a>RT II - OTHER INFORMATION</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 6.&#160;&#160;&#160; </font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibits.</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit No.</font></div>
</div>
</td>
<td valign="bottom" width="70%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font></div>
</div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Incorporation of Integrity Applications, Inc. (1)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Amendment to Certificate of Incorporation of Integrity Applications, Inc. (1)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.3</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bylaws of Integrity Applications, Inc. (1)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences and Rights of Series A 5% Convertible Preferred Stock (2)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.5</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences and Rights of Series B 5.5% Convertible Preferred Stock (3)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.6</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences and Rights of Series C 5.5% Convertible Preferred Stock (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Securities Purchase Agreement (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Series C-1 Common Stock Purchase Warrant (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.3</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Series C-2 Common Stock Purchase Warrant (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.4</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Registration Rights Agreement (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.INS</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Instance Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.SCH</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Schema Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.CAL</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Calculation Linkbase Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.LAB</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Label Linkbase Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.PRE</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Presentation Linkbase Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.DEF</font></div>
</td>
<td valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Definition Linkbase Document (5)</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zd88a52efc43e4c91842cbd65297b11c4" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(1)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1, as filed with the SEC on August 22, 2011, which exhibit is incorporated herein by reference.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zc6d0ce822c884b8cabf5756ea48598b6" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(2)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on March 18, 2013, which exhibit is incorporated herein by reference.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z1e8cb8ce76494da48b160f2910ed1ce7" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(3)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on September 5, 2014, which exhibit is incorporated herein by reference.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="za3a440dc18d2439cbd9dfad0f03a6ecb" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(4)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on April 14, 2016, which exhibit is incorporated herein by reference.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z314d3b3af95741c9afdf13a4d1a5c271" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(5)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Pursuant to Rule 406T of Regulation S-T, the interactive files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</font></div>

<div style="TEXT-ALIGN: center"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 33 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIG<a name="a34">NA</a>TURES</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Dated:&#160; August <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">15</font>, 2016</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
</div>

<table border="0" cellpadding="0" cellspacing="0" id="zd4c87ceac33a4f048a9016a955047997" style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td colspan="2" style="VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">INTEGRITY APPLICATIONS, INC.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr><tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">By:</div>
</td>
<td style="BORDER-BOTTOM: #000000 0.5pt solid; WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">/s/ Avner Gal</div>
</td>
</tr><tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Name:</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Avner Gal</div>
</td>
</tr><tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Title</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Chairman of the Board and Chief Executive Officer</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(Principal Executive Officer)</div>
</td>
</tr></table>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<table cellpadding="0" cellspacing="0" id="zf61f7f324a044a2da22ce9e3db187e8d" style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="PADDING-BOTTOM: 0.5pt; WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="PADDING-BOTTOM: 0.5pt; WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">By:</div>
</td>
<td style="BORDER-BOTTOM: #000000 0.5pt solid; WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">/s/ Eran Hertz</div>
</td>
</tr><tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">Name:</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Eran Hertz</div>
</td>
</tr><tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Title</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">Chief Financial Officer</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt">(Principal Accounting Officer)</div>
</td>
</tr></table>

<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br>
&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 34 -</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade>
</div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHI<a name="a35">BI</a>T INDEX</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit No.</font></div>
</div>
</td>
<td valign="bottom" width="70%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font></div>
</div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Incorporation of Integrity Applications, Inc. (1)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Amendment to Certificate of Incorporation of Integrity Applications, Inc. (1)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.3</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bylaws of Integrity Applications, Inc. (1)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences and Rights of Series A 5% Convertible Preferred Stock (2)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.5</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences and Rights of Series B 5.5% Convertible Preferred Stock (3)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.6</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences and Rights of Series C 5.5% Convertible Preferred Stock (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Securities Purchase Agreement (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Series C-1 Common Stock Purchase Warrant (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.3</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Series C-2 Common Stock Purchase Warrant (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.4</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Registration Rights Agreement (4)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.1</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.2</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.INS</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Instance Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.SCH</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Schema Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.CAL</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Calculation Linkbase Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.LAB</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Label Linkbase Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.PRE</font></div>
</td>
<td valign="top" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Presentation Linkbase Document (5)</font></div>
</td>
</tr><tr>
<td valign="top" width="9%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.DEF</font></div>
</td>
<td valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Definition Linkbase Document (5)</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zd88a52efc43e4c91842cbd65297b11c4" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(1)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1, as filed with the SEC on August 22, 2011, which exhibit is incorporated herein by reference.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="zc6d0ce822c884b8cabf5756ea48598b6" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(2)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on March 18, 2013, which exhibit is incorporated herein by reference.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z1e8cb8ce76494da48b160f2910ed1ce7" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(3)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on September 5, 2014, which exhibit is incorporated herein by reference.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="za3a440dc18d2439cbd9dfad0f03a6ecb" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(4)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on April 14, 2016, which exhibit is incorporated herein by reference.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table cellpadding="0" cellspacing="0" id="z314d3b3af95741c9afdf13a4d1a5c271" style="WIDTH: 100%; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: 'times new roman', times, serif">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; ALIGN: right">(5)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'times new roman', times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Pursuant to Rule 406T of Regulation S-T, the interactive files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><font id="DSPFPageNumber" style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal">
<div style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 35 -</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto" align="center">
</div>

<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>
</div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto" align="center" />
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 31.1</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><font style="FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">THE SECURITIES EXCHANGE ACT OF 1934,</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO SECTION 302 OF</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">I, Avner Gal, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z045374c4591e4726b8ee813ab27847ff" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2016 of Integrity Applications, Inc.;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z87395b6ce4454a1db79aee297b285b57" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zb297ead5e62d48dab22af9ef60e8932c" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z3082dc764e514f5998a15bad3ce0f0db" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z4282c47f8e014addb3470c6c721b8882" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z83f412c7e3e9414eb1cc00189bc9760a" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z836ee72978be4b50ad58b0a23a82437a" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(c)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zd626e2a66573429981ee34b1906ca153" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(d)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z0fccbb642fa14a2cb0f9bd8888bc4aeb" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the Audit Committee of the registrant&#8217;s Board of Directors (or persons performing the equivalent functions):</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z135c89b724a341ad82140d7d2fabfaf7" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zba04297dde9d4ebba0accd77544699fb" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25; FONT-WEIGHT: normal"><br style="LINE-HEIGHT: 1.25" />
</div>

<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z9d9f9d598e9a40fead737c9a7127bb92" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 49.98%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Date: August 15, 2016</div>
</td>
<td style="WIDTH: 5.92%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">By:</div>
</td>
<td style="BORDER-BOTTOM: #000000 0.5pt solid; WIDTH: 44.1%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">/s/ Avner Gal</div>
</td>
</tr>

<tr>
<td style="WIDTH: 49.98%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.92%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 44.1%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Avner Gal</div>
</td>
</tr>

<tr>
<td style="WIDTH: 49.98%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.92%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 44.1%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Chairman of the Board and Chief Executive Officer</div>
</td>
</tr>
</table>

<div id="DSPFPageHeader">&#160;</div>
</div>

<div>&#160;</div>

<div>
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto" align="center" />
</div>

<div style="FONT-WEIGHT: normal">&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto" align="center" />
</div>

<div>&#160;</div>

<div>
<div style="text-align: right; line-height: 1.25; font-variant: normal; font-style: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>Exhibit 31.2</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal;"><font style="FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">THE SECURITIES EXCHANGE ACT OF 1934,</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO SECTION 302 OF</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal;">I, Eran Hertz, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z98952db7214c4790b12513a2a0925fac" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2016 of Integrity Applications, Inc.;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z56a91290f41d4d31b0a847d894a22f1c" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z623790ae0e8445f6a58981aa7ab6116a" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z1acf1a75151741aa9941e35e0d2e129e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z13679a3b05384fc68654abcf8c50c3ca" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z1e9f3be45290453d9ad9df02ef1000ed" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z3350eb4871d94000b7c4961bf0d25edb" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(c)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z708d1e76635745499536bd3c5eaca9f0" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(d)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zab2dcd92cc92426e9561ff3538ce6e4f" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the Audit Committee of the registrant&#8217;s Board of Directors (or persons performing the equivalent functions):</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z767f6278fe0945c99f89589767efc11a" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z0ce7301222ef497cb02b5bd2dfcf75b9" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</td>
</tr>
</table>
</div>

<div style="line-height: 1.25; font-weight: normal;"><br style="LINE-HEIGHT: 1.25" />
</div>

<div>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z54976780314b4b3abfe6f8f10e1dcb72" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 49.98%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Date: August 15, 2016</div>
</td>
<td style="WIDTH: 5.92%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">By:</div>
</td>
<td style="BORDER-BOTTOM: #000000 0.5pt solid; WIDTH: 44.1%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">/s/ Eran Hertz</div>
</td>
</tr>

<tr>
<td style="WIDTH: 49.98%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.92%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 44.1%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Eran Hertz</div>
</td>
</tr>

<tr>
<td style="WIDTH: 49.98%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.92%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 44.1%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Chief Financial Officer</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageHeader">
<div style="line-height: 1.25; font-weight: normal;"><br style="LINE-HEIGHT: 1.25" />
</div>
</div>

<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto" align="center" />
</div>

<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto" align="center" />
</div>

<div style="text-align: right; line-height: 1.25; font-variant: normal; font-style: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>Exhibit 32.1</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal;"><font style="FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">18 U.S.C. SECTION 1350,</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal;">In connection with the Quarterly Report on Form 10-Q of Integrity Applications, Inc. (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>Company</u></font>&#8221;) for the six month period ended June 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>Report</u></font>&#8221;), I, Avner Gal, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z8633f815ebf748b08083bed4c1488625" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(1)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="za2344d170c59445eb28aac142cfd5bec" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(2)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zd97a703224ad43e088052d27a2d9f0da" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">By:</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">/s/ Avner Gal</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Avner Gal</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Chairman of the Board and Chief Executive Officer</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25; font-weight: normal;"><br style="LINE-HEIGHT: 1.25" />
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Dated: August 15, 2016</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>
</div>

<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto" align="center" />
<font style="FONT-WEIGHT: normal"><br style="LINE-HEIGHT: 1.25" />
</font></div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.1.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto" align="center" />
</div>

<div>&#160;</div>

<div>
<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25"></div>
</div>

<div style="text-align: right; line-height: 1.25; font-variant: normal; font-style: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>Exhibit 32.2</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal;"><font style="FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">18 U.S.C. SECTION 1350,</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br />
</font><font style="FONT-WEIGHT: bold">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal;">In connection with the Quarterly Report on Form 10-Q of Integrity Applications, Inc. (the &#8220;Company&#8221;) for the six month period ended June 30, 2016, as filed with the Securities and Exchange Commission on <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>the</u></font> date hereof (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>Report</u></font>&#8221;), I, Eran Hertz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z27b10663e28a418793e010b5dbeb0a91" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(1)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zb42fc32a8c8b4575a56c081aded5fa24" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(2)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z261bce37ff6847d1bb4343d4e4d3d252" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">By:</div>
</td>
<td style="BORDER-BOTTOM: #000000 0.5pt solid; WIDTH: 44%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">/s/ Eran Hertz</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-TOP: #000000 0.5pt solid">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Eran Hertz</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Chief Financial Officer</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25; font-weight: normal;"><br style="LINE-HEIGHT: 1.25" />
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Dated: August 15, 2016</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto" align="center" />
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>igap-20160630.xml
<DESCRIPTION>INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 6%2D30%2D16 10Q.xfr; Date: 2016%2D08%2D15T19:20:15Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80110001 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:igap="http://integrity-app.com/20160630">
    <link:schemaRef xlink:href="igap-20160630.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2016-08-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C620432">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618124">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618122">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618714">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618134">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618154">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618125">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C620431">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618114">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618361">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619593">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619594">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619595">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618360">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619582">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619583">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619584">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618118">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618133">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618356">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618358">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618121">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618138">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-08-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618134373260296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C623225373260296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesB1WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C619667373260296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesB1WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C618150373260296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesB2WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C660587373260312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesB2WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesConeWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesConeWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesConeWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesConeWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesCtwoWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesCtwoWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesCtwoWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:SeriesCtwoWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-06-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_ScenarioPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-06-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_ScenarioPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AprilTwoThousandSixteenOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">igap:PlacementAgentWarrantsTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-29_custom_AgreementWithPlacementAgentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_AgreementWithPlacementAgentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_InitialClosingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="igap:SaleAgreementAxis">igap:InitialClosingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_SecondClosingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RegistrationPaymentArrangementByArrangementAxis">igap:AgreementWithPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="igap:SaleAgreementAxis">igap:SecondClosingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPerShare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="ILS">
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD_Per_NIS">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:ILS</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-08-15" unitRef="Shares" decimals="INF">5805560</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="C620432" unitRef="Shares" decimals="INF">10000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="C620431" unitRef="Shares" decimals="INF">10000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="C620432" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="C620431" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="C618124" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="C618122" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="C618714" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="C618134" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2016-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">4425</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2015-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="C618154" unitRef="Shares" decimals="INF">5690097</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="C618125" unitRef="Shares" decimals="INF">5805560</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="C618361" unitRef="Shares" decimals="INF">5690097</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="C618360" unitRef="Shares" decimals="INF">5805560</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="C618154" unitRef="Shares" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="C618125" unitRef="Shares" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="C618154" unitRef="USDPerShare" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="C618125" unitRef="USDPerShare" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C618154" unitRef="USD" decimals="0">608701</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C618125" unitRef="USD" decimals="0">1405534</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">5827560</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="0">3516073</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="C618154" unitRef="USD" decimals="0">18446</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="C618125" unitRef="USD" decimals="0">69664</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="C618154" unitRef="USD" decimals="0">816223</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="C618125" unitRef="USD" decimals="0">698170</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent contextRef="C618154" unitRef="USD" decimals="0">268792</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="C618125" unitRef="USD" decimals="0">123465</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="C618154" unitRef="USD" decimals="0">1712162</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="C618125" unitRef="USD" decimals="0">2296833</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="C618154" unitRef="USD" decimals="0">220463</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="C618125" unitRef="USD" decimals="0">242142</us-gaap:PropertyPlantAndEquipmentNet>
    <igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent contextRef="C618154" unitRef="USD" decimals="0">164883</igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent>
    <igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent contextRef="C618125" unitRef="USD" decimals="0">167287</igap:FundsInRespectOfEmployeeRightsUponRetirementNoncurrent>
    <us-gaap:Assets contextRef="C618154" unitRef="USD" decimals="0">2132660</us-gaap:Assets>
    <us-gaap:Assets contextRef="C618125" unitRef="USD" decimals="0">2741926</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="C618154" unitRef="USD" decimals="0">1082546</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="C618125" unitRef="USD" decimals="0">466165</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="C618154" unitRef="USD" decimals="0">427886</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="C618125" unitRef="USD" decimals="0">572930</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="C618154" unitRef="USD" decimals="0">1510432</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="C618125" unitRef="USD" decimals="0">1039095</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToOfficersOrStockholdersNoncurrent contextRef="C618154" unitRef="USD" decimals="0">160314</us-gaap:DueToOfficersOrStockholdersNoncurrent>
    <us-gaap:DueToOfficersOrStockholdersNoncurrent contextRef="C618125" unitRef="USD" decimals="0">161992</us-gaap:DueToOfficersOrStockholdersNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent contextRef="C618154" unitRef="USD" decimals="0">174137</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent contextRef="C618125" unitRef="USD" decimals="0">176673</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="C618154" unitRef="USD" decimals="0">321695</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="C618125" unitRef="USD" decimals="0">833153</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:LiabilitiesNoncurrent contextRef="C618154" unitRef="USD" decimals="0">656146</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="C618125" unitRef="USD" decimals="0">1171818</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="C618154" unitRef="USD" decimals="0">2166578</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="C618125" unitRef="USD" decimals="0">2210913</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued contextRef="C618124" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="C618122" unitRef="Shares" decimals="INF">376</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="C618714" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="C618134" unitRef="Shares" decimals="INF">15031</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2016-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">4425</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2015-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="C618124" unitRef="USD" decimals="0">221152</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="C618122" unitRef="USD" decimals="0">221152</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="C618714" unitRef="USD" decimals="0">6715844</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="C618134" unitRef="USD" decimals="0">6715844</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="C618154" unitRef="USD" decimals="0">6936996</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="C618125" unitRef="USD" decimals="0">9288812</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2016-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">2351816</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2015-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockSharesIssued contextRef="C618154" unitRef="Shares" decimals="INF">5690097</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="C618125" unitRef="Shares" decimals="INF">5805560</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="C618154" unitRef="USD" decimals="0">5691</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="C618125" unitRef="USD" decimals="0">5807</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="C618154" unitRef="USD" decimals="0">22309742</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="C618125" unitRef="USD" decimals="0">23652451</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="C618154" unitRef="USD" decimals="0">90168</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="C618125" unitRef="USD" decimals="0">60129</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="C618154" unitRef="USD" decimals="0">-29376515</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="C618125" unitRef="USD" decimals="0">-32476186</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="C618154" unitRef="USD" decimals="0">-6970914</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C618125" unitRef="USD" decimals="0">-8757799</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C618361" unitRef="USD" decimals="0">5691</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C619593" unitRef="USD" decimals="0">22309742</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C619594" unitRef="USD" decimals="0">90168</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C619595" unitRef="USD" decimals="0">-29376515</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C618360" unitRef="USD" decimals="0">5807</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C619582" unitRef="USD" decimals="0">23652451</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C619583" unitRef="USD" decimals="0">60129</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C619584" unitRef="USD" decimals="0">-32476186</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="C618154" unitRef="USD" decimals="0">2132660</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="C618125" unitRef="USD" decimals="0">2741926</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommitmentsAndContingencies contextRef="C618154" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="C618125" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="C618114" unitRef="USD" decimals="0">143167</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">470878</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">381731</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">67342</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="C618114" unitRef="USD" decimals="0">1036305</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1531396</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">880696</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">557980</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="C618114" unitRef="USD" decimals="0">1083762</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1787309</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">1084465</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">605565</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="C618114" unitRef="USD" decimals="0">2120067</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">3318705</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">1965161</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">1163545</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="C618114" unitRef="USD" decimals="0">-1976900</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2847827</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1583430</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-1096203</us-gaap:OperatingIncomeLoss>
    <igap:FinancingIncomeExpensesNet contextRef="C618114" unitRef="USD" decimals="0">1224437</igap:FinancingIncomeExpensesNet>
    <igap:FinancingIncomeExpensesNet contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-32065</igap:FinancingIncomeExpensesNet>
    <igap:FinancingIncomeExpensesNet contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">5568</igap:FinancingIncomeExpensesNet>
    <igap:FinancingIncomeExpensesNet contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">570603</igap:FinancingIncomeExpensesNet>
    <us-gaap:NetIncomeLoss contextRef="C618114" unitRef="USD" decimals="0">-3201337</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2815762</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-2815762</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1588998</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-1666806</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="C618114" unitRef="USD" decimals="0">55720</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-30039</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-8063</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">97383</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="C618114" unitRef="USD" decimals="0">-3145617</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2845801</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1597061</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-1569423</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:Depreciation contextRef="C618114" unitRef="USD" decimals="0">18359</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">27980</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="C618114" unitRef="USD" decimals="0">12147</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">34297</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="C618114" unitRef="USD" decimals="0">-91309</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-64212</us-gaap:FairValueAdjustmentOfWarrants>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="C618114" unitRef="USD" decimals="0">-1872</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-639</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">825</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">1808</igap:LinkageDifferenceOnPrincipalOfLoansFromStockholders>
    <igap:GainLossOnUnitConversion contextRef="C618114" unitRef="USD" decimals="0">-1270971</igap:GainLossOnUnitConversion>
    <igap:GainLossOnUnitConversion contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <igap:GainLossOnUnitConversion contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <igap:GainLossOnUnitConversion contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-497674</igap:GainLossOnUnitConversion>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="C618114" unitRef="USD" decimals="0">3149</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">51053</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="C618114" unitRef="USD" decimals="0">51036</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-130203</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="C618114" unitRef="USD" decimals="0">17474</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-147697</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="C618114" unitRef="USD" decimals="0">145388</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-638908</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="C618114" unitRef="USD" decimals="0">83030</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">132153</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="C618114" unitRef="USD" decimals="0">-1836282</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2887167</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C618114" unitRef="USD" decimals="0">18892</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">46397</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="C618114" unitRef="USD" decimals="0">-43171</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-46397</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock contextRef="C618114" unitRef="USD" decimals="0">47036</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">4753</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="C618114" unitRef="USD" decimals="0">-439939</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="C618114" unitRef="USD" decimals="0">-486975</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">3745726</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="C618114" unitRef="USD" decimals="0">54941</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-15329</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="C618114" unitRef="USD" decimals="0">-2311487</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">796833</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <igap:ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts contextRef="C618118" unitRef="USD" decimals="0">1000000</igap:ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts>
    <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">5300000</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="C618138" unitRef="USD" decimals="0">7300000</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="C618138" unitRef="Pure" decimals="3">0.055</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember" unitRef="Pure" decimals="3">.055</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="C618134373260296" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <igap:PreferredStockConversionPrice contextRef="C618134373260296" unitRef="USDPerShare" decimals="2">5.80</igap:PreferredStockConversionPrice>
    <igap:PreferredStockConversionPrice contextRef="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember" unitRef="USDPerShare" decimals="2">4.50</igap:PreferredStockConversionPrice>
    <igap:ClassOfWarrantOrRightTerm contextRef="C619667373260296">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="C660587373260312">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesConeWarrantMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesCtwoWarrantMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <igap:ClassOfWarrantOrRightTerm contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember">P5Y</igap:ClassOfWarrantOrRightTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="C623225373260296" unitRef="USDPerShare" decimals="2">5.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="C618150373260296" unitRef="USDPerShare" decimals="2">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesConeWarrantMember" unitRef="USDPerShare" decimals="2">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_custom_SeriesCtwoWarrantMember" unitRef="USDPerShare" decimals="2">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember" unitRef="USDPerShare" decimals="2">4.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember" unitRef="USDPerShare" decimals="2">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:InventoryRawMaterials contextRef="C618154" unitRef="USD" decimals="0">205645</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="C618125" unitRef="USD" decimals="0">181461</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="C618154" unitRef="USD" decimals="0">551111</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="C618125" unitRef="USD" decimals="0">412000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods contextRef="C618154" unitRef="USD" decimals="0">59467</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="C618125" unitRef="USD" decimals="0">104709</us-gaap:InventoryFinishedGoods>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="C618114" unitRef="USD" decimals="0">-38269</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-24211</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-19296</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-90872</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="C618114" unitRef="USD" decimals="0">91309</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">64212</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">20702</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">25539</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:InterestExpenseDebt contextRef="C618114" unitRef="USD" decimals="0">8378</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">8575</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">6149</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">5788</us-gaap:InterestExpenseDebt>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="C618114" unitRef="USD" decimals="0">-3434168</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-3099671</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-1745387</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-1795886</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C618114" unitRef="Shares" id="Foot-00-0" decimals="INF">9367247</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-01-01to2016-06-30" unitRef="Shares" id="Foot-00-1" decimals="INF">11220345</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-04-01to2016-06-30" unitRef="Shares" id="Foot-00-2" decimals="INF">12210613</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2015-04-01to2015-06-30" unitRef="Shares" id="Foot-00-3" decimals="INF">9537309</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <dei:DocumentType contextRef="From2016-01-01to2016-06-30">10-Q</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2016-01-01to2016-06-30">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2016-01-01to2016-06-30">2016-06-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2016-01-01to2016-06-30">Integrity Applications, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2016-01-01to2016-06-30">0001506983</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-01-01to2016-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2016-01-01to2016-06-30">2016</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-01-01to2016-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityFilerCategory contextRef="From2016-01-01to2016-06-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="C618154" unitRef="USD" decimals="0">35152</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="C618125" unitRef="USD" decimals="0">35664</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-30039</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-30039</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="C618121" unitRef="USD" decimals="0">47036</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">9453</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">9453</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-01-01to2016-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">9453</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2016-04-01to2016-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">4753</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2015-04-01to2015-06-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">26522</us-gaap:DividendsPreferredStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">34297</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">34297</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="C618154" unitRef="USD" decimals="0">321695</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="C618125" unitRef="USD" decimals="0">833153</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">2057618</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="0">392874</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <igap:ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision contextRef="C618114" unitRef="USD" decimals="0">1573435</igap:ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision>
    <igap:ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <igap:ChangeInFairValueOfSeriesaWarrants contextRef="C618114" unitRef="USD" decimals="0">91309</igap:ChangeInFairValueOfSeriesaWarrants>
    <igap:ChangeInFairValueOfSeriesaWarrants contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">64212</igap:ChangeInFairValueOfSeriesaWarrants>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="C618356" unitRef="Pure" xsi:nil="true" />
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember" unitRef="Pure" xsi:nil="true" />
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="C618356" unitRef="Pure" id="Foot-01-0" decimals="4">1.0514</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember" unitRef="Pure" id="Foot-01-1" decimals="4">.6216</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="C618356" unitRef="Pure" decimals="4">.0101</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" unitRef="Pure" decimals="4">0.0072</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="Pure" decimals="4">.0111</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="C618356" id="Foot-02-0">P2Y8M12D</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" id="Foot-02-1">P1Y8M12D</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2016-01-01to2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" id="Foot-02-2">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2015-06-30_us-gaap_WarrantMember" unitRef="USDPerShare" decimals="2">5.80</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MinimumMember" unitRef="USDPerShare" decimals="INF">4.50</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2016-06-30_us-gaap_WarrantMember_us-gaap_MaximumMember" unitRef="USDPerShare" decimals="INF">7.75</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice contextRef="C618360" unitRef="USDPerShare" id="Foot-03-0" decimals="2">2.38</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2015-06-30_us-gaap_CommonStockMember" unitRef="USDPerShare" id="Foot-03-1" decimals="2">2.31</us-gaap:SharePrice>
    <igap:ClassOfWarrantOrRightFairValue contextRef="C618358" unitRef="USDPerShare" decimals="INF">0.61</igap:ClassOfWarrantOrRightFairValue>
    <igap:ClassOfWarrantOrRightFairValue contextRef="AsOf2015-06-30_us-gaap_WarrantMember" unitRef="USDPerShare" decimals="INF">1.00</igap:ClassOfWarrantOrRightFairValue>
    <igap:NumberOfUnitsSold contextRef="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember" unitRef="Shares" decimals="INF">4425</igap:NumberOfUnitsSold>
    <igap:NumberOfConvertiblePreferredSharesOfferedPerUnit contextRef="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1</igap:NumberOfConvertiblePreferredSharesOfferedPerUnit>
    <igap:ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion contextRef="From2016-06-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_ScenarioPlanMember" unitRef="Shares" decimals="INF">983386</igap:ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-06-30_custom_AprilTwoThousandSixteenOfferingMember_us-gaap_ScenarioPlanMember" unitRef="Shares" decimals="INF">1966772</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheTwoMember" unitRef="Shares" decimals="INF">196678</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-06-30_custom_AgreementWithPlacementAgentMember_custom_PlacementAgentWarrantsTrancheOneMember" unitRef="Shares" decimals="INF">98339</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <igap:NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement contextRef="From2016-02-01to2016-02-29_custom_AgreementWithPlacementAgentMember" unitRef="Shares" decimals="INF">422077</igap:NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement>
    <igap:AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement contextRef="From2016-01-01to2016-06-30_custom_AgreementWithPlacementAgentMember" unitRef="Shares" decimals="INF">439674</igap:AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement>
    <igap:AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance contextRef="From2016-01-01to2016-06-30_custom_AgreementWithPlacementAgentMember" unitRef="USD" decimals="0">341662</igap:AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance>
    <igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_InitialClosingMember" unitRef="Pure" decimals="2">0.06</igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_SecondClosingMember" unitRef="Pure" decimals="2">.10</igap:RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <igap:RegistrationPaymentArrangementCommissionPercentage contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_InitialClosingMember" unitRef="Pure" decimals="2">0.04</igap:RegistrationPaymentArrangementCommissionPercentage>
    <igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_InitialClosingMember" unitRef="Pure" decimals="2">0.03</igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits contextRef="From2016-04-01to2016-06-30_custom_AgreementWithPlacementAgentMember_custom_SecondClosingMember" unitRef="Pure" decimals="2">0.03</igap:NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits>
    <us-gaap:ProceedsFromSaleOfInterestInCorporateUnit contextRef="From2016-04-01to2016-06-30_custom_AprilTwoThousandSixteenOfferingMember" unitRef="USD" decimals="0">3750000</us-gaap:ProceedsFromSaleOfInterestInCorporateUnit>
    <igap:IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement contextRef="C618114" unitRef="USD" decimals="0">-24279</igap:IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement>
    <igap:IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:EarningsPerShareBasic contextRef="C618114" unitRef="USDPerShare" decimals="INF">-0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-04-01to2015-06-30" unitRef="USDPerShare" decimals="INF">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="C618114" unitRef="USDPerShare" decimals="INF">-0.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-04-01to2015-06-30" unitRef="USDPerShare" decimals="INF">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="C618114" unitRef="Shares" decimals="INF">5382682</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">5716566</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">5742468</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-04-01to2015-06-30" unitRef="Shares" decimals="INF">5441253</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="C618114" unitRef="Shares" decimals="INF">5382682</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">5716566</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">5742468</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-04-01to2015-06-30" unitRef="Shares" decimals="INF">5441253</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">107</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">253994</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-254101</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1164657</igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued>
    <igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1164657</igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued>
    <igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="C618114" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">341662</igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities>
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">341662</igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities>
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <igap:AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">9</igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc>
    <igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">20346</igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc>
    <igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-20355</igap:StockIssuedDuringPeriodValueStockDividendPreferredClassc>
    <igap:PreferredStockDividendsSharesPreferredStockClassc contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">8563</igap:PreferredStockDividendsSharesPreferredStockClassc>
    <us-gaap:PreferredStockDividendsShares contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">106900</us-gaap:PreferredStockDividendsShares>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="C618114" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">2508321</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="C618114" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1242158</us-gaap:ProceedsFromIssuanceOfWarrants>
    <igap:FairValueOfWarrantsIssuedAsConsiderationForPlacementServices contextRef="C618114" unitRef="USD" xsi:nil="true" />
    <igap:FairValueOfWarrantsIssuedAsConsiderationForPlacementServices contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">234008</igap:FairValueOfWarrantsIssuedAsConsiderationForPlacementServices>
    <igap:AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">77503</igap:AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital>
    <igap:AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">156505</igap:AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity>
    <us-gaap:DividendsPreferredStockStock contextRef="C618133" unitRef="USD" decimals="0">185795</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock contextRef="From2016-01-01to2016-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">254101</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock contextRef="From2016-04-01to2016-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">131281</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock contextRef="From2015-04-01to2015-06-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">102558</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock contextRef="From2016-01-01to2016-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">20355</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock contextRef="From2015-01-01to2015-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockStock contextRef="From2015-04-01to2015-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockStock contextRef="From2016-04-01to2016-06-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">20355</us-gaap:DividendsPreferredStockStock>
    <igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">211077</igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent>
    <igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent contextRef="From2016-01-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent contextRef="From2016-01-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">211077</igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent>
    <igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent contextRef="From2016-01-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <igap:IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent contextRef="From2016-01-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <igap:IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent contextRef="C618114" unitRef="USD" xsi:nil="true" />
    <igap:IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">211077</igap:IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zac9e7fed437b4ca5a14379154f4125d7" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.85pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;NOTE 1&lt;/font&gt;&lt;font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: 14.2pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="width: 14.2pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;&#13;&lt;div&gt;GENERAL&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z8f13af64574b4e6b9a4cd5f856956603" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.05pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 21.95pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;A.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: normal 10pt times new roman, times, serif; vertical-align: top"&gt;Integrity Applications, Inc. (the "Company") was incorporated on May&amp;#160;18, 2010 under the laws of the State of Delaware.&amp;#160; On July&amp;#160;15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: "Integrity Acquisition"), a wholly owned Israeli subsidiary of the Company, which was established on May&amp;#160;23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: "Integrity Israel"), an Israeli corporation that was previously held by the stockholders of the Company.&amp;#160; Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger. Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.&amp;#160; As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.&amp;#160; Integrity Israel was incorporated in 2001 and commenced its operations in 2002.&amp;#160; Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z817149da75b64388a90a3bd9a7810c6d" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.05pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.7pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;B.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Going concern uncertainty&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 89.85pt"&gt;Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.&amp;#160; The development and commercialization of Integrity Israel's product is expected to require substantial expenditures.&amp;#160; Integrity Israel and the Company (collectively, the "Group") have not yet generated any material revenues from operations, and therefore they are dependent upon external sources for financing their operations. As of June 30, 2016, the Group has incurred an accumulated deficit of $32,476,186, stockholders&amp;#8217; deficit of $8,757,799 and negative operating cash flows.&amp;#160; These factors raise substantial doubt about the Group&amp;#8217;s ability to continue as a going concern.&amp;#160; The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&amp;#160; During 2012, the Company raised a total amount of approximately $1.0 million (net of related expenses) from the issuance of Common Stock. During 2013, the Company raised funds in an approximate amount of $5.3 million (net of related cash expenses) from the issuance of units (the &amp;#8220;Series A Units&amp;#8221;) consisting of shares of the Company&amp;#8217;s Series A Convertible Preferred Stock (the &amp;#8220;Series A Preferred Stock&amp;#8221;) and detachable warrants to purchase shares of the Company&amp;#8217;s Common Stock (the &amp;#8220;Series A Warrants&amp;#8221; or &amp;#8220;Warrants with down round protection&amp;#8221;).&amp;#160; During the period between August and December 2014, the Company raised funds in an aggregate amount of approximately $7.3 million (net of related cash expenses) from the issuance of units (the &amp;#8220;Series B Units&amp;#8221;), each consisting of (a) one share of the Company&amp;#8217;s newly designated Series B 5.5% Convertible Preferred Stock, par value $0.001 per share (the &amp;#8220;Series B Preferred Stock&amp;#8221;), convertible into Common Stock at an initial conversion price of $5.80 per share, (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &amp;#8220;Series B-1 Warrant&amp;#8221;) and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &amp;#8220;Series B-2 Warrant&amp;#8221; and, together with the Series B-1 Warrants, collectively, the &amp;#8220;Series B Warrants&amp;#8221;).&amp;#160; During the three month period ended June 30, 2016, the Company raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) through the issuance of 4,425 units (the &amp;#8220;Series C Units&amp;#8221;), each consisting of (a) one share of the Company&amp;#8217;s newly designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &amp;#8220;Series C Preferred Stock&amp;#8221;), convertible into Common Stock at an initial conversion price of $4.50 per share, (b) a five year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &amp;#8220;Series C-1 Warrant&amp;#8221;) and (c) a five year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &amp;#8220;Series C-2 Warrant&amp;#8221; and, together with the Series C-1 Warrants, collectively, the &amp;#8220;Series C Warrants&amp;#8221;), as described in further detail in Note 3.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 89.85pt"&gt;Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long term loans. There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations as a going concern.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z2a2e40fdebcc42a4b6016473af7e670c" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 23.05pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;C.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Risk factors&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;As described in Note 1A and Note 1B above, the Group has a limited operating history and faces a number of risks and uncertainties, including risks and uncertainties regarding continuation of the development process, demand and market acceptance of the Group's products, the effects of technological changes, competition and the development of products by competitors.&amp;#160; Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group's future results and the availability of necessary financing. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts. The Group has not yet generated material revenues from its operations to fund its activities and therefore is dependent on the receipt of additional funding from its stockholders and/ or new investors in order to continue its operations.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z736ab5cb6070415b807e730680809a16" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 23.05pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;D.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Use of estimates in the preparation of financial statements&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (&amp;#8220;U.S. GAAP&amp;#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series C Units, and (iii) the going concern assumptions.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z07b0863973134126bc8663e54822d6f0" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.85pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;NOTE 2&lt;/font&gt;&lt;font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: 14.2pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="width: 14.2pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z115ccb1ba0cb46a78a2fda3dacc4bab8" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 23.05pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;A.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Basis of presentation&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;Accounting Principles&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&amp;#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The results for the six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December&amp;#160;31, 2016 or for any other interim period or for any future period.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;Principles of Consolidation&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.8pt"&gt;The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="ze3989ad908ac41208ab938c3981d7098" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.05pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.7pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;B.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Warrants with down-round protection&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The Company has determined its derivative warrant liability with respect to the Series A Warrants and warrants issued to Andrew Garrett, Inc., (&amp;#8220;AGI&amp;#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value. Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&amp;#160; The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt"&gt;The changes in the fair value of the Level 3 liability are as follows (in US dollars):&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div align="right" style="text-align: left; line-height: 1.25; margin-left: 99pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Series A Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Balance, Beginning of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;321,695&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2,057,618&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Warrants issued as consideration for placement services&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;234,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;341,662&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Exchange of Series A Warrants pursuant to the &amp;#8220;most favored nation&amp;#8221; provision&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,573,435&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Change in fair value Warrants with Down-Round Protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(91,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Balance, End of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;833,153&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;392,874&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt"&gt;The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; margin-left: 99pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; text-align: center; vertical-align: top; border-top-style: none; border-top-width: medium; font-weight: bold"&gt;June 30,&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: top"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Dividend yield (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Expected volatility (%) (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;62.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;105.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Risk free interest rate (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;0.72-1.11&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.01&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Expected term of options (years) (**)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.70-5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.70&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Exercise price (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;4.50-7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Share price (US dollars) (***)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.31&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Fair value (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;0.61&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90.7pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(*)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90.7pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(**)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&amp;#160;110.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 31.5pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(***)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;The Common Stock price, per share reflects the Company&amp;#8217;s management&amp;#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z88a8390d7f304d73a40584bf75cfbbb6" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 67.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.5pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;C.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Recently issued accounting pronouncements&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z13b081dfc9b24a4cb8939f28e70127d0" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;1.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standard Update 2014-16, &amp;#8220;Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;Effective January 1, 2016, the Group adopted Accounting Standard Update 2014-16, Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity ("ASU 2014-16").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The amendments in ASU 2014-16 clarify how U.S. GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. Furthermore, the amendments clarify that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. Rather, the nature of the host contract depends upon the economic characteristics and risks of the entire hybrid financial instrument. The amendments also clarify that, in evaluating the nature of a host contract, an entity should assess the substance of the relevant terms and features (i.e., the relative strength of the debt-like or equity-like terms and features given the facts and circumstances) when considering how to weigh those terms and features. The assessment of the substance of the relevant terms and features should incorporate a consideration of the characteristics of the terms and features themselves; the circumstances under which the hybrid financial instrument was issued or acquired; and the potential outcomes of the hybrid financial instrument, as well as the likelihood of those potential outcomes.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The amendments in ASU 2014-16 apply to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of shares.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The effects of initially adopting the amendments in ASU 2014-16 were required to be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of shares as of the beginning of the fiscal year for which the amendments are effective. However, retrospective application was permitted to all relevant prior periods.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;Management analyzed the economic characteristics and risks of the Series A Preferred Stock and the Series B Preferred Stock (including the embedded conversion feature of each) in accordance with the provisions of ASU 2014-16 and determined that such instruments are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Preferred Stock themselves (the 'host contract') are clearly and closely related and accordingly, the embedded conversion feature was not required to be bifurcated. As a result of the above determination, ASU 2014-16 did not impact the classification of the Series A Preferred Stock or the Series B Preferred Stock.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zc0777046e1cd4ad384df34848c757cac" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;2.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standard Update 2014-09, &amp;#8220;Revenue from Contracts with Customers&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;In May 2014, the FASB issued Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;An entity should apply the amendments in ASU 2014-09 using one of the following two methods: 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;During 2016, the FASB issued several Accounting Standard Updates (&amp;#8220;ASUs&amp;#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements and Practical Expedients, Principal versus Agent Considerations and Identifying Performance Obligations and Licensing.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;For a public entity, the amendments in ASU 2014-09 (including the amendments introduced through recent ASUs) are effective for annual reporting periods beginning after December 15, 2016, including interim periods within the first annual reporting period (the first quarter of fiscal year 2017 for the Company). Early application is not permitted.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 Times New Roman , Times, serif; margin-left: 108pt"&gt;The Company is in the process of assessing the impact, if any, of ASU 2014-09 (including the amendments introduced through recent ASUs) on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zfa76c0993e284cd2842cc0294a557143" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;3.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standards Update 2014-15, &amp;#8220;Presentation of Financial Statements&amp;#8212;Going Concern&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15, Presentation of Financial Statements&amp;#8212;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern ("ASU 2014-15").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2014-15 provides guidance on management&amp;#8217;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&amp;#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued, when applicable).&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2014-15 also provides guidance related to the required disclosures as a result of management&amp;#8217;s evaluation.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;Due to the current financial condition of the Company and the existing uncertainty regarding its ability to continue as a going concern, management does not believe that the provisions of ASU 2014-15 will have a significant effect on its evaluation of the Company&amp;#8217;s ability to continue as a going concern. However, management is currently considering if additional disclosures will be required as a result of ASU 2014-15.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="za84a407cdd8648dbb1de41b73c3d76eb" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;4.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standard Update 2015-11, &amp;#8220;Simplifying the Measurement of Inventory&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;In July, 2015, The FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) ("ASU 2015-11").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value. Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance. Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;For a public entity, the amendments in ASU 2015-11 are effective, in a prospective manner, for annual reporting periods beginning after December 15, 2016, including interim periods within the first such annual reporting period (the first quarter of fiscal year 2017 for the Company). Early adoption is permitted as of the beginning of an interim or annual reporting period.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The Company is in the process of assessing the impact, if any, of ASU 2015-11 on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z667aec4ed65d4d59b71405d09c73f460" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.85pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;NOTE 4&lt;/font&gt;&lt;font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: 14.2pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="width: 14.2pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;INVENTORIES&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&#13;&lt;table align="right" border="0" cellpadding="0" cellspacing="0" id="z8cb6486e075b498aac1b5e8275a81486" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;December 31,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Raw materials&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;181,461&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;205,645&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Work in process&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;412,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;551,111&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Finished products&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;104,709&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;59,467&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 76%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;698,170&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;816,223&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <igap:FinancingExpensesNetDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div&gt;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;table cellpadding="0" cellspacing="0" id="zc405bc12abec4b92a6608532bd1aa16b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.85pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;NOTE 5&lt;/font&gt;&lt;font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: 14.2pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="width: 14.2pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;FINANCING (INCOME) EXPENSES, NET&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&#13;&lt;table align="right" border="0" cellpadding="0" cellspacing="0" id="z542e75c8ecc8434fa56490440a0600ba" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Six month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Three month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Israeli CPI linkage difference on principal of loans from stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(639&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,872&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1,808&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Exchange rate differences&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;24,211&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;38,269&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;19,296&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;90,872&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Change in fair value of Warrants with down round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(91,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(20,702&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(25,539&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Interest expenses on credit from banks and other&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;8,575&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;8,378&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;6,149&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,788&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1,270,971&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;497,674&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(32,065&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1,224,437&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,568&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;570,603&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;/div&gt;&lt;/div&gt;</igap:FinancingExpensesNetDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div&gt;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;table cellpadding="0" cellspacing="0" id="zcbfb569f9c784ed1b372de2f5b423c7b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.85pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;NOTE 6&lt;/font&gt;&lt;font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: 14.2pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="width: 14.2pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;LOSS PER SHARE&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt"&gt;In periods of net loss, basic loss per share is computed by dividing net loss for the period after consideration of the effect of dividend on preferred stock by the weighted average number of shares outstanding during the period.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt"&gt;The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2016 and 2015 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div align="right" style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z8103e4dce42a4f74a97915ac79ef5c44" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Six month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Three month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Loss for the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(2,815,762&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(3,201,337&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,588,998&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,666,806&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Cash dividend on Series A Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(9,453&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(47,036&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(4,753&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(26,522&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Stock dividend on Series B Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(254,101&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(185,795&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(131,281&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(102,558&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Stock dividend on Series C Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Loss for the period attributable to common stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(3,099,671&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(3,434,168&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,745,387&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,795,886&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z4f0175498f8045bbb3d0acd515972615" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Six month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Three month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: bold 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Number of shares:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Common shares used in computing basic income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,382,682&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,441,253&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Common shares used in computing diluted income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,382,682&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,441,253&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;11,220,345&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;9,367,247&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;12,210,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;9,537,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="ze9b77d1c22564edfb3e70983c6c06269" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.05pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.7pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;&amp;#160;(*)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;Accounting Principles&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&amp;#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The results for the six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December&amp;#160;31, 2016 or for any other interim period or for any future period.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;Principles of Consolidation&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.8pt"&gt;The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table cellpadding="0" cellspacing="0" id="ze3989ad908ac41208ab938c3981d7098" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&lt;tr&gt;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Warrants with down-round protection&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt"&gt;The Company has determined its derivative warrant liability with respect to the Series A Warrants and warrants issued to Andrew Garrett, Inc., (&amp;#8220;AGI&amp;#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value. Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&amp;#160; The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt"&gt;The changes in the fair value of the Level 3 liability are as follows (in US dollars):&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div align="right" style="text-align: left; line-height: 1.25; margin-left: 99pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Series A Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Balance, Beginning of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;321,695&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2,057,618&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Warrants issued as consideration for placement services&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;234,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;341,662&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Exchange of Series A Warrants pursuant to the &amp;#8220;most favored nation&amp;#8221; provision&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,573,435&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Change in fair value Warrants with Down-Round Protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(91,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Balance, End of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;833,153&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;392,874&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt"&gt;The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; margin-left: 99pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; text-align: center; vertical-align: top; border-top-style: none; border-top-width: medium; font-weight: bold"&gt;June 30,&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: top"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Dividend yield (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Expected volatility (%) (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;62.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;105.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Risk free interest rate (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;0.72-1.11&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.01&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Expected term of options (years) (**)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.70-5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.70&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Exercise price (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;4.50-7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Share price (US dollars) (***)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.31&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Fair value (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;0.61&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90.7pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(*)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90.7pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(**)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&amp;#160;110.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 31.5pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(***)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;The Common Stock price, per share reflects the Company&amp;#8217;s management&amp;#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table cellpadding="0" cellspacing="0" id="z88a8390d7f304d73a40584bf75cfbbb6" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&lt;tr&gt;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Recently issued accounting pronouncements&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z13b081dfc9b24a4cb8939f28e70127d0" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;1.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standard Update 2014-16, &amp;#8220;Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;Effective January 1, 2016, the Group adopted Accounting Standard Update 2014-16, Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity ("ASU 2014-16").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The amendments in ASU 2014-16 clarify how U.S. GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. Furthermore, the amendments clarify that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. Rather, the nature of the host contract depends upon the economic characteristics and risks of the entire hybrid financial instrument. The amendments also clarify that, in evaluating the nature of a host contract, an entity should assess the substance of the relevant terms and features (i.e., the relative strength of the debt-like or equity-like terms and features given the facts and circumstances) when considering how to weigh those terms and features. The assessment of the substance of the relevant terms and features should incorporate a consideration of the characteristics of the terms and features themselves; the circumstances under which the hybrid financial instrument was issued or acquired; and the potential outcomes of the hybrid financial instrument, as well as the likelihood of those potential outcomes.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The amendments in ASU 2014-16 apply to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of shares.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The effects of initially adopting the amendments in ASU 2014-16 were required to be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of shares as of the beginning of the fiscal year for which the amendments are effective. However, retrospective application was permitted to all relevant prior periods.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;Management analyzed the economic characteristics and risks of the Series A Preferred Stock and the Series B Preferred Stock (including the embedded conversion feature of each) in accordance with the provisions of ASU 2014-16 and determined that such instruments are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Preferred Stock themselves (the 'host contract') are clearly and closely related and accordingly, the embedded conversion feature was not required to be bifurcated. As a result of the above determination, ASU 2014-16 did not impact the classification of the Series A Preferred Stock or the Series B Preferred Stock.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zc0777046e1cd4ad384df34848c757cac" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;2.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standard Update 2014-09, &amp;#8220;Revenue from Contracts with Customers&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;In May 2014, the FASB issued Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;An entity should apply the amendments in ASU 2014-09 using one of the following two methods: 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;During 2016, the FASB issued several Accounting Standard Updates (&amp;#8220;ASUs&amp;#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements and Practical Expedients, Principal versus Agent Considerations and Identifying Performance Obligations and Licensing.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;For a public entity, the amendments in ASU 2014-09 (including the amendments introduced through recent ASUs) are effective for annual reporting periods beginning after December 15, 2016, including interim periods within the first annual reporting period (the first quarter of fiscal year 2017 for the Company). Early application is not permitted.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 Times New Roman , Times, serif; margin-left: 108pt"&gt;The Company is in the process of assessing the impact, if any, of ASU 2014-09 (including the amendments introduced through recent ASUs) on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zfa76c0993e284cd2842cc0294a557143" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;3.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standards Update 2014-15, &amp;#8220;Presentation of Financial Statements&amp;#8212;Going Concern&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15, Presentation of Financial Statements&amp;#8212;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern ("ASU 2014-15").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2014-15 provides guidance on management&amp;#8217;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&amp;#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued, when applicable).&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2014-15 also provides guidance related to the required disclosures as a result of management&amp;#8217;s evaluation.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;Due to the current financial condition of the Company and the existing uncertainty regarding its ability to continue as a going concern, management does not believe that the provisions of ASU 2014-15 will have a significant effect on its evaluation of the Company&amp;#8217;s ability to continue as a going concern. However, management is currently considering if additional disclosures will be required as a result of ASU 2014-15.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="za84a407cdd8648dbb1de41b73c3d76eb" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;4.&lt;/td&gt;&#13;&lt;td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;Accounting Standard Update 2015-11, &amp;#8220;Simplifying the Measurement of Inventory&amp;#8221;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;In July, 2015, The FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) ("ASU 2015-11").&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value. Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance. Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;For a public entity, the amendments in ASU 2015-11 are effective, in a prospective manner, for annual reporting periods beginning after December 15, 2016, including interim periods within the first such annual reporting period (the first quarter of fiscal year 2017 for the Company). Early adoption is permitted as of the beginning of an interim or annual reporting period.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt"&gt;The Company is in the process of assessing the impact, if any, of ASU 2015-11 on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt"&gt;The changes in the fair value of the Level 3 liability are as follows (in US dollars):&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div align="right" style="text-align: left; line-height: 1.25; margin-left: 99pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Series A Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Balance, Beginning of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;321,695&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2,057,618&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Warrants issued as consideration for placement services&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;234,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;341,662&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Exchange of Series A Warrants pursuant to the &amp;#8220;most favored nation&amp;#8221; provision&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,573,435&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Change in fair value Warrants with Down-Round Protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(91,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Balance, End of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;833,153&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;392,874&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt"&gt;The key inputs used in the fair value calculations were as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; margin-left: 99pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; text-align: center; vertical-align: top; border-top-style: none; border-top-width: medium; font-weight: bold"&gt;June 30,&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom; border-top-style: none; border-top-width: medium"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: top"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Dividend yield (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Expected volatility (%) (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;62.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;105.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Risk free interest rate (%)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;0.72-1.11&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.01&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Expected term of options (years) (**)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.70-5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.70&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Exercise price (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;4.50-7.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Share price (US dollars) (***)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;2.31&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif"&gt;Fair value (US dollars)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;0.61&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90.7pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(*)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;Due to the low trading volume of the Company&amp;#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90.7pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(**)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&amp;#160;110.&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 90pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 31.5pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;(***)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;The Common Stock price, per share reflects the Company&amp;#8217;s management&amp;#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div&gt;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&#13;&lt;table align="right" border="0" cellpadding="0" cellspacing="0" id="z8cb6486e075b498aac1b5e8275a81486" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;December 31,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Raw materials&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;181,461&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;205,645&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Work in process&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;412,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;551,111&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Finished products&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;104,709&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;59,467&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 76%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;698,170&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;816,223&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div&gt;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&#13;&lt;table align="right" border="0" cellpadding="0" cellspacing="0" id="z542e75c8ecc8434fa56490440a0600ba" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Six month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Three month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Israeli CPI linkage difference on principal of loans from stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(639&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,872&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1,808&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Exchange rate differences&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;24,211&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;38,269&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;19,296&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;90,872&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Change in fair value of Warrants with down round protection&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(64,212&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(91,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(20,702&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(25,539&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Interest expenses on credit from banks and other&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;8,575&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;8,378&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;6,149&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,788&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1,270,971&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;497,674&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(32,065&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;1,224,437&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,568&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;570,603&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div&gt;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt"&gt;The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2016 and 2015 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div align="right" style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z8103e4dce42a4f74a97915ac79ef5c44" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;US dollars&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Six month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Three month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;(unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Loss for the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(2,815,762&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(3,201,337&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,588,998&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,666,806&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Cash dividend on Series A Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(9,453&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(47,036&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(4,753&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(26,522&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Stock dividend on Series B Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(254,101&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(185,795&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(131,281&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(102,558&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Stock dividend on Series C Preferred Stock&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(20,355&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Loss for the period attributable to common stockholders&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(3,099,671&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(3,434,168&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,745,387&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;(1,795,886&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt"&gt;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" id="z4f0175498f8045bbb3d0acd515972615" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Number of shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Six month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;Three month period&lt;font style="font: 10pt times new roman, times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: bold 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Number of shares:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Common shares used in computing basic income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,382,682&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,441,253&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: #cceeff"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Common shares used in computing diluted income (loss) per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,716,566&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,382,682&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,742,468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;5,441,253&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;tr style="background-color: white"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt"&gt;Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;11,220,345&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;9,367,247&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;12,210,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 times new roman, times, serif"&gt;9,537,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="ze9b77d1c22564edfb3e70983c6c06269" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 68.05pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.7pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;&amp;#160;(*)&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div id="DSPFPageHeader"&gt;&lt;div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z1bdc38f81db948ff938740db651f898c" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.85pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;NOTE 3&lt;/font&gt;&lt;font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: 14.2pt; vertical-align: top"&gt;&lt;font style="font: bold 10pt times new roman, times, serif"&gt;&amp;#8211;&lt;/font&gt;&lt;font style="width: 14.2pt; display: inline-block; font-size: 1px"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top"&gt;RECENT EVENTS&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="zd9c63d5100a34070a7439b42b0a5d440" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 67.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.5pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;A.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;&#13;&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"&gt;&lt;font style="display: inline; font: 10pt Times New Roman"&gt;During February 2016, the Company entered into an Advisory Agreement with AGI, pursuant to which the Company retained AGI on a non-exclusive basis to provide certain advisory services to the Company. As consideration for such services, the Company extended through December 31, 2019, the expiration date of 422,077 warrants issued to AGI and/or its designees in connection with the Company&amp;#8217;s common stock offering completed in 2010 and the Series A Unit offering completed in 2012. The Advisory Agreement had an initial term of six months, subject to automatic renewal for additional 30 day terms unless terminated by either party with 30 days written notice.&amp;#160;&amp;#160;In April 2016, the Company and AGI amended that Advisory Agreement to extend the term of the Advisory Agreement for an additional six months.&amp;#160;&amp;#160;In consideration for such extension, the Company agreed to modify the terms of the 439,674 warrants issued to AGI and/or its designees in connection with the Series B Unit offering to include full-ratchet anti-dilution protection. As a result of the two agreements the Company recorded in its statement of operations for the six month and three month periods ended June 30, 2016, a one-time charge in the amount of $211,077 representing the incremental fair market value adjustments in respect of the above modified warrants issued to the placement agent. Such incremental fair market value adjustments represent the increase in the fair value of the warrants resulting from the above modifications and were recorded against stockholders&amp;#8217; deficit. In addition, as a result of the inclusion of anti-dilution protection, the Company classified $341,662, representing the fair market value at April 2016 of the above 439,674 warrants issued to AGI out of stockholders deficit and presented them as Warrants with down round protection within long-term liabilities.&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table cellpadding="0" cellspacing="0" id="z2aee9f8d279b435ab28e691f17484b57" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 67.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 22.5pt; font: 10pt times new roman, times, serif; vertical-align: top"&gt;B.&lt;/td&gt;&#13;&lt;td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top"&gt;&#13;&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"&gt;&lt;font style="display: inline; font: 10pt Times New Roman"&gt;During the three month period ended June 30, 2016, the Company raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) from the issuance in four separate closings of 4,425 Series C Units. As of June 30, 2016, the shares of Preferred Stock comprising the Series C Units are convertible into an aggregate of 983,386 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 1,966,772 shares of Common Stock, in each case subject to adjustment as described below.&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Pursuant to a placement agent agreement (the &amp;#8220;Placement Agent Agreement&amp;#8221;) with AGI, at the initial closing of the sale of the Series C Units the Company paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units. At the end of the second, third and fourth closings of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing. In addition, pursuant to the Placement Agent Agreement, the Company is required to issue to AGI: (a) 5 year warrants to purchase up to 196,678 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 98,339 shares of Common Stock at an exercise price of $7.75 per share. The terms of such warrants will be substantially similar to the Series C Warrants except that the warrants issued to AGI will also be exercisable on a cashless basis and will include full ratchet anti-dilution protection.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Subject to certain ownership limitations described below, the Series C Preferred Stock is convertible at the option of the holder at any time and from time to time into shares of Common Stock at a conversion price of $4.50 per share (calculated by dividing the stated value per share of Preferred Stock, which is initially $1,000, by the conversion price per share). The conversion price of the Series C Preferred Stock is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect, as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders. In addition, the holders of Preferred Stock will be entitled to receive any securities or rights to acquire securities or property granted or issued by the Company pro rata to the holders of Common Stock to the same extent as if such holders had converted all of their shares of Series C Preferred Stock prior to such distribution. In the event of a fundamental transaction, such as a merger, consolidation, sale of substantially all assets and similar reorganizations or recapitalizations of the Company, the holders of Series C Preferred Stock will be entitled to receive, upon conversion of their shares of Series C Preferred Stock, any securities or other consideration received by the holders of the Common Stock pursuant to the fundamental transaction.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Holders of Series C Preferred Stock are entitled to receive cumulative dividends at a rate of 5.5% per annum, based on the stated value per share of Series C Preferred Stock. Dividends on the Series C Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on June 30, 2016, and on each conversion date (with respect to the shares of Preferred Stock being converted). For so long as required under the terms of the Certificate of Designations for the Company&amp;#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, dividends will be payable only in shares of Common Stock. Thereafter, dividends on the Series C Preferred Stock will be payable, at the option of the Company, in cash and/or, if certain conditions are satisfied, shares of Common Stock or a combination of both. Shares of Common Stock issued as payment of dividends will be valued at the lower of (a) the then current conversion price of the Series C Preferred Stock or (b) the average of the volume weighted average price for the Common Stock on the principal trading market therefor for the 10 trading days immediately prior to the applicable dividend payment date. The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Subject to any limitations under the terms of the Certificate of Designations for the Company&amp;#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, the Company may become obligated to redeem the Series C Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Series C Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service. In addition, upon the occurrence of certain triggering events, each holder of Series C Preferred Stock will have the option to require the Company to redeem such holder&amp;#8217;s shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder&amp;#8217;s outstanding Series C Preferred Stock.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Subject to certain conditions contained in the Certificate of Designations, Preferences and Rights relating to the Series C Preferred Stock (the &amp;#8220;Certificate of Designations&amp;#8221;), the Company will have the option to force the conversion of the Series C Preferred Stock (in whole or in part) if (a) the volume weighted average price for the Common Stock on its principal trading market exceeds $7.00 for each of any 20 trading days during any 30 consecutive trading day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $50,000 or (b) the Company receives approval to list the Common Stock on a national securities exchange.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Subject to certain exceptions contained in the Certificate of Designations, if the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Series C Preferred Stock (the &amp;#8220;Conversion Shares&amp;#8221;) and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a &amp;#8220;Buy-In&amp;#8221;), the Company will be required to: (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder&amp;#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Series C Preferred Stock equal to the number of shares of Series C Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements. In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Series C Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the fifth trading day following the applicable conversion date and the Company will continue to pay such partial liquidated damages for each trading day after such eighth trading day until such certificates are delivered or the holder rescinds such conversion.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;As long as at least 35% of the originally issued shares of Series C Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Series C Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Subject to the beneficial ownership limitation described below, holders of Series C Preferred Stock will vote together with the holders of Common Stock and Series A Preferred Stock and Series B Preferred Stock on an as-converted basis. Holders will not be permitted to convert their Series C Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding Common Stock (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the &amp;#8220;Beneficial Ownership Limitation&amp;#8221;). In addition, no holder may vote any shares of Series C Preferred Stock (on an as-converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Subject to certain limitations, so long as any purchaser holds any shares of Series C Preferred Stock, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series C Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser after taking into account all of the terms and conditions of the terms granted to the purchasers under the purchase agreement and the terms granted in such subsequent issuance or sale, including all of the components of the Series C Units and of the securities or units involved in such subsequent issuance or sale, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;The Series C Warrants have a five-year term commencing on their respective issuance dates. Until the end of the applicable term, each Series C Warrant will be exercisable at any time and from time to time at an exercise price of $4.50 per share (with respect to the Series C-1 Warrants) or $7.75 per share (with respect to the Series C-2 Warrants). The Series C Warrants contain adjustment provisions substantially similar to those to the adjustment provisions of the Series C Preferred Stock as described above, except that the Series C Warrants do not include dilution protection for issuances of securities at an effective price per share lower than the conversion price of such Series C Warrants. In addition, the Series C Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Series C Preferred Stock. No holder may exercise its Series C Warrants in excess of the Beneficial Ownership Limitation.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;As a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the Series A Warrants, on April 8, 2016, the exercise price per share of the Series A Warrants decreased from $5.80 per share to $4.50 per share and the number of shares of Common Stock issuable upon exercise of each of the Series A Warrants, in the aggregate, increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, will be equal to the aggregate exercise price prior to such adjustment. Also as a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the certificates of designations for the Series A Preferred Stock and Series B Preferred Stock, on April 8, 2016, the conversion price per share of Series A Preferred Stock and Series B Preferred Stock decreased to $4.50 per share.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Based on the terms of the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, respectively, so long as any initial purchaser of Series A Units or Series B Units, as applicable (each, a &amp;#8220;Purchaser&amp;#8221;) holds any shares of Series A Preferred Stock or Series B Preferred Stock, as applicable, if (1) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (2) a Purchaser then holding Series A or Series B Preferred Stock or Warrants reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such Purchaser, then the Purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such Purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such Purchaser).&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Pursuant to the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, the Company was required to and did notify the holders of the Series A Preferred Stock and Series B Preferred Stock of the closing of the sale of the Series C Units,&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;and following receipt thereof such holders of Series A Preferred Stock and Series B Preferred Stock will be entitled, pursuant to the &amp;#8220;most favored nation&amp;#8221; provisions contained in their respective purchase agreements (as described above), to elect to amend the terms of their purchase of Series A Units and Series B Units, respectively, to match the terms of the Series C Units. The Company is obligated to amend the terms of any of Series A Units or Series B Units who timely makes such election and tenders its Series A Units or Series B Units for exchange.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Upon initial recognition, the Series C Preferred Stock issued together with detachable Series C Warrants (classified as equity) were measured based on the relative fair value basis and were presented net of the direct issuance expenses that were allocated to them.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;The Company has determined that due to the economic characteristics and risks of the Series C Preferred Stock, based on their stated or implied substantive terms and features, that such Preferred Stock, are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Series C Preferred Stock themselves (the 'host contract') are clearly and closely related. As a result, the embedded conversion feature was not required to be bifurcated.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25; font-weight: normal"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt"&gt;Since at the issuance dates of the Series C Preferred Stock, the exercise price of the conversion feature (based on the effective conversion rate of the Series C Preferred Stock into Common Stock) was higher than the estimated fair value of the Company&amp;#8217;s Common Stock, it was determined that the conversion feature was not beneficial. Also, due to the liquidation preference and certain redemption rights for the benefit of the holders of the Series C Preferred Stock, upon the occurrence of the certain contingent events, which are not considered as solely within the Company's control management determined that the Series C Preferred Stock were to be presented as temporary equity. On each balance sheet date, the Company&amp;#8217;s management assesses the probability of redemption of the outstanding Preferred Stock. In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will recognize a liability in an amount equal to the aggregate redemption price of the Preferred Stock. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and such redemption amount will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-04" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-2" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-1" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-03" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">The Common Stock price, per share reflects the Company's management's estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3). </link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>igap-20160630.xsd
<DESCRIPTION>TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 6%2D30%2D16 10Q.xfr; Date: 2016%2D08%2D15T19:20:15Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80110001 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +a45o7xRiXhun8uHZnVMWaaEabPtx5R6eekxs2R3HdnaXywqHBlHoSR3Z0L2cUUA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:igap="http://integrity-app.com/20160630" elementFormDefault="qualified" targetNamespace="http://integrity-app.com/20160630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://integrity-app.com/role/igap-daei1" id="igap-daei1">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" id="Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" id="Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" id="Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" id="Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT">
	  <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" id="Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-csocfp" id="igap-csocfp">
	  <link:definition>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-g" id="igap-g">
	  <link:definition>00000008 - Disclosure - GENERAL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-sosap" id="igap-sosap">
	  <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" id="Disclosure-EVENTSDURINGTHEREPORTEDPERIOD">
	  <link:definition>00000010 - Disclosure - RECENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-i" id="igap-i">
	  <link:definition>00000011 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" id="Disclosure-FINANCINGINCOMEEXPENSESNET">
	  <link:definition>00000012 - Disclosure - FINANCING (INCOME) EXPENSES, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" id="Disclosure-LOSSPERSHARE">
	  <link:definition>00000013 - Disclosure - LOSS PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-sosapp" id="igap-sosapp">
	  <link:definition>00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-sosapt" id="igap-sosapt">
	  <link:definition>00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-it1" id="igap-it1">
	  <link:definition>00000016 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" id="Disclosure-FINANCINGINCOMEEXPENSESNETTables">
	  <link:definition>00000017 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" id="Disclosure-LOSSPERSHARETables">
	  <link:definition>00000018 - Disclosure - LOSS PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/GeneralDetails" id="GeneralDetails">
	  <link:definition>00000019 - Disclosure - GENERAL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" id="SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails">
	  <link:definition>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" id="CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails">
	  <link:definition>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" id="EventsDuringReportedPeriodDetails">
	  <link:definition>00000022 - Disclosure - RECENT EVENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/igap-id" id="igap-id">
	  <link:definition>00000023 - Disclosure - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" id="Disclosure-FINANCINGINCOMEEXPENSESNETDetails">
	  <link:definition>00000024 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" id="Disclosure-LOSSPERSHAREDetails">
	  <link:definition>00000025 - Disclosure - LOSS PER SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20160630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20160630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20160630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="igap-20160630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" name="FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_FinancingIncomeExpensesNet" name="FinancingIncomeExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" name="LinkageDifferenceOnPrincipalOfLoansFromStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_GainLossOnUnitConversion" name="GainLossOnUnitConversion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" name="ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockConversionPrice" name="PreferredStockConversionPrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ClassOfWarrantOrRightTerm" name="ClassOfWarrantOrRightTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" name="ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ChangeInFairValueOfSeriesaWarrants" name="ChangeInFairValueOfSeriesaWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ClassOfWarrantOrRightFairValue" name="ClassOfWarrantOrRightFairValue" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfUnitsSold" name="NumberOfUnitsSold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" name="NumberOfConvertiblePreferredSharesOfferedPerUnit" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" name="ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" name="NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" name="AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" name="AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" name="RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_RegistrationPaymentArrangementCommissionPercentage" name="RegistrationPaymentArrangementCommissionPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" name="NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" name="IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" name="AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" name="AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" name="StockIssuedDuringPeriodValueStockDividendPreferredClassc" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PreferredStockDividendsSharesPreferredStockClassc" name="PreferredStockDividendsSharesPreferredStockClassc" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" name="FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" name="AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" name="AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" name="IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" name="IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="igap_FinancingExpensesNetDisclosureTextBlock" name="FinancingExpensesNetDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ExchangeOneMember" name="ExchangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesB1WarrantMember" name="SeriesB1WarrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesB2WarrantMember" name="SeriesB2WarrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesAWarrantMember" name="SeriesAWarrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ArbitrationProceedingsWithShareholderMember" name="ArbitrationProceedingsWithShareholderMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_ExchangeTwoMember" name="ExchangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AprilTwoThousandSixteenOfferingMember" name="AprilTwoThousandSixteenOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesConeWarrantMember" name="SeriesConeWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SeriesCtwoWarrantMember" name="SeriesCtwoWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_AgreementWithPlacementAgentMember" name="AgreementWithPlacementAgentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PlacementAgentWarrantsTrancheTwoMember" name="PlacementAgentWarrantsTrancheTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_PlacementAgentWarrantsTrancheOneMember" name="PlacementAgentWarrantsTrancheOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_InitialClosingMember" name="InitialClosingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SecondClosingMember" name="SecondClosingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="igap_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="igap_EventsDuringReportingPeriodAbstract" name="EventsDuringReportingPeriodAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="igap_TemporaryEquityPolicyPolicyTextBlock" name="TemporaryEquityPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="igap_SaleAgreementAxis" name="SaleAgreementAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="igap_SaleAgreementDomain" name="SaleAgreementDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>igap-20160630_cal.xml
<DESCRIPTION>TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 6%2D30%2D16 10Q.xfr; Date: 2016%2D08%2D15T19:20:15Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80110001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://integrity-app.com/role/igap-daei1" xlink:href="igap-20160630.xsd#igap-daei1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-csocfp" xlink:href="igap-20160630.xsd#igap-csocfp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-g" xlink:href="igap-20160630.xsd#igap-g" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosap" xlink:href="igap-20160630.xsd#igap-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:href="igap-20160630.xsd#Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-i" xlink:href="igap-20160630.xsd#igap-i" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHARE" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapp" xlink:href="igap-20160630.xsd#igap-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapt" xlink:href="igap-20160630.xsd#igap-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-it1" xlink:href="igap-20160630.xsd#igap-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHARETables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/GeneralDetails" xlink:href="igap-20160630.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:href="igap-20160630.xsd#SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:href="igap-20160630.xsd#CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:href="igap-20160630.xsd#EventsDuringReportedPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-id" xlink:href="igap-20160630.xsd#igap-id" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHAREDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-daei1" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_igapFinancingIncomeExpensesNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_GainLossOnUnitConversion" xlink:label="loc_igapGainLossOnUnitConversion" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_igapGainLossOnUnitConversion" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="loc_igapIncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_igapIncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapPaymentsOfDividendsPreferredStockAndPreferenceStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-csocfp" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-g" xlink:title="00000008 - Disclosure - GENERAL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosap" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:title="00000010 - Disclosure - RECENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-i" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:title="00000012 - Disclosure - FINANCING (INCOME) EXPENSES, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:title="00000013 - Disclosure - LOSS PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapp" xlink:title="00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapt" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-it1" xlink:title="00000016 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:title="00000017 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:title="00000018 - Disclosure - LOSS PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/GeneralDetails" xlink:title="00000019 - Disclosure - GENERAL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:title="00000022 - Disclosure - RECENT EVENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-id" xlink:title="00000023 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:title="00000024 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_GainLossOnUnitConversion" xlink:label="loc_igapGainLossOnUnitConversion" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_igapFinancingIncomeExpensesNet" xlink:to="loc_igapGainLossOnUnitConversion" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:title="00000025 - Disclosure - LOSS PER SHARE (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>igap-20160630_def.xml
<DESCRIPTION>TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 6%2D30%2D16 10Q.xfr; Date: 2016%2D08%2D15T19:20:15Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80110001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://integrity-app.com/role/igap-daei1" xlink:href="igap-20160630.xsd#igap-daei1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-csocfp" xlink:href="igap-20160630.xsd#igap-csocfp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-g" xlink:href="igap-20160630.xsd#igap-g" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosap" xlink:href="igap-20160630.xsd#igap-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:href="igap-20160630.xsd#Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-i" xlink:href="igap-20160630.xsd#igap-i" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHARE" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapp" xlink:href="igap-20160630.xsd#igap-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapt" xlink:href="igap-20160630.xsd#igap-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-it1" xlink:href="igap-20160630.xsd#igap-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHARETables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/GeneralDetails" xlink:href="igap-20160630.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:href="igap-20160630.xsd#SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:href="igap-20160630.xsd#CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:href="igap-20160630.xsd#EventsDuringReportedPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-id" xlink:href="igap-20160630.xsd#igap-id" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHAREDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-daei1" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsCurrentAbstract_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapInventoryNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapOtherAssetsCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAssetsCurrent_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssets_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccountsPayableCurrent_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrent_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapDueToOfficersOrStockholdersNoncurrent_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrent_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilities_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommitmentsAndContingencies_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityAbstract_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquityAbstract_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommonStockValue_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_110" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_110" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="loc_igapIncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapIncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:label="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PreferredStockDividendsSharesPreferredStockClassc" xlink:label="loc_igapPreferredStockDividendsSharesPreferredStockClassc_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapPreferredStockDividendsSharesPreferredStockClassc_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="loc_us-gaapPreferredStockDividendsShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsShares_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-csocfp" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:label="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-g" xlink:title="00000008 - Disclosure - GENERAL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosap" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:title="00000010 - Disclosure - RECENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-i" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:title="00000012 - Disclosure - FINANCING (INCOME) EXPENSES, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:title="00000013 - Disclosure - LOSS PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapp" xlink:title="00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapt" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-it1" xlink:title="00000016 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:title="00000017 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:title="00000018 - Disclosure - LOSS PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/GeneralDetails" xlink:title="00000019 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="loc_igapAprilTwoThousandSixteenOfferingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAprilTwoThousandSixteenOfferingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesB1WarrantMember" xlink:label="loc_igapSeriesB1WarrantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesB1WarrantMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesB2WarrantMember" xlink:label="loc_igapSeriesB2WarrantMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesB2WarrantMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesConeWarrantMember" xlink:label="loc_igapSeriesConeWarrantMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesConeWarrantMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesCtwoWarrantMember" xlink:label="loc_igapSeriesCtwoWarrantMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesCtwoWarrantMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquity_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:label="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConversionPrice_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold_170" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightFairValue" xlink:label="loc_igapClassOfWarrantOrRightFairValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_igapClassOfWarrantOrRightFairValue_110" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:title="00000022 - Disclosure - RECENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AgreementWithPlacementAgentMember" xlink:label="loc_igapAgreementWithPlacementAgentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAgreementWithPlacementAgentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="loc_igapAprilTwoThousandSixteenOfferingMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAprilTwoThousandSixteenOfferingMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SaleAgreementAxis" xlink:label="loc_igapSaleAgreementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_igapSaleAgreementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SaleAgreementDomain" xlink:label="loc_igapSaleAgreementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_igapSaleAgreementAxis" xlink:to="loc_igapSaleAgreementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SaleAgreementDomain" xlink:label="loc_igapSaleAgreementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_igapSaleAgreementAxis" xlink:to="loc_igapSaleAgreementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_InitialClosingMember" xlink:label="loc_igapInitialClosingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapInitialClosingMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SecondClosingMember" xlink:label="loc_igapSecondClosingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapSecondClosingMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheOneMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheTwoMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_RegistrationPaymentArrangementCommissionPercentage" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentage_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:label="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-id" xlink:title="00000023 - Disclosure - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:title="00000024 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:title="00000025 - Disclosure - LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="loc_us-gaapDividendsPreferredStockStock_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDividendsPreferredStockStock_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_170" xlink:type="arc" order="7" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>igap-20160630_lab.xml
<DESCRIPTION>TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 6%2D30%2D16 10Q.xfr; Date: 2016%2D08%2D15T19:20:15Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80110001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid in capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated other comprehensive income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US">Liability Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesB1WarrantMember" xlink:label="igap_SeriesB1WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB1WarrantMember" xlink:to="igap_SeriesB1WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesB1WarrantMember_lbl" xml:lang="en-US">Series B-1 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesB2WarrantMember" xlink:label="igap_SeriesB2WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB2WarrantMember" xlink:to="igap_SeriesB2WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesB2WarrantMember_lbl" xml:lang="en-US">Series B-2 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="igap_AprilTwoThousandSixteenOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AprilTwoThousandSixteenOfferingMember" xlink:to="igap_AprilTwoThousandSixteenOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AprilTwoThousandSixteenOfferingMember_lbl" xml:lang="en-US">April 2016 to June 2016 Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="us-gaap_RegistrationPaymentArrangementByArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:to="us-gaap_RegistrationPaymentArrangementByArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegistrationPaymentArrangementByArrangementAxis_lbl" xml:lang="en-US">Registration Payment Arrangement by Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C 5.5% Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesConeWarrantMember" xlink:label="igap_SeriesConeWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesConeWarrantMember" xlink:to="igap_SeriesConeWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesConeWarrantMember_lbl" xml:lang="en-US">Series C-1 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesCtwoWarrantMember" xlink:label="igap_SeriesCtwoWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesCtwoWarrantMember" xlink:to="igap_SeriesCtwoWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesCtwoWarrantMember_lbl" xml:lang="en-US">Series C-2 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AgreementWithPlacementAgentMember" xlink:label="igap_AgreementWithPlacementAgentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AgreementWithPlacementAgentMember" xlink:to="igap_AgreementWithPlacementAgentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AgreementWithPlacementAgentMember_lbl" xml:lang="en-US">Advisory Agreement with Andrew Garrett, Inc.[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="igap_PlacementAgentWarrantsTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheTwoMember" xlink:to="igap_PlacementAgentWarrantsTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PlacementAgentWarrantsTrancheTwoMember_lbl" xml:lang="en-US">Placement Agent Warrants Tranche Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="igap_PlacementAgentWarrantsTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheOneMember" xlink:to="igap_PlacementAgentWarrantsTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PlacementAgentWarrantsTrancheOneMember_lbl" xml:lang="en-US">Placement Agent Warrants Tranche One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_InitialClosingMember" xlink:label="igap_InitialClosingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_InitialClosingMember" xlink:to="igap_InitialClosingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_InitialClosingMember_lbl" xml:lang="en-US">Initial Closing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SaleAgreementAxis" xlink:label="igap_SaleAgreementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SaleAgreementAxis" xlink:to="igap_SaleAgreementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SaleAgreementAxis_lbl" xml:lang="en-US">Sale Agreement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SecondClosingMember" xlink:label="igap_SecondClosingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SecondClosingMember" xlink:to="igap_SecondClosingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SecondClosingMember_lbl" xml:lang="en-US">Second Closing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_DocumentAndEntityInformationAbstract" xlink:label="igap_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DocumentAndEntityInformationAbstract" xlink:to="igap_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">A S S E T S</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xml:lang="en-US">Long-Term Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:to="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_lbl" xml:lang="en-US">Funds in Respect of Employee Rights Upon Retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="us-gaap_DueToOfficersOrStockholdersNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:to="us-gaap_DueToOfficersOrStockholdersNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOfficersOrStockholdersNoncurrent_lbl" xml:lang="en-US">Long-Term Loans from Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="us-gaap_PostemploymentBenefitsLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:to="us-gaap_PostemploymentBenefitsLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitsLiabilityNoncurrent_lbl" xml:lang="en-US">Liability for Employee Rights Upon Retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants with Down-Round Protection</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Total temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock of $ 0.001 par value ("Common Stock"): 40,000,000 shares authorized as of June 30, 2016 and December 31, 2015; 5,805,560 and 5,690,097 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, temporary equity and stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Convertible Preferred Stock, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Convertible Preferred Stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Convertible Preferred Stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Convertible Preferred Stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, marketing and general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="igap_FinancingIncomeExpensesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FinancingIncomeExpensesNet_lbl" xml:lang="en-US">Financing (income) expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive (income) loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Loss per share (Basic)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Loss per share (Diluted)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Common shares used in computing Basic income (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Common shares used in computing Diluted income (loss) per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Loss for the period of six months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued_lbl" xml:lang="en-US">Amounts allocated to Series C-1 and Series C-2 Warrants, net</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_lbl" xml:lang="en-US">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection within long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" xlink:to="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent_lbl" xml:lang="en-US">Incremental fair market value adjustments of modified warrants issued to placement agent</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:to="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc_lbl" xml:lang="en-US">Stock dividend on Series C Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PreferredStockDividendsSharesPreferredStockClassc" xlink:label="igap_PreferredStockDividendsSharesPreferredStockClassc" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockDividendsSharesPreferredStockClassc" xlink:to="igap_PreferredStockDividendsSharesPreferredStockClassc_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockDividendsSharesPreferredStockClassc_lbl" xml:lang="en-US">Stock dividend on Series C Preferred Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xml:lang="en-US">Stock dividend on Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="us-gaap_PreferredStockDividendsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xml:lang="en-US">Stock dividend on Series B Preferred Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xml:lang="en-US">Cash dividend on Series A Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile income (loss) for the period to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:to="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_lbl" xml:lang="en-US">Incremental fair market value adjustments of modified warrants issued to placement agent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in the fair value of Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_lbl" xml:lang="en-US">Linkage difference on principal of loans from stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_GainLossOnUnitConversion" xlink:label="igap_GainLossOnUnitConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_GainLossOnUnitConversion" xlink:to="igap_GainLossOnUnitConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_GainLossOnUnitConversion_lbl" xml:lang="en-US">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Increase in accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Decrease (increase) in inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">(Decrease) increase in accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Increase in other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement_lbl" xml:lang="en-US">Increase in funds in respect of employee rights upon retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Cash dividend on Series A Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds allocated to Series C Warrants, net of cash issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of loan from stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents at end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:to="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_lbl" xml:lang="en-US">Warrants issued as consideration for placement agent services</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_lbl" xml:lang="en-US">Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capita</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_lbl" xml:lang="en-US">Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_2_lbl" xml:lang="en-US">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection within long-term liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:to="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc_2_lbl" xml:lang="en-US">Stock dividend on Series C Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xml:lang="en-US">Stock dividend on Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="igap_EventsDuringReportingPeriodAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_EventsDuringReportingPeriodAbstract" xlink:to="igap_EventsDuringReportingPeriodAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_EventsDuringReportingPeriodAbstract_lbl" xml:lang="en-US">EVENTS DURING THE REPORTED PERIOD [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl" xml:lang="en-US">RECENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingExpensesNetDisclosureTextBlock" xlink:label="igap_FinancingExpensesNetDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingExpensesNetDisclosureTextBlock" xlink:to="igap_FinancingExpensesNetDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_FinancingExpensesNetDisclosureTextBlock_lbl" xml:lang="en-US">FINANCING (INCOME) EXPENSES, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accounting principles</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants with down-round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently issued accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates in the preparation of financial statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional currency</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy" xlink:label="us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy" xlink:to="us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy_lbl" xml:lang="en-US">Liability for employee rights upon retirement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesRoyaltyFees" xlink:label="us-gaap_RevenueRecognitionServicesRoyaltyFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionServicesRoyaltyFees" xlink:to="us-gaap_RevenueRecognitionServicesRoyaltyFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionServicesRoyaltyFees_lbl" xml:lang="en-US">Royalty-bearing grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="us-gaap_StandardProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyPolicy_lbl" xml:lang="en-US">Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted income (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of credit risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_TemporaryEquityPolicyPolicyTextBlock" xlink:label="igap_TemporaryEquityPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_TemporaryEquityPolicyPolicyTextBlock" xlink:to="igap_TemporaryEquityPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_TemporaryEquityPolicyPolicyTextBlock_lbl" xml:lang="en-US">Temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Fair Value of Level 3 Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock_lbl" xml:lang="en-US">Schedule of Warrant Inputs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Financing (Income) Expenses, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Loss and Weighted Average Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:label="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:to="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_lbl" xml:lang="en-US">Proceeds from issuance of Common Stock, net of issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:to="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl" xml:lang="en-US">Proceeds from convertible preferred stock and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Dividend rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PreferredStockConversionPrice" xlink:label="igap_PreferredStockConversionPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConversionPrice" xlink:to="igap_PreferredStockConversionPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_PreferredStockConversionPrice_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="igap_ClassOfWarrantOrRightTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightTerm" xlink:to="igap_ClassOfWarrantOrRightTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ClassOfWarrantOrRightTerm_lbl" xml:lang="en-US">Warrants term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:to="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_lbl" xml:lang="en-US">Shares convertible into</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Number of shares covered by warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:to="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfInterestInCorporateUnit_lbl" xml:lang="en-US">Proceeds from issuance of Series C Units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:to="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_lbl" xml:lang="en-US">Number of convertible preferred shares offered per unit sold</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfUnitsSold" xlink:label="igap_NumberOfUnitsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfUnitsSold" xlink:to="igap_NumberOfUnitsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfUnitsSold_lbl" xml:lang="en-US">Number of units sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance, Beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:to="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_2_lbl" xml:lang="en-US">Warrants issued as consideration for placement services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_3_lbl" xml:lang="en-US">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" xlink:label="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" xlink:to="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision_lbl" xml:lang="en-US">Exchange of Series A Warrants pursuant to the 'most favored nation' provision</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ChangeInFairValueOfSeriesaWarrants" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChangeInFairValueOfSeriesaWarrants" xlink:to="igap_ChangeInFairValueOfSeriesaWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants_lbl" xml:lang="en-US">Change in fair value Warrants with Down-Round Protection</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Balance, End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xml:lang="en-US">Expected term of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="us-gaap_FairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExercisePrice" xlink:to="us-gaap_FairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightFairValue" xlink:label="igap_ClassOfWarrantOrRightFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightFairValue" xlink:to="igap_ClassOfWarrantOrRightFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ClassOfWarrantOrRightFairValue_lbl" xml:lang="en-US">Fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SaleAgreementAxis" xlink:to="igap_SaleAgreementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_SaleAgreementAxis_2_lbl" xml:lang="en-US">SaleAgreementAxis [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Number of common stock shares callable by warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xml:lang="en-US">Commission fee to agent expressed as percentage of aggregate sales price of the Units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_RegistrationPaymentArrangementCommissionPercentage" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentage" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentage_lbl" xml:lang="en-US">Managment fee percentage commission to agent</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_lbl" xml:lang="en-US">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. from the company's common stock offering completed in 2010, that were subsequently extended</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_lbl" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. in connection with the Series B Unit offering, that were subsequently extended</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:label="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:to="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_lbl" xml:lang="en-US">Amount company expects it will classify as the fair market value at the time the warrants are issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in progress</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished products</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_2_lbl" xml:lang="en-US">Israeli CPI linkage difference on principal of loans from stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Exchange rate differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Change in fair value of Warrants with down round protection</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expenses on credit from banks and other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="igap_FinancingIncomeExpensesNet_2_lbl" xml:lang="en-US">Financing (income) expenses, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DividendsPreferredStockCash_2_lbl" xml:lang="en-US">Cash dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="us-gaap_DividendsPreferredStockStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStockStock_lbl" xml:lang="en-US">Stock dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Loss for the period attributable to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xml:lang="en-US">Number of shares:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total weighted average number of common shares related to outstanding convertible preferred stock, options and warrants excluded from the calculations of diluted loss per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AgreementWithPlacementAgentMember" xlink:to="igap_AgreementWithPlacementAgentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AgreementWithPlacementAgentMember_doc" xml:lang="en-US">Agreement with Placement Agent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ArbitrationProceedingsWithShareholderMember" xlink:label="igap_ArbitrationProceedingsWithShareholderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ArbitrationProceedingsWithShareholderMember" xlink:to="igap_ArbitrationProceedingsWithShareholderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ArbitrationProceedingsWithShareholderMember_doc" xml:lang="en-US">Arbitration Proceedings with Shareholder [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightFairValue" xlink:to="igap_ClassOfWarrantOrRightFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ClassOfWarrantOrRightFairValue_doc" xml:lang="en-US">Class Of Warrant Or Right, Fair Value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ClassOfWarrantOrRightTerm" xlink:to="igap_ClassOfWarrantOrRightTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ClassOfWarrantOrRightTerm_doc" xml:lang="en-US">Class Of Warrant Or Right, Term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:to="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion_doc" xml:lang="en-US">Convertible Preferred Stock, Aggregate Number of Shares Issued upon Conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_DocumentAndEntityInformationAbstract" xlink:to="igap_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document and Entity Information [Abstract].</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ExchangeOneMember" xlink:label="igap_ExchangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeOneMember" xlink:to="igap_ExchangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ExchangeOneMember_doc" xml:lang="en-US">Exchange One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ExchangeTwoMember" xlink:label="igap_ExchangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeTwoMember" xlink:to="igap_ExchangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ExchangeTwoMember_doc" xml:lang="en-US">Exchange Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingExpensesNetDisclosureTextBlock" xlink:to="igap_FinancingExpensesNetDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FinancingExpensesNetDisclosureTextBlock_doc" xml:lang="en-US">The entire disclosure relating to financing expenses, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FinancingIncomeExpensesNet" xlink:to="igap_FinancingIncomeExpensesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FinancingIncomeExpensesNet_doc" xml:lang="en-US">Financing Income (Expenses), Net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:to="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent_doc" xml:lang="en-US">Funds In Respect Of Employee Rights Upon Retirement, Noncurrent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_GainLossOnUnitConversion" xlink:to="igap_GainLossOnUnitConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_GainLossOnUnitConversion_doc" xml:lang="en-US">The gain (loss) resulting from a unit conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:to="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders_doc" xml:lang="en-US">Linkage difference on principal of loans from stockholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfUnitsSold" xlink:to="igap_NumberOfUnitsSold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfUnitsSold_doc" xml:lang="en-US">Number Of Units Sold.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockConversionPrice" xlink:to="igap_PreferredStockConversionPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockConversionPrice_doc" xml:lang="en-US">Preferred Stock, Conversion Price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:to="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts_doc" xml:lang="en-US">The cash inflow from the additional capital contribution to the entity, net of issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentage" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentage_doc" xml:lang="en-US">Managment fee percentage commission to agent.</link:label>
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesAWarrantMember" xlink:label="igap_SeriesAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesAWarrantMember" xlink:to="igap_SeriesAWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesAWarrantMember_doc" xml:lang="en-US">Represents information pertaining to Series A warrant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB1WarrantMember" xlink:to="igap_SeriesB1WarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesB1WarrantMember_doc" xml:lang="en-US">Represents information pertaining to series B warrant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesB2WarrantMember" xlink:to="igap_SeriesB2WarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesB2WarrantMember_doc" xml:lang="en-US">Series B2 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_TemporaryEquityPolicyPolicyTextBlock" xlink:to="igap_TemporaryEquityPolicyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_TemporaryEquityPolicyPolicyTextBlock_doc" xml:lang="en-US">Temporary Equity Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" xlink:to="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision_doc" xml:lang="en-US">Change in fair value of Level 3 liability due to exchange of Series A Warrants pursuant to the 'Most favored nation' provision</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChangeInFairValueOfSeriesaWarrants" xlink:to="igap_ChangeInFairValueOfSeriesaWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants_doc" xml:lang="en-US">Change in fair value of Series A Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AprilTwoThousandSixteenOfferingMember" xlink:to="igap_AprilTwoThousandSixteenOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AprilTwoThousandSixteenOfferingMember_doc" xml:lang="en-US">April 2016 Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:to="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfConvertiblePreferredSharesOfferedPerUnit_doc" xml:lang="en-US">Number of convertible preferred shares offered per unit sold.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesConeWarrantMember" xlink:to="igap_SeriesConeWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesConeWarrantMember_doc" xml:lang="en-US">Series C-1 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesCtwoWarrantMember" xlink:to="igap_SeriesCtwoWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SeriesCtwoWarrantMember_doc" xml:lang="en-US">Series C-2 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xml:lang="en-US">Commission fee to agent expressed as percentage of aggregate sales price of the Units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:to="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits_doc" xml:lang="en-US">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheOneMember" xlink:to="igap_PlacementAgentWarrantsTrancheOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PlacementAgentWarrantsTrancheOneMember_doc" xml:lang="en-US">Placement Agent Warrants Tranche One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PlacementAgentWarrantsTrancheTwoMember" xlink:to="igap_PlacementAgentWarrantsTrancheTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PlacementAgentWarrantsTrancheTwoMember_doc" xml:lang="en-US">Placement Agent Warrants Tranche Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. from the company's common stock offering completed in 2010, that were subsequently extended.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:to="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement_doc" xml:lang="en-US">Number of prior warrants provided to Andrew Garrett, Inc. in connection with the Series B Unit offering, that were subsequently extended</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:to="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance_doc" xml:lang="en-US">Amount company expects it will classify as the fair market value at the time the warrants are issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SaleAgreementAxis" xlink:to="igap_SaleAgreementAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SaleAgreementAxis_doc" xml:lang="en-US">Sale Agreement [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_InitialClosingMember" xlink:to="igap_InitialClosingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_InitialClosingMember_doc" xml:lang="en-US">Initial Closing [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SecondClosingMember" xlink:to="igap_SecondClosingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_SecondClosingMember_doc" xml:lang="en-US">Second Closing [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement_doc" xml:lang="en-US">Increase (Decrease) In Funds In Respect Of Employee Rights Upon Retirement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued_doc" xml:lang="en-US">Amount of increase in additional paid in capital (APIC) resulting from the issuance of investor warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:to="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities_doc" xml:lang="en-US">Amount of decrease in additional paid in capital (APIC) resulting from reclassification out of stockholders deficit to liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:to="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc_doc" xml:lang="en-US">Value of stock issued to shareholders as a dividend during the period for Preferred Stock C shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_PreferredStockDividendsSharesPreferredStockClassc" xlink:to="igap_PreferredStockDividendsSharesPreferredStockClassc_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_PreferredStockDividendsSharesPreferredStockClassc_doc" xml:lang="en-US">Number of Class C shares of preferred stock issued as dividends during the period. Excludes stock splits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:to="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices_doc" xml:lang="en-US">Fair value of warrants issued as consideration for placement services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital_doc" xml:lang="en-US">Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:to="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity_doc" xml:lang="en-US">Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" xlink:to="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent_doc" xml:lang="en-US">Incremental fair market value adjustments of modified warrants issued to placement agent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:to="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_doc" xml:lang="en-US">Incremental fair market value adjustments of modified warrants issued to placement agent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_5_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_2_lbl" xml:lang="en-US">Temporary Equity, Other Disclosures [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStockCash_3_lbl" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:to="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent_3_lbl" xml:lang="en-US">IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_GainLossOnUnitConversion" xlink:to="igap_GainLossOnUnitConversion_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_GainLossOnUnitConversion_3_lbl" xml:lang="en-US">GainLossOnUnitConversion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_2_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" xlink:to="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision_3_lbl" xml:lang="en-US">ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ChangeInFairValueOfSeriesaWarrants" xlink:to="igap_ChangeInFairValueOfSeriesaWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ChangeInFairValueOfSeriesaWarrants_3_lbl" xml:lang="en-US">ChangeInFairValueOfSeriesaWarrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStockStock_2_lbl" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ArbitrationProceedingsWithShareholderMember" xlink:to="igap_ArbitrationProceedingsWithShareholderMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ArbitrationProceedingsWithShareholderMember_2_lbl" xml:lang="en-US">ArbitrationProceedingsWithShareholderMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeOneMember" xlink:to="igap_ExchangeOneMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ExchangeOneMember_2_lbl" xml:lang="en-US">ExchangeOneMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_ExchangeTwoMember" xlink:to="igap_ExchangeTwoMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_ExchangeTwoMember_2_lbl" xml:lang="en-US">ExchangeTwoMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igap_SeriesAWarrantMember" xlink:to="igap_SeriesAWarrantMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igap_SeriesAWarrantMember_2_lbl" xml:lang="en-US">SeriesAWarrantMember</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>igap-20160630_pre.xml
<DESCRIPTION>TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: IAI 6%2D30%2D16 10Q.xfr; Date: 2016%2D08%2D15T19:20:15Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80110001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://integrity-app.com/role/igap-daei1" xlink:href="igap-20160630.xsd#igap-daei1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:href="igap-20160630.xsd#Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-csocfp" xlink:href="igap-20160630.xsd#igap-csocfp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-g" xlink:href="igap-20160630.xsd#igap-g" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosap" xlink:href="igap-20160630.xsd#igap-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:href="igap-20160630.xsd#Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-i" xlink:href="igap-20160630.xsd#igap-i" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHARE" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapp" xlink:href="igap-20160630.xsd#igap-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-sosapt" xlink:href="igap-20160630.xsd#igap-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-it1" xlink:href="igap-20160630.xsd#igap-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHARETables" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/GeneralDetails" xlink:href="igap-20160630.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:href="igap-20160630.xsd#SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:href="igap-20160630.xsd#CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:href="igap-20160630.xsd#EventsDuringReportedPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/igap-id" xlink:href="igap-20160630.xsd#igap-id" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:href="igap-20160630.xsd#Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:href="igap-20160630.xsd#Disclosure-LOSSPERSHAREDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-daei1" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_DocumentAndEntityInformationAbstract" xlink:label="loc_igapDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:label="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_igapFundsInRespectOfEmployeeRightsUponRetirementNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToOfficersOrStockholdersNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDueToOfficersOrStockholdersNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_igapFinancingIncomeExpensesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="loc_igapIncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapIncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:label="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PreferredStockDividendsSharesPreferredStockClassc" xlink:label="loc_igapPreferredStockDividendsSharesPreferredStockClassc" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapPreferredStockDividendsSharesPreferredStockClassc" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="loc_us-gaapPreferredStockDividendsShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_GainLossOnUnitConversion" xlink:label="loc_igapGainLossOnUnitConversion" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_igapGainLossOnUnitConversion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="loc_igapIncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_igapIncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapPaymentsOfDividendsPreferredStockAndPreferenceStock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-csocfp" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:label="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:label="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_igapStockIssuedDuringPeriodValueStockDividendPreferredClassc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-g" xlink:title="00000008 - Disclosure - GENERAL">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosap" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD" xlink:title="00000010 - Disclosure - RECENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="loc_igapEventsDuringReportingPeriodAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="loc_us-gaapAdditionalFinancialInformationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_us-gaapAdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-i" xlink:title="00000011 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET" xlink:title="00000012 - Disclosure - FINANCING (INCOME) EXPENSES, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingExpensesNetDisclosureTextBlock" xlink:label="loc_igapFinancingExpensesNetDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapFinancingExpensesNetDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARE" xlink:title="00000013 - Disclosure - LOSS PER SHARE">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapp" xlink:title="00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansNonpensionBenefitsPolicy" xlink:label="loc_us-gaapPensionAndOtherPostretirementPlansNonpensionBenefitsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementPlansNonpensionBenefitsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesRoyaltyFees" xlink:label="loc_us-gaapRevenueRecognitionServicesRoyaltyFees" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionServicesRoyaltyFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaapStandardProductWarrantyPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_TemporaryEquityPolicyPolicyTextBlock" xlink:label="loc_igapTemporaryEquityPolicyPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapTemporaryEquityPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-sosapt" xlink:title="00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:label="loc_us-gaapFairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-it1" xlink:title="00000016 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables" xlink:title="00000017 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHARETables" xlink:title="00000018 - Disclosure - LOSS PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/GeneralDetails" xlink:title="00000019 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="loc_igapAprilTwoThousandSixteenOfferingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAprilTwoThousandSixteenOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesB1WarrantMember" xlink:label="loc_igapSeriesB1WarrantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesB1WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesB2WarrantMember" xlink:label="loc_igapSeriesB2WarrantMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesB2WarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesConeWarrantMember" xlink:label="loc_igapSeriesConeWarrantMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesConeWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SeriesCtwoWarrantMember" xlink:label="loc_igapSeriesCtwoWarrantMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapSeriesCtwoWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:label="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PreferredStockConversionPrice" xlink:label="loc_igapPreferredStockConversionPrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapPreferredStockConversionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:label="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfConvertiblePreferredSharesOfferedPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:label="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapFairValueOfWarrantsIssuedAsConsiderationForPlacementServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:label="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapAdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" xlink:label="loc_igapExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ChangeInFairValueOfSeriesaWarrants" xlink:label="loc_igapChangeInFairValueOfSeriesaWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_igapChangeInFairValueOfSeriesaWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightFairValue" xlink:label="loc_igapClassOfWarrantOrRightFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_igapClassOfWarrantOrRightFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/EventsDuringReportedPeriodDetails" xlink:title="00000022 - Disclosure - RECENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_EventsDuringReportingPeriodAbstract" xlink:label="loc_igapEventsDuringReportingPeriodAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapEventsDuringReportingPeriodAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementByArrangementAxis" xlink:label="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementByArrangementAxis" xlink:to="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AgreementWithPlacementAgentMember" xlink:label="loc_igapAgreementWithPlacementAgentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAgreementWithPlacementAgentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AprilTwoThousandSixteenOfferingMember" xlink:label="loc_igapAprilTwoThousandSixteenOfferingMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegistrationPaymentArrangementArrangementDomain" xlink:to="loc_igapAprilTwoThousandSixteenOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SaleAgreementAxis" xlink:label="loc_igapSaleAgreementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_igapSaleAgreementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SaleAgreementDomain" xlink:label="loc_igapSaleAgreementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapSaleAgreementAxis" xlink:to="loc_igapSaleAgreementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_InitialClosingMember" xlink:label="loc_igapInitialClosingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapInitialClosingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_SecondClosingMember" xlink:label="loc_igapSecondClosingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_igapSaleAgreementDomain" xlink:to="loc_igapSecondClosingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PlacementAgentWarrantsTrancheOneMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_PlacementAgentWarrantsTrancheTwoMember" xlink:label="loc_igapPlacementAgentWarrantsTrancheTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_igapPlacementAgentWarrantsTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfInterestInCorporateUnit" xlink:label="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfInterestInCorporateUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfUnitsSold" xlink:label="loc_igapNumberOfUnitsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfUnitsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ClassOfWarrantOrRightTerm" xlink:label="loc_igapClassOfWarrantOrRightTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapClassOfWarrantOrRightTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:label="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_RegistrationPaymentArrangementCommissionPercentage" xlink:label="loc_igapRegistrationPaymentArrangementCommissionPercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapRegistrationPaymentArrangementCommissionPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:label="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:label="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:label="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapAmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:label="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_igapIncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/igap-id" xlink:title="00000023 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails" xlink:title="00000024 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:label="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapLinkageDifferenceOnPrincipalOfLoansFromStockholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_GainLossOnUnitConversion" xlink:label="loc_igapGainLossOnUnitConversion" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapGainLossOnUnitConversion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="igap-20160630.xsd#igap_FinancingIncomeExpensesNet" xlink:label="loc_igapFinancingIncomeExpensesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_igapFinancingIncomeExpensesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails" xlink:title="00000025 - Disclosure - LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="loc_us-gaapDividendsPreferredStockStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDividendsPreferredStockStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6777643024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Aug. 15, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Integrity Applications, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001506983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,805,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779984080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,405,534<span></span>
</td>
<td class="nump">$ 608,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">69,664<span></span>
</td>
<td class="nump">18,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">698,170<span></span>
</td>
<td class="nump">816,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">123,465<span></span>
</td>
<td class="nump">268,792<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,296,833<span></span>
</td>
<td class="nump">1,712,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net</a></td>
<td class="nump">242,142<span></span>
</td>
<td class="nump">220,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Long-Term Restricted Cash</a></td>
<td class="nump">35,664<span></span>
</td>
<td class="nump">35,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent', window );">Funds in Respect of Employee Rights Upon Retirement</a></td>
<td class="nump">167,287<span></span>
</td>
<td class="nump">164,883<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,741,926<span></span>
</td>
<td class="nump">2,132,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">466,165<span></span>
</td>
<td class="nump">1,082,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">572,930<span></span>
</td>
<td class="nump">427,886<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,039,095<span></span>
</td>
<td class="nump">1,510,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOfficersOrStockholdersNoncurrent', window );">Long-Term Loans from Stockholders</a></td>
<td class="nump">161,992<span></span>
</td>
<td class="nump">160,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent', window );">Liability for Employee Rights Upon Retirement</a></td>
<td class="nump">176,673<span></span>
</td>
<td class="nump">174,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants with Down-Round Protection</a></td>
<td class="nump">833,153<span></span>
</td>
<td class="nump">321,695<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,171,818<span></span>
</td>
<td class="nump">656,146<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,210,913<span></span>
</td>
<td class="nump">2,166,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingent Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="nump">9,288,812<span></span>
</td>
<td class="nump">6,936,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock of $ 0.001 par value ("Common Stock"): 40,000,000 shares authorized as of June 30, 2016 and December 31, 2015; 5,805,560 and 5,690,097 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">5,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="nump">23,652,451<span></span>
</td>
<td class="nump">22,309,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">60,129<span></span>
</td>
<td class="nump">90,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(32,476,186)<span></span>
</td>
<td class="num">(29,376,515)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(8,757,799)<span></span>
</td>
<td class="num">(6,970,914)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity and stockholders' deficit</a></td>
<td class="nump">2,741,926<span></span>
</td>
<td class="nump">2,132,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="nump">221,152<span></span>
</td>
<td class="nump">221,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="nump">6,715,844<span></span>
</td>
<td class="nump">6,715,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C 5.5% Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="nump">$ 2,351,816<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds In Respect Of Employee Rights Upon Retirement, Noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FundsInRespectOfEmployeeRightsUponRetirementNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOfficersOrStockholdersNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOfficersOrStockholdersNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6410138&amp;loc=d3e79691-111665<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779391952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
<td class="nump">5,805,560<span></span>
</td>
<td class="nump">5,690,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">5,805,560<span></span>
</td>
<td class="nump">5,690,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible Preferred Stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, shares issued</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, shares outstanding</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, shares issued</a></td>
<td class="nump">15,031<span></span>
</td>
<td class="nump">15,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, shares outstanding</a></td>
<td class="nump">15,031<span></span>
</td>
<td class="nump">15,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C 5.5% Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, shares issued</a></td>
<td class="nump">4,425<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, shares outstanding</a></td>
<td class="nump">4,425<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780361328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 381,731<span></span>
</td>
<td class="nump">$ 67,342<span></span>
</td>
<td class="nump">$ 470,878<span></span>
</td>
<td class="nump">$ 143,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">880,696<span></span>
</td>
<td class="nump">557,980<span></span>
</td>
<td class="nump">1,531,396<span></span>
</td>
<td class="nump">1,036,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, marketing and general and administrative expenses</a></td>
<td class="nump">1,084,465<span></span>
</td>
<td class="nump">605,565<span></span>
</td>
<td class="nump">1,787,309<span></span>
</td>
<td class="nump">1,083,762<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,965,161<span></span>
</td>
<td class="nump">1,163,545<span></span>
</td>
<td class="nump">3,318,705<span></span>
</td>
<td class="nump">2,120,067<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">1,583,430<span></span>
</td>
<td class="nump">1,096,203<span></span>
</td>
<td class="nump">2,847,827<span></span>
</td>
<td class="nump">1,976,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FinancingIncomeExpensesNet', window );">Financing (income) expenses, net</a></td>
<td class="nump">5,568<span></span>
</td>
<td class="nump">570,603<span></span>
</td>
<td class="num">(32,065)<span></span>
</td>
<td class="nump">1,224,437<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period</a></td>
<td class="nump">1,588,998<span></span>
</td>
<td class="nump">1,666,806<span></span>
</td>
<td class="nump">2,815,762<span></span>
</td>
<td class="nump">3,201,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (income) loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">8,063<span></span>
</td>
<td class="num">(97,383)<span></span>
</td>
<td class="nump">30,039<span></span>
</td>
<td class="num">(55,720)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss for the period</a></td>
<td class="nump">$ 1,597,061<span></span>
</td>
<td class="nump">$ 1,569,423<span></span>
</td>
<td class="nump">$ 2,845,801<span></span>
</td>
<td class="nump">$ 3,145,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share (Basic)</a></td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share (Diluted)</a></td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Common shares used in computing Basic income (loss) per share</a></td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">5,441,253<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
<td class="nump">5,382,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Common shares used in computing Diluted income (loss) per share</a></td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">5,441,253<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
<td class="nump">5,382,682<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FinancingIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Income (Expenses), Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FinancingIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6766586128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - 6 months ended Jun. 30, 2016 - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated other comprehensive income [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2015</a></td>
<td class="nump">$ 5,691<span></span>
</td>
<td class="nump">$ 22,309,742<span></span>
</td>
<td class="nump">$ 90,168<span></span>
</td>
<td class="num">$ (29,376,515)<span></span>
</td>
<td class="num">$ (6,970,914)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2015</a></td>
<td class="nump">5,690,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,690,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period of six months</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,815,762)<span></span>
</td>
<td class="num">$ (2,815,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(30,039)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(30,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued', window );">Amounts allocated to Series C-1 and Series C-2 Warrants, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,164,657<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,164,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities', window );">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection within long-term liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(341,662)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(341,662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent', window );">Incremental fair market value adjustments of modified warrants issued to placement agent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">211,077<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">211,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc', window );">Stock dividend on Series C Preferred Stock</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">20,346<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,355)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockDividendsSharesPreferredStockClassc', window );">Stock dividend on Series C Preferred Stock, shares</a></td>
<td class="nump">8,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend on Series B Preferred Stock</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">253,994<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(254,101)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Stock dividend on Series B Preferred Stock, shares</a></td>
<td class="nump">106,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividend on Series A Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,453)<span></span>
</td>
<td class="num">(9,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">34,297<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,297<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2016</a></td>
<td class="nump">$ 5,807<span></span>
</td>
<td class="nump">$ 23,652,451<span></span>
</td>
<td class="nump">$ 60,129<span></span>
</td>
<td class="num">$ (32,476,186)<span></span>
</td>
<td class="num">$ (8,757,799)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2016</a></td>
<td class="nump">5,805,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,805,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of investor warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from reclassification out of stockholders deficit to liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental fair market value adjustments of modified warrants issued to placement agent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_IncrementalFairMarketValueAdjustmentOfModifiedWarrantsIssuedToPlacementAgent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockDividendsSharesPreferredStockClassc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Class C shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockDividendsSharesPreferredStockClassc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period for Preferred Stock C shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66904339&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779477072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period</a></td>
<td class="num">$ (2,815,762)<span></span>
</td>
<td class="num">$ (3,201,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile income (loss) for the period to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">27,980<span></span>
</td>
<td class="nump">18,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">34,297<span></span>
</td>
<td class="nump">12,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent', window );">Incremental fair market value adjustments of modified warrants issued to placement agent</a></td>
<td class="nump">211,077<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in the fair value of Warrants with down-round protection</a></td>
<td class="num">(64,212)<span></span>
</td>
<td class="num">(91,309)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders', window );">Linkage difference on principal of loans from stockholders</a></td>
<td class="num">(639)<span></span>
</td>
<td class="num">(1,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_GainLossOnUnitConversion', window );">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,270,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(51,053)<span></span>
</td>
<td class="num">(3,149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease (increase) in inventory</a></td>
<td class="nump">130,203<span></span>
</td>
<td class="num">(51,036)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">147,697<span></span>
</td>
<td class="num">(17,474)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">(Decrease) increase in accounts payable</a></td>
<td class="num">(638,908)<span></span>
</td>
<td class="nump">145,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Increase in other current liabilities</a></td>
<td class="nump">132,153<span></span>
</td>
<td class="nump">83,030<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="num">(2,887,167)<span></span>
</td>
<td class="num">(1,836,282)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement', window );">Increase in funds in respect of employee rights upon retirement</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(24,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(46,397)<span></span>
</td>
<td class="num">(18,892)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(46,397)<span></span>
</td>
<td class="num">(43,171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Cash dividend on Series A Preferred Stock</a></td>
<td class="num">(4,753)<span></span>
</td>
<td class="num">(47,036)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses</a></td>
<td class="nump">2,508,321<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds allocated to Series C Warrants, net of cash issuance expenses</a></td>
<td class="nump">1,242,158<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Repayment of loan from stockholders</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(439,939)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">3,745,726<span></span>
</td>
<td class="num">(486,975)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(15,329)<span></span>
</td>
<td class="nump">54,941<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">796,833<span></span>
</td>
<td class="num">(2,311,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of the period</a></td>
<td class="nump">608,701<span></span>
</td>
<td class="nump">5,827,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of the period</a></td>
<td class="nump">$ 1,405,534<span></span>
</td>
<td class="nump">$ 3,516,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_GainLossOnUnitConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) resulting from a unit conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_GainLossOnUnitConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Funds In Respect Of Employee Rights Upon Retirement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental fair market value adjustments of modified warrants issued to placement agent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Linkage difference on principal of loans from stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6939902&amp;loc=d3e20148-110875<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6766704016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices', window );">Warrants issued as consideration for placement agent services</a></td>
<td class="nump">$ 234,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital', window );">Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capita</a></td>
<td class="nump">77,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity', window );">Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity</a></td>
<td class="nump">156,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities', window );">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection within long-term liabilities</a></td>
<td class="nump">341,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc', window );">Stock dividend on Series C Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend on Series B Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated deficit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities', window );">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection within long-term liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc', window );">Stock dividend on Series C Preferred Stock</a></td>
<td class="nump">20,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Stock dividend on Series B Preferred Stock</a></td>
<td class="nump">$ 254,101<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from reclassification out of stockholders deficit to liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct issuance expense allocated to Series C Preferred Stock and recorded as a reduction of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountOfDirectIssuanceExpenseAllocatedToSeriescPreferredStockAsReductionOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct issuance expense allocated to Series C-1 and Series C-2 Warrants and recorded as a reduction of additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountOfDirectIssuanceExpenseAllocatedToWarrantsAsReductionOfAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants issued as consideration for placement services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period for Preferred Stock C shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_StockIssuedDuringPeriodValueStockDividendPreferredClassc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6771172144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: left; line-height: 1.25; font-weight: normal"></div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zac9e7fed437b4ca5a14379154f4125d7" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 53.85pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">NOTE 1</font><font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="width: 14.2pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">&#8211;</font><font style="width: 14.2pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">
<div>GENERAL</div>

<div>&#160;</div>
</td>
</tr></table>
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z8f13af64574b4e6b9a4cd5f856956603" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.05pt">&#160;</td>
<td style="width: 21.95pt; font: bold 10pt times new roman, times, serif; vertical-align: top">A.</td>
<td style="text-align: justify; width: auto; font: normal 10pt times new roman, times, serif; vertical-align: top">Integrity Applications, Inc. (the "Company") was incorporated on May&#160;18, 2010 under the laws of the State of Delaware.&#160; On July&#160;15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: "Integrity Acquisition"), a wholly owned Israeli subsidiary of the Company, which was established on May&#160;23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: "Integrity Israel"), an Israeli corporation that was previously held by the stockholders of the Company.&#160; Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger. Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.&#160; As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.&#160; Integrity Israel was incorporated in 2001 and commenced its operations in 2002.&#160; Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z817149da75b64388a90a3bd9a7810c6d" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.05pt">&#160;</td>
<td style="width: 22.7pt; font: bold 10pt times new roman, times, serif; vertical-align: top">B.</td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Going concern uncertainty</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 89.85pt">Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.&#160; The development and commercialization of Integrity Israel's product is expected to require substantial expenditures.&#160; Integrity Israel and the Company (collectively, the "Group") have not yet generated any material revenues from operations, and therefore they are dependent upon external sources for financing their operations. As of June 30, 2016, the Group has incurred an accumulated deficit of $32,476,186, stockholders&#8217; deficit of $8,757,799 and negative operating cash flows.&#160; These factors raise substantial doubt about the Group&#8217;s ability to continue as a going concern.&#160; The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.&#160; During 2012, the Company raised a total amount of approximately $1.0 million (net of related expenses) from the issuance of Common Stock. During 2013, the Company raised funds in an approximate amount of $5.3 million (net of related cash expenses) from the issuance of units (the &#8220;Series A Units&#8221;) consisting of shares of the Company&#8217;s Series A Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) and detachable warrants to purchase shares of the Company&#8217;s Common Stock (the &#8220;Series A Warrants&#8221; or &#8220;Warrants with down round protection&#8221;).&#160; During the period between August and December 2014, the Company raised funds in an aggregate amount of approximately $7.3 million (net of related cash expenses) from the issuance of units (the &#8220;Series B Units&#8221;), each consisting of (a) one share of the Company&#8217;s newly designated Series B 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series B Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $5.80 per share, (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-1 Warrant&#8221;) and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series B Preferred Stock (each a &#8220;Series B-2 Warrant&#8221; and, together with the Series B-1 Warrants, collectively, the &#8220;Series B Warrants&#8221;).&#160; During the three month period ended June 30, 2016, the Company raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) through the issuance of 4,425 units (the &#8220;Series C Units&#8221;), each consisting of (a) one share of the Company&#8217;s newly designated Series C 5.5% Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series C Preferred Stock&#8221;), convertible into Common Stock at an initial conversion price of $4.50 per share, (b) a five year warrant to purchase, at an exercise price of $4.50 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-1 Warrant&#8221;) and (c) a five year warrant to purchase, at an exercise price of $7.75 per share, up to such number of shares of Common Stock issuable upon conversion of such share of Series C Preferred Stock (each a &#8220;Series C-2 Warrant&#8221; and, together with the Series C-1 Warrants, collectively, the &#8220;Series C Warrants&#8221;), as described in further detail in Note 3.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 89.85pt">Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long term loans. There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations as a going concern.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z2a2e40fdebcc42a4b6016473af7e670c" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.4pt">&#160;</td>
<td style="width: 23.05pt; font: bold 10pt times new roman, times, serif; vertical-align: top">C.</td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Risk factors</td>
</tr></table>
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">As described in Note 1A and Note 1B above, the Group has a limited operating history and faces a number of risks and uncertainties, including risks and uncertainties regarding continuation of the development process, demand and market acceptance of the Group's products, the effects of technological changes, competition and the development of products by competitors.&#160; Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group's future results and the availability of necessary financing. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts. The Group has not yet generated material revenues from its operations to fund its activities and therefore is dependent on the receipt of additional funding from its stockholders and/ or new investors in order to continue its operations.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z736ab5cb6070415b807e730680809a16" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.4pt">&#160;</td>
<td style="width: 23.05pt; font: bold 10pt times new roman, times, serif; vertical-align: top">D.</td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Use of estimates in the preparation of financial statements</td>
</tr></table>
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the Warrants with down-round protection, (ii) the allocation of the proceeds and the related issuance costs of the Series C Units, and (iii) the going concern assumptions.</div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6728099136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z07b0863973134126bc8663e54822d6f0" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 53.85pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">NOTE 2</font><font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="width: 14.2pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">&#8211;</font><font style="width: 14.2pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z115ccb1ba0cb46a78a2fda3dacc4bab8" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.4pt">&#160;</td>
<td style="width: 23.05pt; font: bold 10pt times new roman, times, serif; vertical-align: top">A.</td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Basis of presentation</td>
</tr></table>
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">&#160;</div>

<div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">Accounting Principles</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The results for the six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2016 or for any other interim period or for any future period.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">Principles of Consolidation</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.8pt">The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="ze3989ad908ac41208ab938c3981d7098" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.05pt">&#160;</td>
<td style="width: 22.7pt; font: bold 10pt times new roman, times, serif; vertical-align: top">B.</td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Warrants with down-round protection</td>
</tr></table>
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The Company has determined its derivative warrant liability with respect to the Series A Warrants and warrants issued to Andrew Garrett, Inc., (&#8220;AGI&#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value. Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&#160; The key inputs used in the fair value calculations were as follows:</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div align="right" style="text-align: left; line-height: 1.25; margin-left: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Series A Warrants</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Balance, Beginning of the period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">321,695</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2,057,618</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Warrants issued as consideration for placement services</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">234,008</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">341,662</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Exchange of Series A Warrants pursuant to the &#8220;most favored nation&#8221; provision</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,573,435</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Change in fair value Warrants with Down-Round Protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(91,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Balance, End of period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">833,153</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">392,874</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt">The key inputs used in the fair value calculations were as follows:</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25; margin-left: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
<td colspan="6" style="vertical-align: bottom; text-align: center; vertical-align: top; border-top-style: none; border-top-width: medium; font-weight: bold">June 30,</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: top">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Dividend yield (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Expected volatility (%) (*)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">62.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">105.14</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Risk free interest rate (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">0.72-1.11</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.01</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Expected term of options (years) (**)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.70-5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.70</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Exercise price (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">4.50-7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5.80</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Share price (US dollars) (***)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.31</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Fair value (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">0.61</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90.7pt">&#160;</td>
<td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top">(*)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90.7pt">&#160;</td>
<td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top">(**)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&#160;110.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 31.5pt; font: 10pt times new roman, times, serif; vertical-align: top">(***)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).</td>
</tr></table>
</div>



<div style="text-align: justify; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z88a8390d7f304d73a40584bf75cfbbb6" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 67.5pt">&#160;</td>
<td style="width: 22.5pt; font: bold 10pt times new roman, times, serif; vertical-align: top">C.</td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Recently issued accounting pronouncements</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z13b081dfc9b24a4cb8939f28e70127d0" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">1.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standard Update 2014-16, &#8220;Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">Effective January 1, 2016, the Group adopted Accounting Standard Update 2014-16, Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity ("ASU 2014-16").</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The amendments in ASU 2014-16 clarify how U.S. GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. Furthermore, the amendments clarify that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. Rather, the nature of the host contract depends upon the economic characteristics and risks of the entire hybrid financial instrument. The amendments also clarify that, in evaluating the nature of a host contract, an entity should assess the substance of the relevant terms and features (i.e., the relative strength of the debt-like or equity-like terms and features given the facts and circumstances) when considering how to weigh those terms and features. The assessment of the substance of the relevant terms and features should incorporate a consideration of the characteristics of the terms and features themselves; the circumstances under which the hybrid financial instrument was issued or acquired; and the potential outcomes of the hybrid financial instrument, as well as the likelihood of those potential outcomes.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The amendments in ASU 2014-16 apply to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of shares.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The effects of initially adopting the amendments in ASU 2014-16 were required to be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of shares as of the beginning of the fiscal year for which the amendments are effective. However, retrospective application was permitted to all relevant prior periods.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">Management analyzed the economic characteristics and risks of the Series A Preferred Stock and the Series B Preferred Stock (including the embedded conversion feature of each) in accordance with the provisions of ASU 2014-16 and determined that such instruments are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Preferred Stock themselves (the 'host contract') are clearly and closely related and accordingly, the embedded conversion feature was not required to be bifurcated. As a result of the above determination, ASU 2014-16 did not impact the classification of the Series A Preferred Stock or the Series B Preferred Stock.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zc0777046e1cd4ad384df34848c757cac" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">2.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standard Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">In May 2014, the FASB issued Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09").</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">An entity should apply the amendments in ASU 2014-09 using one of the following two methods: 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">During 2016, the FASB issued several Accounting Standard Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements and Practical Expedients, Principal versus Agent Considerations and Identifying Performance Obligations and Licensing.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">For a public entity, the amendments in ASU 2014-09 (including the amendments introduced through recent ASUs) are effective for annual reporting periods beginning after December 15, 2016, including interim periods within the first annual reporting period (the first quarter of fiscal year 2017 for the Company). Early application is not permitted.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: 10pt/1.25 Times New Roman , Times, serif; margin-left: 108pt">The Company is in the process of assessing the impact, if any, of ASU 2014-09 (including the amendments introduced through recent ASUs) on its consolidated financial statements.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zfa76c0993e284cd2842cc0294a557143" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">3.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standards Update 2014-15, &#8220;Presentation of Financial Statements&#8212;Going Concern&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">In August 2014, the FASB issued Accounting Standards Update 2014-15, Presentation of Financial Statements&#8212;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern ("ASU 2014-15").</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 36pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2014-15 provides guidance on management&#8217;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued, when applicable).</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2014-15 also provides guidance related to the required disclosures as a result of management&#8217;s evaluation.&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">Due to the current financial condition of the Company and the existing uncertainty regarding its ability to continue as a going concern, management does not believe that the provisions of ASU 2014-15 will have a significant effect on its evaluation of the Company&#8217;s ability to continue as a going concern. However, management is currently considering if additional disclosures will be required as a result of ASU 2014-15.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="za84a407cdd8648dbb1de41b73c3d76eb" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">4.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standard Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">In July, 2015, The FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) ("ASU 2015-11").</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value. Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance. Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">For a public entity, the amendments in ASU 2015-11 are effective, in a prospective manner, for annual reporting periods beginning after December 15, 2016, including interim periods within the first such annual reporting period (the first quarter of fiscal year 2017 for the Company). Early adoption is permitted as of the beginning of an interim or annual reporting period.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The Company is in the process of assessing the impact, if any, of ASU 2015-11 on its consolidated financial statements.</div>

</div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6770383920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_EventsDuringReportingPeriodAbstract', window );"><strong>EVENTS DURING THE REPORTED PERIOD [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">RECENT EVENTS</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: left; line-height: 1.25; font-weight: normal"></div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z1bdc38f81db948ff938740db651f898c" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 53.85pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">NOTE 3</font><font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="width: 14.2pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">&#8211;</font><font style="width: 14.2pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">RECENT EVENTS</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zd9c63d5100a34070a7439b42b0a5d440" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 67.5pt">&#160;</td>
<td style="width: 22.5pt; font: 10pt times new roman, times, serif; vertical-align: top">A.</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">
<div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">During February 2016, the Company entered into an Advisory Agreement with AGI, pursuant to which the Company retained AGI on a non-exclusive basis to provide certain advisory services to the Company. As consideration for such services, the Company extended through December 31, 2019, the expiration date of 422,077 warrants issued to AGI and/or its designees in connection with the Company&#8217;s common stock offering completed in 2010 and the Series A Unit offering completed in 2012. The Advisory Agreement had an initial term of six months, subject to automatic renewal for additional 30 day terms unless terminated by either party with 30 days written notice.&#160;&#160;In April 2016, the Company and AGI amended that Advisory Agreement to extend the term of the Advisory Agreement for an additional six months.&#160;&#160;In consideration for such extension, the Company agreed to modify the terms of the 439,674 warrants issued to AGI and/or its designees in connection with the Series B Unit offering to include full-ratchet anti-dilution protection. As a result of the two agreements the Company recorded in its statement of operations for the six month and three month periods ended June 30, 2016, a one-time charge in the amount of $211,077 representing the incremental fair market value adjustments in respect of the above modified warrants issued to the placement agent. Such incremental fair market value adjustments represent the increase in the fair value of the warrants resulting from the above modifications and were recorded against stockholders&#8217; deficit. In addition, as a result of the inclusion of anti-dilution protection, the Company classified $341,662, representing the fair market value at April 2016 of the above 439,674 warrants issued to AGI out of stockholders deficit and presented them as Warrants with down round protection within long-term liabilities.</font></div>
</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z2aee9f8d279b435ab28e691f17484b57" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 67.5pt">&#160;</td>
<td style="width: 22.5pt; font: 10pt times new roman, times, serif; vertical-align: top">B.</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">
<div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt Times New Roman">During the three month period ended June 30, 2016, the Company raised funds in an aggregate amount of approximately $3.75 million (net of related cash expenses) from the issuance in four separate closings of 4,425 Series C Units. As of June 30, 2016, the shares of Preferred Stock comprising the Series C Units are convertible into an aggregate of 983,386 shares of Common Stock, and the Series C Warrants comprising the Series C Units are exercisable for an aggregate of 1,966,772 shares of Common Stock, in each case subject to adjustment as described below.</font></div>
</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Pursuant to a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with AGI, at the initial closing of the sale of the Series C Units the Company paid AGI, as a commission, an amount equal to 6% of the aggregate sales price of the Series C Units, plus 4% of the aggregate sales price as a management fee plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units. At the end of the second, third and fourth closings of the sale of the Series C Units, the Company paid AGI, as a commission, an amount equal to 10% of the aggregate sales price of the Series C Units sold in such closing, plus a non-accountable expense allowance equal to 3% of the aggregate sales price of the Series C Units sold in such closing. In addition, pursuant to the Placement Agent Agreement, the Company is required to issue to AGI: (a) 5 year warrants to purchase up to 196,678 shares of Common Stock at an exercise price of $4.50 per share and (b) 5 year warrants to purchase up to 98,339 shares of Common Stock at an exercise price of $7.75 per share. The terms of such warrants will be substantially similar to the Series C Warrants except that the warrants issued to AGI will also be exercisable on a cashless basis and will include full ratchet anti-dilution protection.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Subject to certain ownership limitations described below, the Series C Preferred Stock is convertible at the option of the holder at any time and from time to time into shares of Common Stock at a conversion price of $4.50 per share (calculated by dividing the stated value per share of Preferred Stock, which is initially $1,000, by the conversion price per share). The conversion price of the Series C Preferred Stock is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect, as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders. In addition, the holders of Preferred Stock will be entitled to receive any securities or rights to acquire securities or property granted or issued by the Company pro rata to the holders of Common Stock to the same extent as if such holders had converted all of their shares of Series C Preferred Stock prior to such distribution. In the event of a fundamental transaction, such as a merger, consolidation, sale of substantially all assets and similar reorganizations or recapitalizations of the Company, the holders of Series C Preferred Stock will be entitled to receive, upon conversion of their shares of Series C Preferred Stock, any securities or other consideration received by the holders of the Common Stock pursuant to the fundamental transaction.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Holders of Series C Preferred Stock are entitled to receive cumulative dividends at a rate of 5.5% per annum, based on the stated value per share of Series C Preferred Stock. Dividends on the Series C Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on June 30, 2016, and on each conversion date (with respect to the shares of Preferred Stock being converted). For so long as required under the terms of the Certificate of Designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, dividends will be payable only in shares of Common Stock. Thereafter, dividends on the Series C Preferred Stock will be payable, at the option of the Company, in cash and/or, if certain conditions are satisfied, shares of Common Stock or a combination of both. Shares of Common Stock issued as payment of dividends will be valued at the lower of (a) the then current conversion price of the Series C Preferred Stock or (b) the average of the volume weighted average price for the Common Stock on the principal trading market therefor for the 10 trading days immediately prior to the applicable dividend payment date. The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Subject to any limitations under the terms of the Certificate of Designations for the Company&#8217;s outstanding Series A Preferred Stock or Series B Preferred Stock, the Company may become obligated to redeem the Series C Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Series C Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service. In addition, upon the occurrence of certain triggering events, each holder of Series C Preferred Stock will have the option to require the Company to redeem such holder&#8217;s shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder&#8217;s outstanding Series C Preferred Stock.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Subject to certain conditions contained in the Certificate of Designations, Preferences and Rights relating to the Series C Preferred Stock (the &#8220;Certificate of Designations&#8221;), the Company will have the option to force the conversion of the Series C Preferred Stock (in whole or in part) if (a) the volume weighted average price for the Common Stock on its principal trading market exceeds $7.00 for each of any 20 trading days during any 30 consecutive trading day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $50,000 or (b) the Company receives approval to list the Common Stock on a national securities exchange.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Subject to certain exceptions contained in the Certificate of Designations, if the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Series C Preferred Stock (the &#8220;Conversion Shares&#8221;) and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a &#8220;Buy-In&#8221;), the Company will be required to: (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder&#8217;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Series C Preferred Stock equal to the number of shares of Series C Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements. In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Series C Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the fifth trading day following the applicable conversion date and the Company will continue to pay such partial liquidated damages for each trading day after such eighth trading day until such certificates are delivered or the holder rescinds such conversion.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">As long as at least 35% of the originally issued shares of Series C Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Series C Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Series C Preferred Stock; enter into certain transactions with affiliates of the Company; or enter into any agreement with respect to the foregoing.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Subject to the beneficial ownership limitation described below, holders of Series C Preferred Stock will vote together with the holders of Common Stock and Series A Preferred Stock and Series B Preferred Stock on an as-converted basis. Holders will not be permitted to convert their Series C Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding Common Stock (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the &#8220;Beneficial Ownership Limitation&#8221;). In addition, no holder may vote any shares of Series C Preferred Stock (on an as-converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Subject to certain limitations, so long as any purchaser holds any shares of Series C Preferred Stock, if (a) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (b) a purchaser then holding Series C Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such purchaser after taking into account all of the terms and conditions of the terms granted to the purchasers under the purchase agreement and the terms granted in such subsequent issuance or sale, including all of the components of the Series C Units and of the securities or units involved in such subsequent issuance or sale, then the purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such purchaser).</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">The Series C Warrants have a five-year term commencing on their respective issuance dates. Until the end of the applicable term, each Series C Warrant will be exercisable at any time and from time to time at an exercise price of $4.50 per share (with respect to the Series C-1 Warrants) or $7.75 per share (with respect to the Series C-2 Warrants). The Series C Warrants contain adjustment provisions substantially similar to those to the adjustment provisions of the Series C Preferred Stock as described above, except that the Series C Warrants do not include dilution protection for issuances of securities at an effective price per share lower than the conversion price of such Series C Warrants. In addition, the Series C Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Series C Preferred Stock. No holder may exercise its Series C Warrants in excess of the Beneficial Ownership Limitation.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">As a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the Series A Warrants, on April 8, 2016, the exercise price per share of the Series A Warrants decreased from $5.80 per share to $4.50 per share and the number of shares of Common Stock issuable upon exercise of each of the Series A Warrants, in the aggregate, increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, will be equal to the aggregate exercise price prior to such adjustment. Also as a result of the initial issuance and sale of the Series C Units, pursuant to the terms of the certificates of designations for the Series A Preferred Stock and Series B Preferred Stock, on April 8, 2016, the conversion price per share of Series A Preferred Stock and Series B Preferred Stock decreased to $4.50 per share.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Based on the terms of the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, respectively, so long as any initial purchaser of Series A Units or Series B Units, as applicable (each, a &#8220;Purchaser&#8221;) holds any shares of Series A Preferred Stock or Series B Preferred Stock, as applicable, if (1) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (2) a Purchaser then holding Series A or Series B Preferred Stock or Warrants reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such Purchaser, then the Purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such Purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such Purchaser).</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Pursuant to the purchase agreements relating to the issuance and sale of the Series A Units and the Series B Units, the Company was required to and did notify the holders of the Series A Preferred Stock and Series B Preferred Stock of the closing of the sale of the Series C Units,<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>and following receipt thereof such holders of Series A Preferred Stock and Series B Preferred Stock will be entitled, pursuant to the &#8220;most favored nation&#8221; provisions contained in their respective purchase agreements (as described above), to elect to amend the terms of their purchase of Series A Units and Series B Units, respectively, to match the terms of the Series C Units. The Company is obligated to amend the terms of any of Series A Units or Series B Units who timely makes such election and tenders its Series A Units or Series B Units for exchange.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Upon initial recognition, the Series C Preferred Stock issued together with detachable Series C Warrants (classified as equity) were measured based on the relative fair value basis and were presented net of the direct issuance expenses that were allocated to them.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">The Company has determined that due to the economic characteristics and risks of the Series C Preferred Stock, based on their stated or implied substantive terms and features, that such Preferred Stock, are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Series C Preferred Stock themselves (the 'host contract') are clearly and closely related. As a result, the embedded conversion feature was not required to be bifurcated.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90pt">Since at the issuance dates of the Series C Preferred Stock, the exercise price of the conversion feature (based on the effective conversion rate of the Series C Preferred Stock into Common Stock) was higher than the estimated fair value of the Company&#8217;s Common Stock, it was determined that the conversion feature was not beneficial. Also, due to the liquidation preference and certain redemption rights for the benefit of the holders of the Series C Preferred Stock, upon the occurrence of the certain contingent events, which are not considered as solely within the Company's control management determined that the Series C Preferred Stock were to be presented as temporary equity. On each balance sheet date, the Company&#8217;s management assesses the probability of redemption of the outstanding Preferred Stock. In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will recognize a liability in an amount equal to the aggregate redemption price of the Preferred Stock. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and such redemption amount will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.</div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_EventsDuringReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_EventsDuringReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6763153792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: left; line-height: 1.25; font-weight: normal"></div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z667aec4ed65d4d59b71405d09c73f460" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 53.85pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">NOTE 4</font><font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="width: 14.2pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">&#8211;</font><font style="width: 14.2pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">INVENTORIES</td>
</tr></table>
</div>
</div>
</div>

<div>
<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif">&#160;</div>

<div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif">
<table align="right" border="0" cellpadding="0" cellspacing="0" id="z8cb6486e075b498aac1b5e8275a81486" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">December 31,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Raw materials</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">181,461</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">205,645</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Work in process</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">412,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">551,111</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Finished products</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">104,709</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">59,467</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 76%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">698,170</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">816,223</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both">&#160;</div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6770347872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING (INCOME) EXPENSES, NET<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FinancingExpensesNetDisclosureTextBlock', window );">FINANCING (INCOME) EXPENSES, NET</a></td>
<td class="text"><div><div><div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif"><table cellpadding="0" cellspacing="0" id="zc405bc12abec4b92a6608532bd1aa16b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 53.85pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">NOTE 5</font><font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="width: 14.2pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">&#8211;</font><font style="width: 14.2pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">FINANCING (INCOME) EXPENSES, NET</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"><br />
</div>

<div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif">
<table align="right" border="0" cellpadding="0" cellspacing="0" id="z542e75c8ecc8434fa56490440a0600ba" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Six month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Three month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Israeli CPI linkage difference on principal of loans from stockholders</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(639</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,872</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">825</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1,808</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Exchange rate differences</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">24,211</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">38,269</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">19,296</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">90,872</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Change in fair value of Warrants with down round protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(91,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(20,702</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(25,539</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Interest expenses on credit from banks and other</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">8,575</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">8,378</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">6,149</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,788</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1,270,971</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">497,674</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 52%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(32,065</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1,224,437</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,568</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">570,603</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FinancingExpensesNetDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure relating to financing expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FinancingExpensesNetDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6770406944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">LOSS PER SHARE</a></td>
<td class="text"><div><div><div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif"><table cellpadding="0" cellspacing="0" id="zcbfb569f9c784ed1b372de2f5b423c7b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 53.85pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">NOTE 6</font><font id="TRGRRTFtoHTMLTab" style="width: 53.85pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="width: 14.2pt; vertical-align: top"><font style="font: bold 10pt times new roman, times, serif">&#8211;</font><font style="width: 14.2pt; display: inline-block; font-size: 1px">&#160;</font></td>
<td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">LOSS PER SHARE</td>
</tr></table>
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt">In periods of net loss, basic loss per share is computed by dividing net loss for the period after consideration of the effect of dividend on preferred stock by the weighted average number of shares outstanding during the period.</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt">The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2016 and 2015 are as follows:</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif">&#160;</div>

<div align="right" style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt">
<table border="0" cellpadding="0" cellspacing="0" id="z8103e4dce42a4f74a97915ac79ef5c44" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Six month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Three month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Loss for the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(2,815,762</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(3,201,337</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,588,998</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,666,806</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(9,453</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(47,036</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(4,753</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(26,522</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(254,101</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(185,795</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(131,281</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(102,558</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Loss for the period attributable to common stockholders</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(3,099,671</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(3,434,168</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,745,387</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,795,886</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both">&#160;</div>

<div style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt">
<table border="0" cellpadding="0" cellspacing="0" id="z4f0175498f8045bbb3d0acd515972615" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Six month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Three month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: justify; font: bold 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Number of shares:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Common shares used in computing basic income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,382,682</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,441,253</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Common shares used in computing diluted income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,382,682</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,441,253</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">11,220,345</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">9,367,247</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">12,210,613</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">9,537,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both">&#160;</div>

<div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif">
<table cellpadding="0" cellspacing="0" id="ze9b77d1c22564edfb3e70983c6c06269" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.05pt">&#160;</td>
<td style="width: 22.7pt; font: 10pt times new roman, times, serif; vertical-align: top">&#160;(*)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6754718384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Accounting principles</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">Accounting Principles</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company&#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The results for the six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2016 or for any other interim period or for any future period.</div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">Principles of Consolidation</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.8pt">The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.</div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants with down-round protection</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: justify; line-height: 1.25"><table cellpadding="0" cellspacing="0" id="ze3989ad908ac41208ab938c3981d7098" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"><tr><td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Warrants with down-round protection</td>
</tr></table>
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 90.7pt">The Company has determined its derivative warrant liability with respect to the Series A Warrants and warrants issued to Andrew Garrett, Inc., (&#8220;AGI&#8221;) as part of the Series A Unit offering, the Series B Unit offering and the Series C Unit offering to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value. Because the warrants contain a down round protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.&#160; The key inputs used in the fair value calculations were as follows:</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div align="right" style="text-align: left; line-height: 1.25; margin-left: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Series A Warrants</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Balance, Beginning of the period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">321,695</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2,057,618</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Warrants issued as consideration for placement services</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">234,008</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">341,662</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Exchange of Series A Warrants pursuant to the &#8220;most favored nation&#8221; provision</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,573,435</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Change in fair value Warrants with Down-Round Protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(91,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Balance, End of period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">833,153</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">392,874</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt">The key inputs used in the fair value calculations were as follows:</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25; margin-left: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
<td colspan="6" style="vertical-align: bottom; text-align: center; vertical-align: top; border-top-style: none; border-top-width: medium; font-weight: bold">June 30,</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: top">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Dividend yield (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Expected volatility (%) (*)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">62.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">105.14</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Risk free interest rate (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">0.72-1.11</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.01</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Expected term of options (years) (**)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.70-5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.70</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Exercise price (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">4.50-7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5.80</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Share price (US dollars) (***)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.31</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Fair value (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">0.61</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90.7pt">&#160;</td>
<td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top">(*)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90.7pt">&#160;</td>
<td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top">(**)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&#160;110.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 31.5pt; font: 10pt times new roman, times, serif; vertical-align: top">(***)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).</td></tr></table></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued accounting pronouncements</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: justify; line-height: 1.25"><table cellpadding="0" cellspacing="0" id="z88a8390d7f304d73a40584bf75cfbbb6" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif"><tr><td style="text-align: justify; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Recently issued accounting pronouncements</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z13b081dfc9b24a4cb8939f28e70127d0" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">1.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standard Update 2014-16, &#8220;Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">Effective January 1, 2016, the Group adopted Accounting Standard Update 2014-16, Derivatives and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity ("ASU 2014-16").</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The amendments in ASU 2014-16 clarify how U.S. GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. Furthermore, the amendments clarify that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. Rather, the nature of the host contract depends upon the economic characteristics and risks of the entire hybrid financial instrument. The amendments also clarify that, in evaluating the nature of a host contract, an entity should assess the substance of the relevant terms and features (i.e., the relative strength of the debt-like or equity-like terms and features given the facts and circumstances) when considering how to weigh those terms and features. The assessment of the substance of the relevant terms and features should incorporate a consideration of the characteristics of the terms and features themselves; the circumstances under which the hybrid financial instrument was issued or acquired; and the potential outcomes of the hybrid financial instrument, as well as the likelihood of those potential outcomes.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The amendments in ASU 2014-16 apply to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of shares.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The effects of initially adopting the amendments in ASU 2014-16 were required to be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of shares as of the beginning of the fiscal year for which the amendments are effective. However, retrospective application was permitted to all relevant prior periods.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">Management analyzed the economic characteristics and risks of the Series A Preferred Stock and the Series B Preferred Stock (including the embedded conversion feature of each) in accordance with the provisions of ASU 2014-16 and determined that such instruments are considered as more akin to equity than debt. Accordingly, it was determined that the economic characteristics and the risks of the embedded conversion option to Common Stock and those of the Preferred Stock themselves (the 'host contract') are clearly and closely related and accordingly, the embedded conversion feature was not required to be bifurcated. As a result of the above determination, ASU 2014-16 did not impact the classification of the Series A Preferred Stock or the Series B Preferred Stock.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zc0777046e1cd4ad384df34848c757cac" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">2.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standard Update 2014-09, &#8220;Revenue from Contracts with Customers&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">In May 2014, the FASB issued Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09").</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">An entity should apply the amendments in ASU 2014-09 using one of the following two methods: 1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or, 2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">During 2016, the FASB issued several Accounting Standard Updates (&#8220;ASUs&#8221;) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements and Practical Expedients, Principal versus Agent Considerations and Identifying Performance Obligations and Licensing.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">For a public entity, the amendments in ASU 2014-09 (including the amendments introduced through recent ASUs) are effective for annual reporting periods beginning after December 15, 2016, including interim periods within the first annual reporting period (the first quarter of fiscal year 2017 for the Company). Early application is not permitted.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: 10pt/1.25 Times New Roman , Times, serif; margin-left: 108pt">The Company is in the process of assessing the impact, if any, of ASU 2014-09 (including the amendments introduced through recent ASUs) on its consolidated financial statements.</div>



<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zfa76c0993e284cd2842cc0294a557143" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">3.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standards Update 2014-15, &#8220;Presentation of Financial Statements&#8212;Going Concern&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">In August 2014, the FASB issued Accounting Standards Update 2014-15, Presentation of Financial Statements&#8212;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern ("ASU 2014-15").</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 36pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2014-15 provides guidance on management&#8217;s responsibility to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued, when applicable).</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2014-15 also provides guidance related to the required disclosures as a result of management&#8217;s evaluation.&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">&#160;</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">Due to the current financial condition of the Company and the existing uncertainty regarding its ability to continue as a going concern, management does not believe that the provisions of ASU 2014-15 will have a significant effect on its evaluation of the Company&#8217;s ability to continue as a going concern. However, management is currently considering if additional disclosures will be required as a result of ASU 2014-15.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="za84a407cdd8648dbb1de41b73c3d76eb" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 18pt; font: bold 10pt times new roman, times, serif; vertical-align: top">4.</td>
<td style="text-align: left; width: auto; font: bold 10pt times new roman, times, serif; vertical-align: top">Accounting Standard Update 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">In July, 2015, The FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330) ("ASU 2015-11").</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">ASU 2015-11 outlines that inventory within the scope of its guidance be measured at the lower of cost and net realizable value. Inventory measured using last-in, first-out (LIFO) and the retail inventory method (RIM) are not impacted by the new guidance. Prior to the issuance of ASU 2015-11, inventory was measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin).</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">For a public entity, the amendments in ASU 2015-11 are effective, in a prospective manner, for annual reporting periods beginning after December 15, 2016, including interim periods within the first such annual reporting period (the first quarter of fiscal year 2017 for the Company). Early adoption is permitted as of the beginning of an interim or annual reporting period.</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 108pt">The Company is in the process of assessing the impact, if any, of ASU 2015-11 on its consolidated financial statements.</div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41620-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579240-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579245-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41675-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41638-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6585003152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Fair Value of Level 3 Liability</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt">The changes in the fair value of the Level 3 liability are as follows (in US dollars):</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div align="right" style="text-align: left; line-height: 1.25; margin-left: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="zf3b9e27d3ae44dbf90ded2045f648965" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Series A Warrants</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Balance, Beginning of the period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">321,695</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2,057,618</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Warrants issued as consideration for placement services</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">234,008</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">341,662</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Exchange of Series A Warrants pursuant to the &#8220;most favored nation&#8221; provision</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,573,435</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Change in fair value Warrants with Down-Round Protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(91,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Balance, End of period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">833,153</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">392,874</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

</div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock', window );">Schedule of Warrant Inputs</a></td>
<td class="text"><div><div id="DSPFPageHeader"><div style="text-align: center; font: bold 10pt/1.25 Times New Roman, Times, serif"><div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; text-indent: 0.7pt; margin-left: 90pt">The key inputs used in the fair value calculations were as follows:</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal"><br />
</div>

<div style="text-align: left; line-height: 1.25; margin-left: 99pt">
<table border="0" cellpadding="0" cellspacing="0" id="z134bcb1c7c434e4dbb4d17f611656267" style="width: 87%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
<td colspan="6" style="vertical-align: bottom; text-align: center; vertical-align: top; border-top-style: none; border-top-width: medium; font-weight: bold">June 30,</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom; border-top-style: none; border-top-width: medium">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: top">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 0.5pt; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Dividend yield (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Expected volatility (%) (*)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">62.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">105.14</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Risk free interest rate (%)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">0.72-1.11</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.01</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Expected term of options (years) (**)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.70-5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.70</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Exercise price (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">4.50-7.75</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5.80</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Share price (US dollars) (***)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">2.31</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif">Fair value (US dollars)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">0.61</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; clear: both; font-weight: normal"><br />
</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="zc331ced78499489a8306aeb318a1c71b" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90.7pt">&#160;</td>
<td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top">(*)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">Due to the low trading volume of the Company&#8217;s Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z952f67327d4440449e97c41aef873090" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90.7pt">&#160;</td>
<td style="width: 28.35pt; font: 10pt times new roman, times, serif; vertical-align: top">(**)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No.&#160;110.</td>
</tr></table>
</div>

<div style="text-align: left; line-height: 1.25; font-weight: normal">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table cellpadding="0" cellspacing="0" id="z793196a755ad4c009a4266d1bd59cca4" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 90pt">&#160;</td>
<td style="width: 31.5pt; font: 10pt times new roman, times, serif; vertical-align: top">(***)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">The Common Stock price, per share reflects the Company&#8217;s management&#8217;s estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).</td></tr></table></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quantitative information about the inputs used in the fair value measurement of liabilities. This disclosure may include, but is not limited to, the fair value of the liability, valuation technique used to measure fair value, the inputs used to measure fair value, the ranges of the inputs, and the weighted averages of the inputs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6755709392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div><div><div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif">&#160;</div>

<div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif">
<table align="right" border="0" cellpadding="0" cellspacing="0" id="z8cb6486e075b498aac1b5e8275a81486" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">December 31,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Raw materials</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">181,461</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">205,645</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Work in process</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">412,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">551,111</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 76%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Finished products</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">104,709</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">59,467</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 76%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">698,170</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">816,223</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both">&#160;</div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6762986240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING (INCOME) EXPENSES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Financing (Income) Expenses, Net</a></td>
<td class="text"><div><div><div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif"></div>

<div style="text-align: left; font: bold 10pt/1.25 Times New Roman, Times, serif">
<table align="right" border="0" cellpadding="0" cellspacing="0" id="z542e75c8ecc8434fa56490440a0600ba" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Six month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Three month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Israeli CPI linkage difference on principal of loans from stockholders</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(639</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,872</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">825</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1,808</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Exchange rate differences</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">24,211</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">38,269</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">19,296</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">90,872</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Change in fair value of Warrants with down round protection</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(64,212</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(91,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(20,702</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(25,539</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Interest expenses on credit from banks and other</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">8,575</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">8,378</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">6,149</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,788</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1,270,971</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">497,674</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #cceeff; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 52%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(32,065</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">1,224,437</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,568</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">570,603</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; background-color: #ffffff; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6763010608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Loss and Weighted Average Number of Shares</a></td>
<td class="text"><div><div><div style="text-align: justify; font: normal 10pt/1.25 Times New Roman, Times, serif; margin-left: 68.05pt">The loss and the weighted average number of shares used in computing basic and diluted loss per share for the six and three month periods ended June 30, 2016 and 2015 are as follows:</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif">&#160;</div>

<div align="right" style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt">
<table border="0" cellpadding="0" cellspacing="0" id="z8103e4dce42a4f74a97915ac79ef5c44" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">US dollars</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Six month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Three month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">(unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Loss for the period</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(2,815,762</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(3,201,337</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,588,998</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,666,806</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Cash dividend on Series A Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(9,453</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(47,036</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(4,753</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(26,522</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Stock dividend on Series B Preferred Stock</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(254,101</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(185,795</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(131,281</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(102,558</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Stock dividend on Series C Preferred Stock</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(20,355</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Loss for the period attributable to common stockholders</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(3,099,671</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(3,434,168</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,745,387</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">(1,795,886</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">)</div>
</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both">&#160;</div>

<div style="text-align: left; font: bold 10pt/1.25 times new roman, times, serif; margin-left: 81pt">
<table border="0" cellpadding="0" cellspacing="0" id="z4f0175498f8045bbb3d0acd515972615" style="width: 90%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Number of shares</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Six month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">Three month period<font style="font: 10pt times new roman, times, serif"><br />
</font>ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid; vertical-align: bottom">
<div style="text-align: center; font: bold 10pt/1.25 times new roman, times, serif">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
</tr><tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; vertical-align: bottom">
<div style="text-align: justify; font: bold 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Number of shares:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Common shares used in computing basic income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,382,682</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,441,253</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: justify; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Common shares used in computing diluted income (loss) per share</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,716,566</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,382,682</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,742,468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">5,441,253</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr><tr style="background-color: white">
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; vertical-align: bottom">
<div style="text-align: left; font: 10pt/1.25 times new roman, times, serif; text-indent: -11.35pt; margin-left: 11.35pt">Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (*)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">11,220,345</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">9,367,247</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">12,210,613</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt/1.25 times new roman, times, serif">9,537,309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom">&#160;</td>
</tr></table>
</div>

<div style="text-align: left; font: normal 10pt/1.25 Times New Roman, Times, serif; clear: both">&#160;</div>

<div style="text-align: justify; font: bold 10pt/1.25 Times New Roman, Times, serif">
<table cellpadding="0" cellspacing="0" id="ze9b77d1c22564edfb3e70983c6c06269" style="width: 100%; font: 10pt times new roman, times, serif; font-size: 10pt; font-family: times new roman, times, serif">
<tr>
<td style="width: 68.05pt">&#160;</td>
<td style="width: 22.7pt; font: 10pt times new roman, times, serif; vertical-align: top">&#160;(*)</td>
<td style="text-align: justify; width: auto; font: 10pt times new roman, times, serif; vertical-align: top">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780258112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 32,476,186<span></span>
</td>
<td class="nump">$ 32,476,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,376,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' deficit</a></td>
<td class="nump">$ 8,757,799<span></span>
</td>
<td class="nump">$ 8,757,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,970,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts', window );">Proceeds from issuance of Common Stock, net of issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock', window );">Proceeds from convertible preferred stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB1WarrantMember', window );">Series B-1 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB2WarrantMember', window );">Series B-2 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock', window );">Proceeds from convertible preferred stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember', window );">April 2016 to June 2016 Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion', window );">Shares convertible into</a></td>
<td class="nump">983,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares covered by warrants</a></td>
<td class="nump">1,966,772<span></span>
</td>
<td class="nump">1,966,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit', window );">Proceeds from issuance of Series C Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember', window );">April 2016 to June 2016 Offering [Member] | Series C-1 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember', window );">April 2016 to June 2016 Offering [Member] | Series C-2 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">7.75<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember', window );">April 2016 to June 2016 Offering [Member] | Series C 5.5% Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par value per share</a></td>
<td class="nump">0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_PreferredStockConversionPrice', window );">Conversion price</a></td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit', window );">Number of convertible preferred shares offered per unit sold</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Aggregate Number of Shares Issued upon Conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfConvertiblePreferredSharesOfferedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of convertible preferred shares offered per unit sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfConvertiblePreferredSharesOfferedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Units Sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_PreferredStockConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Conversion Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_PreferredStockConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity, net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflows (outflows) from issuing and redeeming redeemable preferred stock; includes convertible and nonconvertible redeemable preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow resulting from the sale of an interest in a corporate unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInterestInCorporateUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB1WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB1WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB2WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesB2WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesConeWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesConeWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesCtwoWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_SeriesCtwoWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6615199008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of the period</a></td>
<td class="nump">$ 321,695<span></span>
</td>
<td class="nump">$ 2,057,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices', window );">Warrants issued as consideration for placement services</a></td>
<td class="nump">234,008<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities', window );">Amount classified out of stockholders deficit and presented as Warrants with Down-Round Protection</a></td>
<td class="nump">341,662<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision', window );">Exchange of Series A Warrants pursuant to the 'most favored nation' provision</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,573,435)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ChangeInFairValueOfSeriesaWarrants', window );">Change in fair value Warrants with Down-Round Protection</a></td>
<td class="num">(64,212)<span></span>
</td>
<td class="num">(91,309)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of period</a></td>
<td class="nump">$ 833,153<span></span>
</td>
<td class="nump">$ 392,874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from reclassification out of stockholders deficit to liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ChangeInFairValueOfSeriesaWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Series A Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ChangeInFairValueOfSeriesaWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Level 3 liability due to exchange of Series A Warrants pursuant to the 'Most favored nation' provision</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ExchangeOfSeriesaWarrantsPursuantToMostFavoredNationProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants issued as consideration for placement services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FairValueOfWarrantsIssuedAsConsiderationForPlacementServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6766872032">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">62.16%<span></span>
</td>
<td class="nump">105.14%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.01%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected term of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightFairValue', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected term of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected term of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Common Stock price, per share reflects the Company's management's estimation of the fair value per share of Common Stock as of June 30, 2016 and 2015. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units and the Series B Units (See Note 3).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779893776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT EVENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Feb. 29, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent', window );">Incremental fair market value adjustments of modified warrants issued to placement agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,077<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement', window );">Number of prior warrants provided to Andrew Garrett, Inc. from the company's common stock offering completed in 2010, that were subsequently extended</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement', window );">Number of prior warrants provided to Andrew Garrett, Inc. in connection with the Series B Unit offering, that were subsequently extended</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance', window );">Amount company expects it will classify as the fair market value at the time the warrants are issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 341,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Placement Agent Warrants Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock shares callable by warrants</a></td>
<td class="nump">98,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,339<span></span>
</td>
<td class="nump">98,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Placement Agent Warrants Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ClassOfWarrantOrRightTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock shares callable by warrants</a></td>
<td class="nump">196,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,678<span></span>
</td>
<td class="nump">196,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Commission fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_RegistrationPaymentArrangementCommissionPercentage', window );">Managment fee percentage commission to agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember', window );">Advisory Agreement with Andrew Garrett, Inc.[Member] | Second Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Commission fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits', window );">Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember', window );">April 2016 to June 2016 Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit', window );">Proceeds from issuance of Series C Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_NumberOfUnitsSold', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion', window );">Shares convertible into</a></td>
<td class="nump">983,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common stock shares callable by warrants</a></td>
<td class="nump">1,966,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,966,772<span></span>
</td>
<td class="nump">1,966,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of prior warrants provided to Andrew Garrett, Inc. in connection with the Series B Unit offering, that were subsequently extended</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AdditionalNumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount company expects it will classify as the fair market value at the time the warrants are issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_AmountCompanyExpectsItWillClassifyAsFairMarketValueAtDateOfWarrantsIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ClassOfWarrantOrRightTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ClassOfWarrantOrRightTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Aggregate Number of Shares Issued upon Conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_ConvertiblePreferredStockAggregateNumberOfSharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental fair market value adjustments of modified warrants issued to placement agent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_IncrementalFairMarketValueAdjustmentsOfModifiedWarrantsIssuedToPlacementAgent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-accountable expense allowance fee to agent expressed as percentage of aggregate sales price of the Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NonaccountableExpenseAllowanceCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of prior warrants provided to Andrew Garrett, Inc. from the company's common stock offering completed in 2010, that were subsequently extended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfPriorWarrantsProvidedToConsultantExtendedUnderAdvisoryAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_NumberOfUnitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Units Sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_NumberOfUnitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission fee to agent expressed as percentage of aggregate sales price of the Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_RegistrationPaymentArrangementCommissionPercentagExpressedAsPercentageOfAggregateSalesPriceOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_RegistrationPaymentArrangementCommissionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Managment fee percentage commission to agent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_RegistrationPaymentArrangementCommissionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow resulting from the sale of an interest in a corporate unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInterestInCorporateUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AgreementWithPlacementAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=igap_PlacementAgentWarrantsTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_SaleAgreementAxis=igap_InitialClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_SaleAgreementAxis=igap_InitialClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_SaleAgreementAxis=igap_SecondClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_SaleAgreementAxis=igap_SecondClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementByArrangementAxis=igap_AprilTwoThousandSixteenOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6744144928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 181,461<span></span>
</td>
<td class="nump">$ 205,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in progress</a></td>
<td class="nump">412,000<span></span>
</td>
<td class="nump">551,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td>
<td class="nump">104,709<span></span>
</td>
<td class="nump">59,467<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 698,170<span></span>
</td>
<td class="nump">$ 816,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6769528192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING (INCOME) EXPENSES, NET (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders', window );">Israeli CPI linkage difference on principal of loans from stockholders</a></td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
<td class="num">$ (639)<span></span>
</td>
<td class="num">$ (1,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Exchange rate differences</a></td>
<td class="nump">19,296<span></span>
</td>
<td class="nump">90,872<span></span>
</td>
<td class="nump">24,211<span></span>
</td>
<td class="nump">38,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of Warrants with down round protection</a></td>
<td class="num">(20,702)<span></span>
</td>
<td class="num">(25,539)<span></span>
</td>
<td class="num">(64,212)<span></span>
</td>
<td class="num">(91,309)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expenses on credit from banks and other</a></td>
<td class="nump">6,149<span></span>
</td>
<td class="nump">5,788<span></span>
</td>
<td class="nump">8,575<span></span>
</td>
<td class="nump">8,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_GainLossOnUnitConversion', window );">Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">497,674<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,270,971<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_igap_FinancingIncomeExpensesNet', window );">Financing (income) expenses, net</a></td>
<td class="nump">$ 5,568<span></span>
</td>
<td class="nump">$ 570,603<span></span>
</td>
<td class="num">$ (32,065)<span></span>
</td>
<td class="nump">$ 1,224,437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_FinancingIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Income (Expenses), Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_FinancingIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_GainLossOnUnitConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) resulting from a unit conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_GainLossOnUnitConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Linkage difference on principal of loans from stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igap_LinkageDifferenceOnPrincipalOfLoansFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780866240">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,588,998)<span></span>
</td>
<td class="num">$ (1,666,806)<span></span>
</td>
<td class="num">$ (2,815,762)<span></span>
</td>
<td class="num">$ (3,201,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividend</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Loss for the period attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,745,387)<span></span>
</td>
<td class="num">$ (1,795,886)<span></span>
</td>
<td class="num">$ (3,099,671)<span></span>
</td>
<td class="num">$ (3,434,168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Number of shares:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Common shares used in computing Basic income (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">5,441,253<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
<td class="nump">5,382,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Common shares used in computing Diluted income (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,742,468<span></span>
</td>
<td class="nump">5,441,253<span></span>
</td>
<td class="nump">5,716,566<span></span>
</td>
<td class="nump">5,382,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total weighted average number of common shares related to outstanding convertible preferred stock, options and warrants excluded from the calculations of diluted loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,210,613<span></span>
</td>
<td class="nump">9,537,309<span></span>
</td>
<td class="nump">11,220,345<span></span>
</td>
<td class="nump">9,367,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividend</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (4,753)<span></span>
</td>
<td class="num">$ (26,522)<span></span>
</td>
<td class="num">$ (9,453)<span></span>
</td>
<td class="num">$ (47,036)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Stock dividend</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(131,281)<span></span>
</td>
<td class="num">(102,558)<span></span>
</td>
<td class="num">(254,101)<span></span>
</td>
<td class="num">(185,795)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C 5.5% Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Stock dividend</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (20,355)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (20,355)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">All outstanding convertible Preferred Stock, stock options and warrants have been excluded from the calculation of the diluted net loss per share for all the reported periods, because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>37
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>@"%,;X[)9J4@B,WHX*[O]C\ E!+ P04    " !QBP])>Q>T)50!  !8$
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M-R>N;&5]>TC]B$YN5?4%4$L#!!0    ( '&+#TF97)PC$ 8  )PG   3
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M8X.O3=5=/U>O'UW?U$O(>E47/Z?OX^GZ?9E^<6(.XP-P#L!; *AD@)P#Y%U
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M6+(N4T_1*EVDA10-@>)0\CB$@',&O.?Y<Z<3$F*+,<5#H$!4/!#!!>0UQO*
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MWR]:=E3FM-3GPNX_[87BEVD[?=_3;_\!4$L#!!0    ( '&+#TF4'#>-W ,
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MSG7=F=X=^=*+O)C\-%^4YMP-IU%_WDP?U]-%5]\>_Q7,?UCL_@-02P,$%
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MRR+6GDQ9Z,$)KN#)(#M(R<S'$80>#WB#+X5GWG8N%$A9D)E7<PG*<JV0@>:
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MS ^G,B BX#>'V6[V*'@_:_T6#C_;(\Z"!1#0N*# _'*!)Q B"/G$[XOF9\I
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M,R\;9YBD&6KCA.C>FU(52^%HOA,%^6!J9E#-KM9A9LZ\S)QA\F/0S*T&F\]
MKCJ8D3/HT3.GTLZYT2BGPZ::CQL&?X%BDN=0S5:#W?#(0XI.$"2#[0N<@,60
M6OV&FY*WNE_N@$Q$0N,@IY+-<3S5:X.=NM;=<#1@C#Y.#K_1X2!H-OY"GMZF
M\[^O-.O5I3C*/XOF>*[;X$-UG:K&,Z&#4IWLN47+7C0G6>P?-Z4\=,.EZ*^;
MZ11PNNG4Y7ZH^3A97?\'4$L#!!0    ( '&+#TE33WI=4 (   D'   9
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M<'"X%64[_GK;<]N)ZFHR\ZK\2UZ+>KQ>Y#]Q,)G!!G@RP#>#6QS8@$P&Y&Y
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M#;>LOV_D5P3YT(G3]:/([<O,ZC]02P,$%     @ <8L/282V%$[T 0  8 4
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M@4(4J:- GA_B(AP@#07 +D#J Y!D#9F[,IRF=TDV$!,8DM6^#"49P5D8!S_
MP2N<3WF(P\%>'@S-X4I"LMJ791DT3Q@G>X"3K7!0$"?S5R?!>5($<7Q95F"2
MAVG( QKBT13!/=@3+PLI-C /[FCMRS:0H"^_'O .PT O[!>5E[97T4%H<ZZF
M0W 60C,3+'DRI37FNEL&G)VU[>:F+]T-X 9:#/?[;+E4JW]02P,$%     @
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MY>"H5"5UINA)[^6SOIK>7U)YK.K'0#\7[66M?:G4I;M[WB_ JW]02P,$%
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MLZ28K9<,$QA1CP\<32*RIF0F&D4Y&)D))9$Q#.:OK%!(V]0)J6?O5B%+N&F
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M4$L! A0#%     @ <8L/24AU!>[%    *P(   L              ( !R $
M %]R96QS+RYR96QS4$L! A0#%     @ <8L/27L7M"54 0  6!   !H
M         ( !M@(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ <8L/22Q#QD)' @  Z0<  !               ( !0@0  &1O8U!R
M;W!S+V%P<"YX;6Q02P$"% ,4    " !QBP]).V-[*3\!  !I P  $0
M        @ &W!@  9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !QBP])
MF5R<(Q &  "<)P  $P              @ $E"   >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( '&+#TE-FVS94@(  %(+   -              "
M 68.  !X;"]S='EL97,N>&UL4$L! A0#%     @ <8L/20PA&;CQ @  , D
M  \              ( !XQ   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M '&+#TF(<LH52@(  (T'   8              "  0$4  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !QBP])(L"GUX4$  "?%0  &
M            @ &!%@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ <8L/20LR<B*U @  WPL  !@              ( !/!L  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( '&+#TF4'#>-W ,  #\0
M   8              "  2<>  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " !QBP])O:<&?*\#  "\$   &               @ $Y(@
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ <8L/22ZQ?'A(
M!   ^1(  !@              ( !'B8  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( '&+#TD^7%Y%,@(  .T&   8              "
M 9PJ  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !QBP])
M(6RTVZ$!  "Q P  &               @ $$+0  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ <8L/2>]-<EZB 0  L0,  !@
M     ( !VRX  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M '&+#TDQO&=[H@$  +$#   9              "  ;,P  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ <8L/2>N*C<2D 0  L0,  !D
M             ( !C#(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " !QBP]):CQL*J(!  "Q P  &0              @ %G-   >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( '&+#TD^2;TDHP$
M +$#   9              "  4 V  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ <8L/256AK)?0 0  X 0  !D              ( !
M&C@  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !QBP])
MZ/$5(;(!   6!   &0              @ $A.@  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( '&+#TF+J,TXI0$  +$#   9
M      "  0H\  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ <8L/2:/^Y+FE 0  L0,  !D              ( !YCT  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !QBP])PZ4&0*8!  "Q P
M&0              @ '"/P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( '&+#TG$='9P+P0  &45   9              "  9]!  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ <8L/25-/>EU0
M @  "0<  !D              ( !!48  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " !QBP])E$5%;SH#   2#@  &0
M@ &,2   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( '&+
M#TGYL)VOK@,  *41   9              "  ?U+  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ <8L/282V%$[T 0  8 4  !D
M         ( !XD\  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " !QBP]).!WO'<L"  "K"0  &0              @ $-4@  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( '&+#TG'V7Q#I0,   P/
M   9              "  0]5  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ <8L/2>GJ<P"-0@  -A4! !0              ( !ZU@
K 'AL+W-H87)E9%-T<FEN9W,N>&UL4$L%!@     B "( ( D  *J;      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>75</ContextCount>
  <ElementCount>143</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>21</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-daei1</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Statement-CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-csocfp</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-g</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-sosap</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - RECENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD</Role>
      <ShortName>RECENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-i</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - FINANCING (INCOME) EXPENSES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET</Role>
      <ShortName>FINANCING (INCOME) EXPENSES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-LOSSPERSHARE</Role>
      <ShortName>LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-sosapp</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-sosapt</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-sosap</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-it1</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-i</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables</Role>
      <ShortName>FINANCING (INCOME) EXPENSES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNET</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-LOSSPERSHARETables</Role>
      <ShortName>LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-LOSSPERSHARE</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/GeneralDetails</Role>
      <ShortName>GENERAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-g</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/SummaryOfSignificantAccountingPoliciesChangesInFairValueOfLevel3LiabilityDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Changes in Fair Value of Level 3 Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-sosapt</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/CommonStockPreferredStockAndWarrantsWith-downRoundProtectionScheduleOfWarrantInputsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Warrant Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-sosapt</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - RECENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/EventsDuringReportedPeriodDetails</Role>
      <ShortName>RECENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-EVENTSDURINGTHEREPORTEDPERIOD</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/igap-id</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/igap-it1</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - FINANCING (INCOME) EXPENSES, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETDetails</Role>
      <ShortName>FINANCING (INCOME) EXPENSES, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-FINANCINGINCOMEEXPENSESNETTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="igap-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integrity-app.com/role/Disclosure-LOSSPERSHAREDetails</Role>
      <ShortName>LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integrity-app.com/role/Disclosure-LOSSPERSHARETables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>igap-20160630.xml</File>
    <File>igap-20160630.xsd</File>
    <File>igap-20160630_cal.xml</File>
    <File>igap-20160630_def.xml</File>
    <File>igap-20160630_lab.xml</File>
    <File>igap-20160630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>43
<FILENAME>0001178913-16-006243-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-16-006243-xbrl.zip
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M,O'M8-OXYH0#=)O9IEG*AK#6UYMK'T#5VK)K+P!NV\GK*'BB6D>P=7A?<E0
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M.]>:3Q]B[)!B"Y?E!_Z%ZS\1#(.%1R\!?  " PB* MQB3^>*&.9@$F3P"0U
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M1#JR./-__!<!H@4:SI"Z^/LP02*F/_2K>!R+O8]J3L6L*W*5:T9@U\X!J<Z
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MN7?.8#RV)Y-]Y5 9&C0TN)D&A\.A/79>S[71/1K<4JF^GX.1<.(J]0>6S2V
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MU<#10HM(">?3;2:<C.U^?[+S?",\-XOYA"^DL+$)L_>E*A]%(+)1L&/P%<4
MG+Q9"*<N@"8QO'[P\.\^1]5G+B5(BXU!H[,H2W *_2@B?QB>X.0Q$:XP,LCP
M!=TXMS8:YRT2N^M.]9<\+F[*4UDY$<$X X-N'BYA>8LPES9O[92VJ[M;5VW"
MK**[R*T6<7?%OL)R%*3X0)JO$'2DC>%?2$+X_Z3Y/$+(>@B\E7/.50Q?^-8
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M2*R(B@ :5%$(WP>DV@=LP6X%Z#^XVL$M EDBLU/S5LKS?(O=$ @OEUU&&(#
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M!6QU_^+*Z@I5> U487JY[MK+M7DW:]^BH0:__.D=[E/X(_X+?_X_4$L#!!0
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M=V'?!R%J=Z'?MZQO/576W*XU6 KH'-!\)QPO.B&E9/P4T7IG)-3^:0"]@V?
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M^AGZ.+8*T"NLVQ\>XP&<KKW: $9O;O<!E=>@/&2?+ZM(P="'N(?#746!QEE
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M=_#FGCW[])Q+$Y*V3]O[=.]QP6E\-@$6:/OLOLEQ; &Z-1;7,DG83[^2#,2
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M<NQHU6I=Y>=$Y&=.AN3RKE#KR@_IG/W9&7^M0C@).EJ*2A%24.%#25,U#5*
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MS^$X?QYN=_R&@(GS U]8?.SC+H88!ZPY_23W)MUS63+@'*4@!-=?=NHGC2O
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MB?SJ<O4;_L<#H)#]Y/\ 4$L! A0#%     @ <8L/23XIMW2WBP  D\ & !$
M             ( !     &EG87 M,C Q-C V,S N>&UL4$L! A0#%     @
M<8L/23 ]J\ N#   26,  !$              ( !YHL  &EG87 M,C Q-C V
M,S N>'-D4$L! A0#%     @ <8L/2?*F[J!I#0  ^IH  !4
M ( !0Y@  &EG87 M,C Q-C V,S!?8V%L+GAM;%!+ 0(4 Q0    ( '&+#TD-
M_;**WQ@  #)_ 0 5              "  =^E  !I9V%P+3(P,38P-C,P7V1E
M9BYX;6Q02P$"% ,4    " !QBP])R#3&3X([   "$P, %0
M@ 'QO@  :6=A<"TR,#$V,#8S,%]L86(N>&UL4$L! A0#%     @ <8L/22 _
M:@#8)0  PD@" !4              ( !IOH  &EG87 M,C Q-C V,S!?<')E
:+GAM;%!+!08     !@ & (H!  "Q( $    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
